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A B S T R A C T 
The oxygen free radicals, . although made as 
byproducts of normal oxygen dependent reactions, 
nevertheless have a wide potential for causing cell 
injury. The damage to DNA caused by reactive oxygen 
species (ROS) is known to be mutagenic and probably 
represents a major natural hazard for the genomic 
stability of living cells. Among the ROS that are likely 
to be generated inside cells, hydroxyl radicals ('OH) are 
the most reactive. Due to its extreme reactivity, an 
hydroxyl radical can attack virtually any target molecule 
it encounters. The hydroxyl radicals are formed in 
biological systems via ionizing radiation or through the 
Haber-Weiss or Fenton reactions. A major portion of the 
toxicity of hydrogen peroxide in living cells is 
attributed to DNA damage mediated by a Fenton reaction in 
which a reduced metal bound to DNA is oxidized by 
hydrogen peroxide to form thc2 hydroxyl radical. The 
radical generated at the metal binding site attacks DNA 
at either the sugar or the base, leading to 
conformational changes, single stranded breaks and the 
formation of altered bases. 
In the present study, aqueous solutions of calf 
thymus DNA and its fragments of 3 00 bp were exposed to 
hydrogen peroxide in presence of ultraviolet light (254 
nm). Double helical DNA fragments were prepared by brief 
digestion of calf thymus DNA with micrococcal and SI 
nucleases followed by fractionation on Sepharose 4B; 
their double strandedness was confirmed by Tm 
measurement. The chemical alterations in DNA mediated by 
hydroxyl radical were detected by UV spectroscopy, 
thermal denaturation studies, fluorescence intensity 
measurements, sedimentation in alkaline sucrose density 
gradient and by nuclease SI sensitivity. The irradiated 
nucleic acid samples in the presence of hydrogen peroxide 
showed a significant increase in absorbance at 2 60 nm as 
compared to corresponding unmodified conformers, thereby 
reflecting the presence of single stranded regions in the 
treated DNA. 
The Tm of ROS-DNA was found to be 7 6°C whereas, 
native DNA showed a Tm of 89°C. The onset of melting was 
around 40°C for ROS-DNA in contrast to native DNA wherein 
absorption at 260 nm changed abruptly when a critical 
degree of denaturation was reached, suggesting a 
cooperative transition phenomenon. A net decrease of 13°C 
in the Tm value for ROS-DNA indicates a partial 
destruction of its secondary structure. Short DNA 
fragments of 300 bp irradiated in the presence of 
hydrogen peroxide also exhibited a decrease in Tm value 
by almost 8°C relative to its fully paired parent duplex 
DNA of 3 00 bp. 
The free energy of denaturation ( AGq°) of ROS-DNA 
was found to be 2.322 k.cal.deg"^ at 40°C which decreased 
to 0.969 k.cal.deg"^ at 68°C. The positive change in free 
energy and its distribution over a wide range of 
temperature speculates the presence of thermodynamically 
unfavourable structure in ROS-DNA. The disruption of 
Watson-Crick base pairing between the two strands was 
evident at relatively lower temperature (below 50°C). In 
contrast, native DNA displayed a tremendous stability of 
the duplex as there was sharp transition from the native 
to denatured state between 85°C to 87°C. 
Changes in physico-chemical characteristics of ROS-
DNA were reflected through sedimentation in alkaline 
sucrose density gradient. Decrease in molecular weight of 
ROS-DNA was observed as reflected by a change in 
sedimentation rate indicating possible DNA breakage. 
Polyacrylamide gel electrophoresis under denaturing and 
non-denaturing conditions showed severe degradation of 
DNA modified with hydroxyl radical. Fluorescence 
intensity measurements of ROS-DNA extracted from 
denaturing and non-denaturing acrylamide gels further 
reflected the presence of single stranded regions in 
modified DNA. The nuclease SI sensitivity of modified 
VIII 
polymer was also investigated. ROS-DNA was rapidly 
degraded by the enzyme; whereas native DNA and DNA 
hydrogen peroxide complex (without UV exposure) were 
resistant to nuclease SI digestion. 
In addition to the alterations within sugar 
phosphate backbone, hydroxyl radical was also found to 
induce DNA base modifications. Ion exchange 
chromatography on DEAE Sephadex A 25 column revealed the 
modification of thymine and adenine. Thymine was found to 
be modified to the extent of 54%, while adenine around 
20%. No modification was observed in cytosine and guanine 
residues. A similar distribution of base products was 
obtained with ROS-DNA fragments of 300 bp. In both the 
polymers, thymine was the preferred base for 
modification. 
The antigenicity of hydroxyl radical modified 
nucleic acid polymers was probed by inducing antibodies 
in both goat and rabbits. The repertoire of specificities 
of induced antibodies were evaluated by direct binding 
and inhibition ELISA. The ROS-DNA was a particularly 
potent immunizing stimulus, inducing high titre 
antibodies. Inhibition studies revealed nearly 87-*^  and 
89% inhibition in the antibody binding by ROS-DNA and 
ROS-DNA of 300 bp respectively. In addition to the 
immunogen, both the antibodies showed a considerable 
recognition of native DNA, thereby suggesting the 
recognition of an antigenic determinant commo.-'. to both 
modified and double stranded native DNA. 
The induced antibodies exhibited a broad spectrum of 
reactivity as indicated by their binding to a variety of 
nucleic acid antigens. Analysis of the purified 
antibodies revealed that antibody populations were 
present, which recognized native B-, A- and allied 
conformations of nucleic acids. The ROS-DNA binding of 
these antibodies was specifically inhibited by heat 
denatured DNA. A significant portion of the anti-ROS DNA 
antibodies also recognized poly(rG). poly(dC', a polymer 
VIII 
known to attain A-/analogous conformation, indicating 
that some features of A- helix are present in ROS-DNA 
antigen. Inability to show binding with single stranded 
homopolymers (poly dA, poly dT, poly dG, poly dC) 
suggested that linear deoxyribose phosphate backbone was 
relatively unimportant to binding by immunized 
antibodies. An efficient binding of anti-ROS DNA antibody 
population was observed with various synthetic 
polydeoxyribonucleotides. All the polynucleotides had 
nearly equivalent inhibitory activity producing a 50% 
inhibition at 5.0 ug/ml. These results imply that for the 
synthetic polynucleotides, the sugar phosphate backbone 
was relevant to the antigenic determinant of the anti-ROS 
DNA antibodies. 
Quantitative precipitation reactions revealed a high 
affinity of anti-ROS DNA antibodies. The affinity 
constant of immune IgG for ROS-DNA was in the order of 
1.142 X 10~® M. Interaction between immunized antibodies 
and modified DNA antigens. of short stretches (300 bp) 
were facilitated by gel retardation assay. These results 
reiteriated the formation of immune complexes between 
induced antibodies and modified fragments. Besides the 
modified antigen, a specific binding was observed to 
native DNA fragments suggesting the existence of cross 
reactive epitopes between native and modified DNA. 
The contribution of lysine residues to the 
immunochemical reactivity of anti-ROS DNA antibodies was 
investigated by modifying the free amino groups of lysine 
residues with acetic anhydride. The modification of 
lysine residues paralleled loss in antibody activity to 
the extent of 50%, suggesting that such residues might be 
involved in the antigen binding site of the 
immunoglobulin molecule. 
In the present work, twelve sera from patients with 
SLE were tested for antibodies directed against native 
and ROS-DNA. Such antibodies were found in ten out of 
twelve SLE patients with various titres. Specificity for 
VIII 
antigenic determinants on DNA was assessed by direct and 
inhibition ELISA assays. In a direct assay, each antibody 
bound ROS-DNA in preference to double stranded DNA with 
variation of about 3 fold. This preference was confirmed 
by inhibition ELISA indicating that the concentration of 
double stranded DNA required for 50% inhibition was 2.5 
to 50 times greater than that of ROS-DNA. 
The size of antigenic determinant recognized by the 
antibodies was assessed by analysis of binding with 
increasing chain length (50 - 800 bp) of DNA fragments. 
Experiments using fractions of narrow size distribution 
showed that inhibition of ROS-DNA and native DNA binding 
by SLE antibodies required a stretch greater than 4C bp. 
The smallest reactive fragments were between 50-70 bp in 
length. There was a transition to markedly increased 
antibody binding with fractions between 200-3 00 cp in 
size. In addition, the apparent antibody affinity on the 
basis of 50% inhibition in antibody binding shv -Jd that 
ROS-DNA fragments were manifold mere efficient inhibitors 
than unmodified fragments. The quantitative precipitin 
reactions exhibited high specificity of SLE IgG for ROS-
DNA. The affinity constants of SLE IgG for native and 
modified fragments were in the order of 4.07 x 10""® M and 
6.26 X 10~® M, respectively. The increase in case of 
modified fragments was approximately 1.53 fold 
In conclusion, hydrogen peroxide in the presence of 
short wavelength UV light was able to induce alterations 
in the physico-chemical characteristics of nati'^ 'e •DN^ and 
its fragments of 300 bp, thereby rendering it immunogenic 
in experimental animals. The immunized antibodies were 
specific for ROS-DNA but, showed considerable binding to 
native DNA as well. Specificity analysis of the purified 
antibodies also revealed the recognition of native B-, A-
and allied conformations presented by various synthetic 
polynucleotides. More specifically, ROS-mediated attack 
resulted in increased binding of anti-DNA autcar.tibo .ies 
to ROS-DNA as compared to native DNA. Il.e&e res alts 
demonstrate that anti-DNA antibodies can be induced by 
ROS-DNA and that some of autoimmune DNA binding 
antibodies found in SLE may result from response to 
reactive oxygen species. 
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A B S T R A C T 
The oxygen free radicals, although made as 
byproducts of normal oxygen dependent reactions, 
nevertheless have a wide potential for causing cell 
injury. The damage to DNA caused by reactive oxygen 
species (ROS) is known to be mutagenic and probably 
represents a major natural hazard for the genomic 
stability of living cells. Among the ROS that are likely 
to be generated inside cells, hydroxyl radicals ('OH) are 
the most reactive. Due to its extreme reactivity, an 
hydroxyl radical can attack virtually any target molecule 
it encounters. The hydroxyl radicals are formed in 
biological systems via ionizing radiation or through the 
Haber-Weiss or Fenton reactions. A major portion of the 
toxicity of hydrogen peroxide in living cells is 
attributed to DNA damage mediated by a Fenton reaction in 
which a reduced metal bound to DNA is oxidized by 
hydrogen peroxide to form the hydroxyl radical. The 
radical generated at the metal binding site attacks DNA 
at either the sugar or the base, leading to 
conformational changes, single stranded breaks and the 
formation of altered bases. 
In the present study, aqueous solutions of calf 
thymus DNA and its fragments of 3 00 bp were exposed to 
hydrogen peroxide in presence of ultraviolet light (254 
nm). Double helical DNA fragments were prepared by brief 
digestion of calf thymus DNA with micrococcal and SI 
nucleases followed by fractionation on Sepharose 4B; 
their double strandedness was confirmed by Tm 
measurement. The chemical alterations in DNA mediated by 
hydroxyl radical were detected by UV spectroscopy, 
thermal denaturation studies, fluorescence intensity 
measurements, sedimentation in alkaline sucrose density 
gradient and by nuclease SI sensitivity. The irradiated 
nucleic acid samples in the presence of hydrogen peroxide 
showed a significant increase in absorbance at 260 nm as 
compared to corresponding unmodified fconformers, thereby 
reflecting the presence of single stranded regions in the 
treated DNA. 
The Tm of ROS-DNA was found to be 76°C whereas, 
native DNA showed a Tm of 89°C. The onset of melting was 
around 4 0°C for ROS-DNA in contrast to native DNA wherein 
absorption at 260 nm changed abruptly when a critical 
degree of denaturation was reached, suggesting a 
cooperative transition phenomenon. A net decrease of 13°C 
in the Tm value for ROS-DNA indicates a partial 
destruction of its secondary structure. Short DNA 
fragments of 300 bp irradiated in the presence of 
hydrogen peroxide also exhibited a decrease in Tm value 
by almost 8°C relative to its fully paired parent duplex 
DNA of 3 00 bp. 
The free energy of denaturation ( AGp®) of ROS-DNA 
was found to be 2.322 k.cal.deg"^ at 40°C which decreased 
to 0.969 k.cal.deg"^ at 68°C. The positive change in free 
energy and its distribution over a wide range of 
temperature speculates the presence of thermodynamically 
unfavourable structure in ROS-DNA. The disruption of 
Watson-Crick base pairing between the two strands was 
evident at relatively lower temperature (below 50°C). In 
contrast, native DNA displayed a tremendous stability of 
the duplex as there was sharp transition from the native 
to denatured state between 85°C to 87°C. 
Changes in physico-chemical characteristics of ROS-
DNA were reflected through sedimentation in alkaline 
sucrose density gradient. Decrease in molecular weight of 
ROS-DNA was observed as reflected by a change in 
sedimentation rate indicating possible DNA breakage. 
Polyacrylamide gel electrophoresis under denaturing and 
non-denaturing conditions showed severe degradation of 
DNA modified with hydroxyl radical. Fluorescence 
intensity measurements of ROS-DNA extracted from 
denaturing and non-denaturing acrylamide gels further 
reflected the presence of single stranded regions in 
modified DNA. The nuclease SI sensitivity of modified 
VIII 
polymer was also investigated. ROS-DNA was rapidly 
degraded by the enzyme; whereas native DNA and DNA 
hydrogen peroxide complex (without UV exposure) were 
resistant to nuclease SI digestion. 
In addition to the alterations within sugar 
phosphate backbone, hydroxyl radical was also found to 
induce DNA base modifications. Ion exchange 
chromatography on DEAE Sephadex A 25 column revealed the 
modification of thymine and adenine. Thymine was found to 
be modified to the extent of 54%, while adenine around 
20%. No modification was observed in cytosine and guanine 
residues. A similar distribution of base products was 
obtained with ROS-DNA fragments of 300 bp. In both the 
polymers, thymine was the preferred base for 
modification. 
The antigenicity of hydroxyl radical modified 
nucleic acid polymers was probed by inducing antibodies 
in both goat and rabbits. The repertoire of specificities 
of induced antibodies were evaluated by direct binding 
and inhibition ELISA. The ROS-DNA was a particularly 
potent immunizing stimulus, inducing high titre 
antibodies. Inhibition studies revealed nearly 87% and 
89% inhibition in the antibody binding by ROS-DNA and 
ROS-DNA of 300 bp respectively. In addition to the 
immunogen, both the antibodies showed a considerable 
recognition of native DNA, thereby suggesting the 
recognition of an antigenic determinant common to both 
modified and double stranded native DNA. » 
The induced antibodies exhibited a broad spectrum of 
reactivity as indicated by their binding to a variety of 
nucleic acid antigens. Analysis of the purified 
antibodies revealed that antibody populations were 
present, which recognized native B-, A- and allied 
conformations of nucleic acids. The ROS-DNA binding of 
these antibodies was specifically inhibited by heat 
denatured DNA. A significant portion of the anti-ROS DNA 
antibodies also recognized poly(rG). poly(dC), a polymer 
VIII 
known to attain A-/analogous conformation, indicating 
that some features of A- helix are present in ROS-DNA 
antigen. Inability to show binding with single stranded 
homopolymers (poly dA, poly dT, poly dG, poly dC) 
suggested that linear deoxyribose phosphate backbone was 
relatively unimportant to binding by immunized 
antibodies. An efficient binding of anti-ROS DNA antibody 
population was observed with various synthetic 
polydeoxyribonucleotides. All the polynucleotides had 
nearly equivalent inhibitory activity producing a 50% 
inhibition at 5.0 ug/ml. These results imply that for the 
synthetic polynucleotides, the sugar phosphate backbone 
was relevant to the antigenic deteinninant of the anti-ROS 
DNA antibodies. 
Quantitative precipitation reactions revealed a high 
affinity of anti-ROS DNA antibodies. The affinity 
constant of immune IgG for ROS-DNA was in the order of 
1.142 X 10~® M. Interaction between immunized antibodies 
and modified DNA antigens. of short stretches (300 bp) 
were facilitated by gel retardation assay. These results 
reiteriated the formation of immune complexes between 
induced antibodies and modified fragments. Besides the 
modified antigen, a specific binding was observed to 
native DNA fragments suggesting the existence of cross 
reactive epitopes between native and modified DNA. 
The contribution of lysine residues to the 
immunochemical reactivity of anti-ROS DNA antibodies was 
investigated by modifying the free amino groups of lysine 
residues with acetic anhydride. The modification of 
lysine residues paralleled loss in antibody activity to 
the extent of 50%, suggesting that such residues might be 
involved in the antigen binding site of the 
immunoglobulin molecule. 
In the present work, twelve sera from patients with 
SLE were tested for antibodies directed against native 
and ROS-DNA. Such antibodies were found in ten out of 
twelve SLE patients with various titres. Specificity for 
VIII 
antigenic determinants on DNA was assessed by direct and 
inhibition ELISA assays. In a direct assay, each antibody 
bound ROS-DNA in preference to double stranded DNA with 
variation of about 3 fold. This preference was confirmed 
by inhibition ELISA indicating that the concentration of 
double stranded DNA required for 50% inhibition was 2.5 
to 50 times greater than that of ROS-DNA. 
The size of antigenic determinant recognized by the 
antibodies was assessed by analysis of binding with 
increasing chain length (50 - 800 bp) of DNA fragments. 
Experiments using fractions of narrow size distribution 
showed that inhibition of ROS-DNA and native DNA binding 
by SLE antibodies required a stretch greater than 40 bp. 
The smallest reactive fragments were between 50-70 bp in 
length. There was a transition to markedly increased 
antibody binding with fractions between 200-300 bp in 
size. In addition, the apparent antibody affinity on the 
basis of 50% inhibition in antibody binding showed that 
ROS-DNA fragments were manifold more efficient inhibitors 
than unmodified fragments. The quantitative precipitin 
reactions exhibited high specificity of SLE IgG for ROS-
DNA. The affinity constants of SLE IgG for native and 
modified fragments were in the order of 4.07 x 10~® M and 
6.26 X 10~® M, respectively. The increase in case of 
modified fragments was approximately 1.53 fold. 
In conclusion, hydrogen peroxide in the presence of 
short wavelength UV light was able to induce alterations 
in the physico-chemical characteristics of native •DNA and 
its fragments of 300 bp, thereby rendering it immunogenic 
in experimental animals. The immunized antibodies were 
specific for ROS-DNA but, showed considerable binding to 
native DNA as well. Specificity analysis of the purified 
antibodies also revealed the recognition of native B-, A-
and allied conformations presented by various synthetic 
polynucleotides. More specifically, ROS-mediated attack 
resulted in increased binding of anti-DNA autoantibodies 
to ROS-DNA as compared to native DNA. These results 
demonstrate that anti-DNA antibodies can be induced by 
ROS-DNA and that some of autoimmune DNA binding 
antibodies found in SLE may result from response to 
reactive oxygen species. 
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1 I N T R O D U C T I O N 
The native form of double stranded DNA is a polymer 
formed by two polydeoxyribosephosphate backbones that 
spiral around the centrally situated purine and 
pyrimidine bases and is known as B-DNA. One of the 
significant developments in recent years is the awareness 
that the double helix has considerable conformational 
flexibility. DNA is no longer considered as a static 
molecule but rather a dynamic structure in which 
different conformations are in equilibrium with each 
other (Dickerson et al., 1982; Kennard, 1983; Rich et 
al., 1984; Pechenaya, 1993). Conformational diversity of 
the DNA helix appears to be used quite extensively by 
living organisms with regard to protein-DNA recognition 
and thus DNA function (Travers, 1989). In several cases 
DNA recognition by proteins seems to rely heavily - if 
not entirely - on DNA conformation and flexibility as 
opposed to base sequence per se (Otwinowski et al., 1988; 
Goodman and Nash, 1989). The generation of antibodies 
specific for unique conformations can provide sensitive 
and selective reagents that can measure the presence of 
specific conformation present as minor components in 
complex materials of biological origin (Stollar, 1986). 
1.1. Antigenicity of DNA 
Since the first reports of anti-DNA antibodies in 
sera of patients with systemic lupus erythematosus (SLE) 
in 1957, the immunogenicity of nucleic acids has received 
considerable attention, and one striking feature has 
emerged:,Although most nucleic acids are considered 
immunogenic, double stranded DNA of the B-conformation is 
not (Stollar, 1986) . Injecting this form of DNA into MRL 
mice, which develop a spontaneous form of lupus failed to 
elicit high double stranded DNA antibody levels (Hughes, 
1986). Normal animals immunized with DNA, show only 
limited antibody production which is almost exclusively 
directed to single stranded DNA (ss DNA) (Plescia et al., 
1964) . A decisive demonstration of experimental anti-DNA 
antibodies appeared only in 1960, in the form of 
antibodies to denatured (single stranded) DNA of T-even 
bacteriophage (Levine et al., 1960). The antibodies were 
directed to the modified bases of these phages. Quite 
different antibodies have been induced by immunization 
with helical nucleic acids, usually injected as complexes 
formed between helical synthetic polynucleotides and 
methylated bovine serum albumin (Stollar, 1973, 1975; 
Lacour et al., 1973). Although native DNA itself has not 
been immunogenic in this form, heat denatured DNA, 
synthetic homopolynucleotides, chemically modified DNA 
and certain helical synthetic polynucleotides have 
induced immune responses (Stollar, 1973, 1975, 1986, 
1989; Anderson et al., 1988). An important property of 
the resulting antibodies is that they generally do not 
cross react with native DNA. For example, antibodies to 
A-helical forms such as double stranded RNA or RNA-DNA 
hybrids have shown high selectivity for either of these 
forms of helix, and have served as reagents for the 
identification of the corresponding double stranded RNA 
helices in virus infected cells (Stollar and Stollar, 
1970; Ng et al. , 1983) or of annealed RNA-DNA hybrid in 
polytene chromosomes of Drosophila (Rudkin and Stollar, 
1977 ; Alcover et al., 1982 ; Bunsen et al. , 1982). 
Antibodies of high selectivity have been induced by left 
handed Z-DNA, and they provided the first identification 
of Z-DNA in chromosomes (Lafer et al., 1981a; Stollar, 
1986). Injection of histone-DNA complexes yielded some 
anti-histone but not anti-DNA antibodies (Stollar and 
Ward, 1970); nor did immunization with isolated 
nucleosomes induce anti-DNA antibodies (Einck et al., 
1982) . One of the polynucleotide antigen used by Lee et 
al. (1985) was poly(dT-dC).poly(dG-dA), a duplex DNA. A 
monoclonal antibody from animals immunized with this 
polymer gave a weak cross reaction with calf thymus DNA 
(Lee et al., 1985). A monoclonal IgM antibody selective 
for native DNA was obtained by Huang et al. (1985) from a 
mouse immunized with DNA and several different synthetic 
DNA analogues. Recently, injection of bacterial native 
DNA into normal mice induced antisera that bound native 
bacterial but not mammalian DNA (Gilkeson et al., 1989). 
Injection of BK virus into rabbits induced antibody to 
both native DNA and histone (Flaegstad et al., 1988). 
Some cracks in the apparent barrier to the 
experimental induction of anti-native DNA antibodies have 
come from detailed analysis of the response to 
deoxyribonucleotide-protein conjugates by Jacob and 
coworkers (1982, 1985). The majority of the antibodies 
induced in rabbits or rats were specific for denatured 
DNA. However, close examination revealed a much smaller 
population that reacted with native DNA (Jacob and Jacob, 
1985). Antibodies induced by 5-methylcytosine also 
include some population that react with a native circular 
XP12 phage DNA that is rich in 5--methylcytosine content 
(Adouard et al., 1985). 
1.2. Immunogenic Analogues of DNA 
1.2.1. Z-DNA 
A number of synthetic analogues of DNA have been of 
considerable interest as immunogens. Left handed Z-DNA 
has been a prominant example (Stollar, 1989). The Z-DNA 
helix differs from B-DNA in several structural features 
that render it highly immunogenic and easily 
distinguished from B-DNA by the antibodies it induces. 
The purine bases of Z-DNA are rotated into syn- rather 
than the anti-conformation of B-DNA (Wang et al., 1979). 
The pyrimidines flip over as well, but their turning is 
accompanied by rotation of the deoxyribose, so the anti-
configuration is maintained. With this alternating 
different geometry of adjacent bases, there are 
associated changes in the backbone geometry, the base 
stacking, and the orientation of the base pair axis to 
the fiber axis (Wang et al., 1979). 
Immunochemical studies have shown that Z-DNA is a 
powerful immunogen eliciting a highly specific antibody 
response (Lafer et al., 1981 a). Both polyclonal and 
monoclonal antibodies specific for Z-DNA have served as 
sensitive reagents for the detection of Z-epitopes by 
relatively simple antigen-antibody binding assay (Lafer 
et al., 1981 a; Malfoy et al., 1982; Pohl et al., 1982; 
Hanau et al., 1984; Zarling et al., 1984 a,b). Antibodies 
to Z-DNA have had major application in the search for 
naturally occurring Z-DNA. Antibodies have identified Z-
DNA sites in supercoiled plasmid and viral DNA's 
(Nordheim et al., 1982; Nordheim and Rich, 1983; Miller 
et al., 1983; Hagen et al., 1985) and have served to 
titrate the transition from the B-form to Z-form as a 
function of superhelical density (Nordheim et al., 1982) 
or counterion or polyamine concentration (Thomas et al., 
1988) . They have also been used to identify and isolate 
Z-DNA regions from a library of E^ . coli genomic DNA 
(Thomae et al., 1983; Hoheisel and Pohl, 1987). 
1.2.2. Right handed helical polynucleotides 
Certain right handed helical double stranded 
polydeoxyribonucleotides differ slightly from the average 
B-DNA helix and are immunogenic (beyond the adjuvant-
induced autoantibody expansion). They elicit antibodies 
that recognize the difference between them and native B-
DNA. Poly(dG).poly(dC) is an example of an immunogenic 
right handed helical polydeoxy-ribonucleotide. It has 
induced specific antibody in normal rabbits (Stollar, 
1970) and mice (Madaio et al., 1984) and a monoclonal 
antibody specific for this polymer has been described 
(Lee et al., 1984). Earlier studies using complement 
fixation assay indicated that rabbit anti 
poly(dG).poly(dC) sera reacted with the polymer, but not 
with native or denatured DNA, poly(dA-dT), double 
stranded RNA or DNA-RNA hybrid (Stollar, 1970). Extension 
of these experiments with a competitive radioimmunoassay, 
indicated the presence of some antibody that cross 
reacted with poly(G).poly(dC) or poly(G).poly(C), but 
there was still antibody specific for the 
poly(dG).poly(dC) (Lafer and Stollar, 1984). Lee and 
colleagues (1984) prepared a monoclonal antibody specific 
for poly(dG).poly(dC), it also distinguished this polymer 
completely from native DNA. At the same time, second 
monoclonal antibody to poly(dG).poly(dm5C) was prepared; 
it reacted with native DNA of phage XP12 (Lee et al., 
1984), which contains m5C residues in place of C (Ehrlich 
et al., 1975). This antibody did not react with native 
DNA from other sources. 
Other right handed helical DNA analogues have 
induced wea)r~responses. On immunization of rabbits with 
methylated BSA complexes of right handed poly(dG-dC), 
Lafer and Stollar (1984) and Zarling et al. (1984 a), 
noted the formation of some antibody specific for the 
right handed form of the polymer. It did not react with 
native E. coli DNA, native or denatured calf thymus DNA, 
poly(dG).poly(dC), or poly(dA-dT). A slightly stronger 
response was obtained on immunization of mice with 
poly(dG-dA).poly(dT-dC) (Madaio et al., 1984). A 
monoclonal antibody directed to this polymer bound to 
several polynucleotides immobilized on a solid phase, but 
showed greater selectivity in binding to competing 
nucleic acids in solution (Lee et al., 1985). Calf thymus 
DNA was a weak competitor. On the basis of the cross 
reactions it was proposed that the antibody straddles a 
backbone and interacts with bases in both grooves of the 
helix. 
Diekmann and Zarling (1987) found that the duplex of 
homopolymers, poly(dA).poly(dT) induced specific 
antibodies: these antibodies did not react with other 
synthetic polynuclegtides or with native DNA except for 
that of protozoal kinetoplast DNA regions, which contain 
sequences of oligo(A) on one strand and oligo(dT) on the 
other. These findings reflect the differences in 
structure between poly(dA).poly(dT) and B-helical DNA 
(Arnott et al., 1983) and the presence of varying 
configurations within naturally occurring DNA. 
1.2.3. Chemically modified DNA 
Chemically modified DNA is usually immunogenic. The 
first experimental anti-DNA system described, that of 
phage T4 DNA, provided an example of this activity 
(Levine et al., 1960). Later experiments emphasized the 
importance of the modified base for both immunogenicity 
and specificity (Gruenewald and Stollar, 1973). The same 
is true for modified bases that occur in ultraviolet 
treated (Seaman et al., 1972), photo-oxidized (Seaman et 
al., 1966) or alkylated DNA (Poirier, 1981; Sundquist et 
al., 1987; Muller and Rajewsky, 1980). Antibodies can be 
induced by immunization with methylated BSA complexes of 
the modified DNA, as with cisplatin modified DNA 
(Sundquist et al., 1987; Poirier, 1981) or with modified 
nucleosides or nucleotides conjugated to proteins (Muller 
and Rajewsky, 1980). As with antibodies induced by 
synthetic polynucleotides, those induced by modified DNA 
do not react with native B-helical DNA. 
1.3. Genotoxicity of Oxygen 
Naturally occurring compounds are probably far more 
important contributors to excessive genetic instability 
(Ames et al., 1987). An ever-present, potent genotoxicant 
that makes up one fifth of the earths atmosphere is 
molecular oxygen (O2). As a genotoxicant oxygen is 
unique, not only because it is indispensable for the 
production of metabolic energy in most eukaryotes, but 
also since the action of many other genotoxicants is 
thought to be mediated by oxygen toxicity (Joenje, 1989). 
From the cited literature it appears that Oj is a 
plausible candidate for being a driving force of 
processes that lead to spontaneous genomic instability. 
Thus, the genotoxicology of O2 and its metabolites is of 
fundamental interest to basic research on the etiology of 
aging and carcinogenesis (Ames, 1983; Strehler, 1986). 
Oxygen induced cellular damage is caused by the 
intracellular production of partial reduction products of 
oxygen, which are the chemically reactive species, 
superoxide (©2"), hydrogen peroxide (H2O2) and hydroxyl 
radical ("OH), in amounts that overwhelm the cellular 
defences (Hill, 1981; Halliwell, 1987; Halliwell and 
Gutteridge, 1989). These activated oxygen species, 
together with electronically excited form singlet oxygen 
(^Oj), are often loosely called "oxygen radicals", even 
though H2O2 and ^©2 are actually no free radical species, 
while ground state (triplet) molecular oxygen is in fact 
a biradical (Joenje, 1989; Halliwell and Gutteridge, 
1990) . 
Increased cellular production of reactive oxygen 
species (ROS) has been noticed under different stressing 
conditions, such as upon exposure to visible and 
ultraviolet light (Hoffmann and Meneghini, 1979 a; 
Parshad et al., 1978), ionizing radiation (Hart, 1972), 
during metabolism of certain compounds such as aromatic 
hydrocarbons (Lorentzen and TS'O, 1977), quinones (Nohl 
et al; 1986) and paraquat (Hassan and Fridovich, 1977). 
Under such circumstances lesions may be produced in 
important cellular components. Obviously the defence 
provided by cellular antioxidants may be overwhelmed and 
then undesirable reactions between oxygen species and 
cellular structures take place (Ames, 1983; Cerutti, 
1985; Simic, et al., 1988; Meneghini, 1988). It has been 
considered by many investigators that even at normal 
steady state concentration oxygen species may be 
continuously producing cumulative damage in specific 
targets (such as DNA) which may eventually lead to tissue 
degeneration (Figure 1). 
1.4. Generation of Radicals in Biosystems 
Free radicals of oxygen, can be generated in 
biosystems by three major processes (Simic et al., 1989). 
The types of oxy-radicals and some of their precursor 
peroxycompounds are shown in Table 1. 
1.4.1. Reduction of oxygen 
One electron reduction of oxygen leads to formation 
of superoxide radical (Farhataziz and Rodgers, 1987) 
©2 + e~ > O2" (1) 
The source of the electron may be endogeneous or 
exogeneous. Exogeneous chemical sources of that can 
conviniently be used to assess the genotoxic potential of 
this oxygen metabolite include (i) xanthine oxidase 
acting aerobically on xanthine or hypoxanthine, which 
produces a steady flux of Oj" (McCord and Fridovich, 
1968) and (ii) potassium superoxide (KO2), which 
dissolves in water with the liberation of superoxide 
anion radical. 
©2 + X/XQJ^ > 02" + products (2) 
Alternatively, the electron may originate from a 
"leaky" electron transport chain (Boveris et al., 1972; 
Loschen et al., 1974; Forman and Boveris, 1982; Nohl and 
Jordan, 1986). Damaged mitochondria may leak an electron 
via a semiquinone radical (Nohl et al. , 1986) of 
ubiquinone (UQ) (Land et al., 1971). 
O2 + 'UQ > 02~ + UQ (3) 
Indirect evidence (Karam and Simic, 1989) suggests, 
for example, that organic solvents such as carbon 
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Figure 1. Possible pathways fiar the induction of DNA damage by 
various reactive oxygen species. 
TABLE 1 
Classes of Oxy-Radicals and Related Oxygen Species 
Species Name Origin 
Triplet oxygen Stable atmospheric form 
Singlet oxygen ^Oj, Peroxidation 
RH Parent molecule Diverse 
R- Free radical RH 
ROO- Peroxy radical R-+02, ROOH 
H2L Linoleic acid Fats, membranes 
HL- Linoleic acid H2L 
radical 
HLOO- Linoleic acid HL-+02, HLOOH 
peroxy radical 
•O2H Hydroperoxy radical •O2- + H+ 
•02" Superoxide radical ©2 + e" 
•OH Hydroxyl radical H2O2, H2O 
H2O2 Hydrogen peroxide •02", Biogeneration 
RO- Alkoxy radical ROOH, ROOR 
HLO- Linoleic acid HLOOH + e~ 
alkoxy radical (e.g. Fe(II)) 
ROOH Hydroperoxide ROO', ^©2 
ROOR Peroxide Peroxidation 
0 
/ \ Epoxide Unsaturated ROO' or 
> c — c < ROO-
ROO Phenoxy radical Phenols, ROOH, phenolic 
antioxidants 
ArO- Aroxy radical Hydroxylated aromatics 
Source: Simic, M.G., Bergtold, D.S. and Karann, L.R. 
(1989) Mut. Res. 214, 3-12. 
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tetrachloride, ethanol and benzene may initiate reaction 
(3) . 
Once the superoxide radical is generated, it can 
recombine in a superoxide dismutase catalyzed reaction 
(Getzoff et al., 1983; Benovic et al., 1983) 
O2" + ©2" + > H2O2 + O2 (4) 
Reaction (4) is expected to be a predominant 
reaction in cells because the reactivity of 03" is very 
limited, excluding its reaction with cytochrome C. 
1.4.2. Reduction of peroxides 
Another significant source of oxy-radicals are 
endogeneously generated peroxides, i.e. hydrogen peroxide 
and hydroperoxides (ROOH). The peroxy compounds can be 
readily reduced by the well known Haber-Weiss reaction 
(Haber and Weiss, 1934) , in which ferrous iron and some 
of its complexes act as electron donors. 
H2O2 + Fe (II) > -OH + OH" + Fe (III) (5) 
ROOH + Fe (II) > RO- + OH" + Fe (III) (6) 
Reactions (5) and (6) are relatively fast (K - l-io'^ 
Sec~^) and do not require a high concentration of Fe 
(II) . 
1.4.3. Exogeneous agents 
Oxy-radicals may also be generated directly or 
indirectly by exogeneous agents or processes. The most 
thoroughly studied agents are ionizing radiations. 
Interaction of ionizing radiations with biosystems leads 
to ionization of biocomponents with yields roughly 
proportional to the mass fraction of each component 
(Farhataziz and Rodgers, 1987). 
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Water is the major component of most biosystems and 
is split into hydroxy radicals in two steps (Repine et 
al., 1981). The first step, 
2° > «2< HoO > H^ O'"*" + e (7) 
is followed by rapid deprotonation 
+ HjO > -OH + HjO"^ (8) 
Direct ionization of biocomponents results in generation 
of a variety of bioradicals, 
Bio > •Bio'*' + e" (9) 
•Bio'^ > -Bio (-H) + H"^  (10) 
The 'Bio (-H) radicals may be S-, 0-, N-, and C-centered 
or highly resonant hetero cyclic radicals. 
1.5. Cellular Defences 
In general, aerobic cells are capable of reducing 
oxygen to water without the formation of intermediates. 
The enzyme responsible for this process is the copper 
containing cytochrome oxidase, whose mechanism of action 
is still poorly understood. However, a small fraction of 
cellular dioxygen is reduced by monovalent steps, with 
the concomitant production of the intermediate oxygen 
species (Hill, 1981; Halliwell, 1987; Halliwell and 
Gutteridge, 1989; Simic et al., 1989). The hydroxyl 
radical is specially reactive, attacking virtually any 
organic compound with kinetics which are close to 
diffusion limited processes (Scholes, 1983; Hutchinson, 
1985; Buxton et al., 1988; Halliwell and Gutteridge, 
1986). The reason why monoelectronic reduction occurs in 
the cell is not well understood. Investigations have 
shown that microsomal metabolism of certain compounds, 
like alcohol, may require 'OH radical as oxidant (Klein 
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et al., 1983). The possibility of a physiological role 
for the reactive intermediates of oxygen reduction is 
well exemplified by the controlled production of Oj" by 
the NADPH oxidase bound to membranes of phagocytic cells 
(Jones, 1985; Yusa et al., 1984; Patton et al., 1980; 
Peskin and Shlyahova, 1986); this enzyme is known to play 
an important role in the killing of invading 
microorganisms (Michell, 1984). Several enzymes are 
known to reduce dioxygen into 03" and /or H2O2 (Halliwell 
and Gutteridge, 1984; Sanderson and Morley, 1986; Gupta 
and Bhattacharjee, 1988; Laval, 1988; Shadley and Wolff, 
1987; Spitz et al., 1988; Keizer et al., 1988; 
Schraufstatter et al., 1988). However, the accumulation 
of these species in the cell would certainly be 
deleterious and has to be prevented. The cells are 
equipped with enzymatic and non-enzymatic mechanisms for 
this task. Superoxide dismutase (SOD), are enzymes 
widely distributed in aerobic organisms, which accelerate 
the dismutation of (Fridovich, 1978; Diguiseppi and 
Fridovich, 1984; Aust et al., 1985; Halliwell and 
Gutteridge, 1986). 
Superoxide 
2H"'" + 202~ > H2O2 + O2 (4) 
dismutase 
Hydrogen peroxide itself is not risk free; its 
decomposition is catalyzed by catalase and its reduction 
by glutathione peroxidase: 
Catalase 
2 HjOj > 2H2O + O2 (11) 
Glutathione 
H2O2 + 2 RH > R-R + 2H2O (12) 
peroxidase 
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since reactions of 'OH radicals with organic 
compounds exhibit kinetics close to diffusion limited 
processes, it is not feasible to scavenge this species by 
means of an enzymatically catalyzed reaction (Halliwell 
and Gutteridge, 1986; Halliwell and Gutteridge, 1988; 
Czapski and Goldstein, 1986; Czapski, 1984; Borg and 
Schaich, 1984). Antioxidant compounds, may, however, 
provide such scavenging action due to the high rate 
constant of their reactions with hydroxyl radical. The 
simultaneous action of antioxidant enzymes and 
antioxidant small molecular weight compounds (like 
glutathione, ascorbic acid and vitamin E) constitute the 
first line of defence against the reactive oxygen 
species(Ketterer et al., 1983, 1988; Tan et al., 1986, 
1988; Ketterer and Meyer, 1989; Halliwell and Gutteridge, 
1984; Meneghini, 1988). 
1.6. Cellular Generation of Oxygen Free Radicals with 
Relevance to DNA 
The characterization of cell damage caused by oxygen 
species has been complicated both by the variety of 
direct and indirect effects observed and by the diversity 
of oxidative stresses that have been used. Because the 
cell is particularly sensitive to DNA damage, genetic and 
physical effects of oxidative stresses upon cellular DNA 
are well documented (Imlay and Linn, 1988; Imlay et al., 
1988; Blakely et al., 1990; Fiorani et al., 1990; Mello-
Filho et al., 1984; Mello-Filho and Meneghini, 1984; 
Schaufstatter et al., 1986 b; Joenje, 1989; Chaudhuri et 
al., 1992). When DNA is exposed to a hydrogen peroxide 
solution, no modification of molecular weight occurs 
(Hoffmann and Meneghini, 1979 b) . If instead DNA is 
exposed to a source of O2", strand breaks are observed. 
However, catalase fully protects DNA from the O2" action 
(Lesko et al., 1980; Brawn and Fridovich, 1981; Mello-
Filho and Meneghini, 1985). These results can be 
explained if O2" and H2O2, produced from O2" by 
14 
spontaneous dismutation, are simultaneously required for 
strand break production. The chemical process which 
better expresses these requisites is the Haber-Weiss 
reaction (Haber and Weiss, 1934). 
H2O2 + O2" > 'OH + OH" + O2 (13) 
This reaction produces an 'OH radical which is the 
species that ultimately attacks DNA. In fact, if DNA is 
exposed to a source of Oj"" in the presence of an 'OH 
radical scavenger, no strand breaks are observed (Lesko 
et al., 1980; Brawn and Fridovich, 1981; Mello-Filho and 
Meneghini, 1985). Ethanol, mannitol, thiourea, benzoate 
and dimethyl sulphoxide are 'OH radical scavengers 
frequently used (Chapman and Gillespie, 1981; Misra and 
Fridovich, 1976; Gutteridge and Halliwell, 1982; 
Halliwell, 1978; Goldstein and Czapski, 1984). 
Reaction (13) is thermodynamically feasible but 
kinetically very slow unless certain transition metals 
are present (Halliwell, 1978; McCord and Day, 1978). Iron 
is an excellent catalyst and through its mediation 
reaction (13) can be understood as the sum of two other 
reactions 
O2" + > Fe2+ + O2 (14) 
Fe^ "*" + H2O2 > OH- + 0H~ + Fe^ "*" (15) 
Oj- + H2O2 > O2 + OH" + OH- (13) 
Reaction (13) has been known for a long time and is 
referred to as the Fenton reaction (Fenton, 1893). 
At least two other biological transition metals, 
copper and cobalt are Fenton reactants too (Samuni et 
al., 1983; Moorhouse et al., 1985; Gutteridge and 
Halliwell, 1982; Goldstein and Czapski, 1986; Nackerdien 
et al., 1991). Most of the biological copper is bound to 
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proteins, like ceruloplasmin and albumin, or to amino 
acids, in which form it may participate in the Fenton 
reaction and the resultant 'OH radical may attack the 
ligand to which the copper is bound (Czapski, 1984). 
1.7. Structural Alterations Produced in DNA by Reactive 
Oxygen Species 
It has been known for a long time that reactive 
oxygen species produce DNA damage (Rhaese and Freese, 
1968). Apparently 03" and H2O2 alone cannot oxidize DNA 
(Lesko et al., 1980, 1982; Brawn and Fridovich, 1981; 
Mello-Filho and Meneghini, 1985; Lafleur et al., 1988). 
The hydroxyl rad^ical is a powerful DNA oxidant but has a 
very short lifetime (T<1 ns) and cannot be detected or 
monitored directly. Most of the knowledge about "OH 
radicals (kinetics and mechanisms) has been obtained by 
pulse radiolysis (Farhataziz and Rodgers, 1987) of 
simplified model systems. 
Inspite of their versatile reactivity, the reactions 
of 'OH radicals with biomolecules can be generalized. 
Hydroxyl radicals abstract H-atoms from C-H and S-H bonds 
or they add to double bonds and aromatic nuclei (benzene 
ring, purines, pyrimidines, etc.). 
1.7.1. Reactions with DNA bases 
DNA bases, being unsaturated molecules, give 
predominantly OH adducts, by addition of 'OH radical to 
double bonds. The products of X-radiolysis of thymine 
free base have been isolated and characterized and 
approximately 60% have been shown to be hydroperoxides 
(Teoule and Cadet, 1978; Simic and Jovanovic, 1986; 
Scholes, 1983). These are either products of the 
reaction of oxygen with radicals resulting from the 
addition of 'OH radical across the thymine hydroxy-
hydroperoxides or with the radical produced by hydrogen 
abstraction from the thymine 5-methyl group to give 5-
hydroperoxymethyl uracil (Schulte-Frohlinde and Von 
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Sonntag, 1985; Tofigh and Frenkel, 1989). The same 
radicals and presumably the same hydroxyperoxides are 
produced during radiolysis of single and double stranded 
DNA in vitro and double stranded DNA in vivo (Swinehart 
et al., 1974; Roti Roti and Cerutti, 1974; Dizdaroglu et 
al., 1991). Guanine generates four isomeric OH adducts 
(0' Neil, 1983; Simic and Jovanovic, 1986). Because of 
the high reactivity of 'OH radical and the high 
concentration of biomaterial in cells, reactions of 'OH 
with biomaterials are very difficult to prevent even by 
the most reactive 'OH radical scavengers. 
1.7.2. Reactions with deoxyribose 
All deoxyribose C-H bonds are highly reactive with 
•OH radical. There are numerous studies of this reaction 
for deoxyribose alone and a variety of nuclear materials 
(Von Sonntag, 1987). In nucleosides and polynucleotides, 
about 20% of 'OH radicals appear to react with 
deoxyribose. The exact percentage for DNA is not 
available, but it is not expected to be vastly different. 
Secondary reactions of the resulting deoxyribose 
centered radicals eventually cause the backbone to break, 
in essence by disintegration of the sugars themselves 
(Hertzberg and Dervan, 1984; Mello-Filho et al., 1984; 
Birnboim, 1982; Lewis and Adams, 1985; Frenkel et al., 
1986; Frenkel and Chrzan, 1987 a,b). 
1.8. Reactions of Hydroxy Radicals with Proteins 
Amino acids are highly reactive with 'OH radicals 
(Buxton et al., 1988) with K ~ 10® - 10^° M"^ Sec"^. 
Being the major non-aqueous constituent of organisms and 
cells, proteins, therefore, are the primary reactants 
with 'OH radicals in these systems. 
Phenylalanine, a relatively abundant (~4% in muscle 
tissue) and highly reactive amino acid, gives three 
isomeric products in the reaction with 'OH radical i.e. 
0 - , m- and p- tyrosine (Dizdaroglu and Simic, 1981). 
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since o- tyrosine cannot be detected in tissue at the 0.1 
ppm level (Hoskins and Davis, 1988; Karam and Simic, 
1988), it may be used as a specific biomarker of 'OH 
radical generation in vivo (Karam and Simic, 1988). 
1.9. Lipid Peroxidation and Amplification of Damage 
In contrast to the peroxidation of DNA components 
that result in one or two damaged sites per initial 
radical, peroxidation of lipids may generate multiple 
damage per initial radical (Kirkland, 1991) . This 
amplification of damage is achieved by shorter or longer 
chain reactions (Gutteridge, 1986, 1988; Halliwell and 
Gutteridge, 1985). However, it is doubtful that fatty 
acid peroxy radical would (i) escape the lipid 
environment (ii) diffuse to DNA without being activated 
by reducing biocomponents and (iii) react with DNA 
(Jovanovic and Simic, 1986; Simic et al., 1989). 
Hydroperoxides, on the other hand have been shown to 
damage cellular DNA (Biaglow et al., 1987) and may be a 
major component in clastogenic factors (Cerutti, 1985) 
responsible for cytotoxicity and genotoxicity. The 
mechanisms by which peroxidation processes damage DNA 
have not been determined, although certain mechanisms may 
be postulated. 
Hydroperoxides are precursors of alkoxy radicals 
e.g. linoleic alkoxy radical HLO' or in general RO'. 
Being more hydrophilic than the parent lipid molecule, 
hydroperoxides may enter the cytosol and diffuse to DNA. 
If alkoxy radicals are generated in the immediate 
vicinity of DNA, the highly reactive (Neta et al., 1983) 
alkoxy radical may damage DNA by H-atom abstraction from 
deoxyribose and by the addition to the bases, 
HLO- + DNA > -DNA (-H) + HLOH (16) 
> -DNA - DHL (17) 
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Reaction (16) would lead to a strand break, whereas 
reaction (17) would result in a damaged base (base 
adduct). 
1.10. Biological Responses to the Action of Oxygen 
Species on DNA 
A universal and immediate response to DNA damage is 
DNA repair. Given the appreciable specificity of the DNA 
repair systems and considering the relatively large 
spectrum of DNA lesions produced by oxygen species, 
several repair pathways are likely to be elicited when 
cells are exposed to such species (Sage, 1993; Imlay and 
Linn, 1986, 1988; Carlsson and Carpenter, 1980). In 
mammalian cells these repair pathways are ill 
characterized. Most of the repair studies have focused on 
single strand breaks (Bradley and Erickson, 1981; Wang et 
al., 1980; Cantoni et al., 1986) which in fact represent 
a mixture of different DNA structural modifications 
including direct phosphodiester breaks, breaks originated 
from chemical modifications in the deoxyribose rings, 
breaks which are generated in alkaline conditions by 
labilization of phosphodiester bonds adjacent to sites 
that lost the base, and finally breaks corresponding to 
repair intermediates brought about by repair 
endonucleases (Ananthaswamy and Eisenstark, 1977; Imlay 
and Linn, 1986; Carlsson and Carpenter, 1980; Meneghini, 
1988) . 
1.11. Mutations and Chromosome Alterations 
Inspite of a first line of defence, constituted by 
the antioxidants, and of a second line of defence, 
performed by repair enzymes, lesions produced by active 
oxygen species may still remain in DNA and produce 
chromosomal damage, cell killing, mutation and cell 
transformation (Meneghini and Hoffmann, 1980; Mello-Filho 
and Meneghini, 1984; Larramendy et al.,1987; Imlay et 
al., 1988; Cerutti, 1985; Goldstein and Witz, 1990). 
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While the mutagenicity of alkylated DNA bases 
induced by alkylating agents is well established, 
mutagenic properties of oxidatively altered bases have 
not been investigated comprehensively. Thymine glycol 
substitution in DNA does not seem to be mutagenic at low 
levels but seem to perturb polymerase activity (Hayes et 
al., 1988). 8-hydroxyguanine, on the other hand, appears 
to cause misreading of DNA sequences (Kuchino et al., 
1987) ; in addition to misreading of the 8-hydroxyguanine, 
pyrimidines next to it also are misread. 
Chromosome aberrations (CA) and sister chromatid 
exchanges (SCE) are induced by active oxygen species. 
There seems to be a correlation between these events and 
mutagenesis and carcinogenesis. Induction of CA and SCE 
have different requirements in terms of active oxygen 
species. Thus in HeLa cells H2O2 is sufficient to produce 
sister chromatid exchanges, but although necessary is not 
sufficient to produce chromosome aberrations (Estervig 
and Wang, 1984). This is in agreement with other studies 
which have shown that the system xanthine/xanthine 
oxidase produces SCE and CA in CHO cells and that they 
both are prevented by catalase but only CA is prevented 
by superoxide dismutase (Philips et al., 1984). It seems 
that DNA strand breaks produced by H2O2 may give rise to 
SCE whereas some other factor is required for CA. 
Perhaps ©2" is important because it participates in the 
formation of lipid peroxides in the membrane which could 
be somehow involved in the production of CA (Meneghini, 
1988) . 
1.12. Carcinogenesis 
Among the myraid reactions that participate in the 
many paths to clinically overt human cancer, there are 
certain reactions for which reasonable evidence exists to 
infer a role for free radicals. The most clear cut case 
is of radiation induced carcinogenesis. Free radical 
chemistry in biological systems was first worked out in 
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irradiated solutions, including interactions at the level 
of nucleic acids, DNA, the nucleus, whole cells and 
organisms. 
The use of transformation of cells in culture has 
been of paramount importance as an in vitro model of 
carcinogenesis. Although yet a complex system it has been 
possible to dissect in vitro malignant transformation 
into some operationally defined steps, in analogy to in 
vivo carcinogenesis. Two of these steps are initiation 
and promotion. It has become widely accepted that 
initiation of cell transformation involves mutagenic 
events in genes responsible for control of cell growth 
(Guerrero et al., 1984; Marshall et al., 1984). 
Promotion, on the other hand, is the phenomenon of 
enhancement of transformation of previously initiated 
cells by agents which per se are not necessarily 
carcinogenic, like phorbol myristate acetate (PMA). The 
importance of active oxygen species in both initiation 
and promotion has become increasingly appreciated in 
recent years (Ames, 1983). One very important discovery 
was that certain antioxidants can prevent the promotion 
process in several cell transformation system (Solanki et 
al., 1984; Goldstein et al., 1981; Kensler et al., 1983; 
Kennedy et al., 1984; Borek and Troll, 1983; Nakamura et 
al., 1985; Armato et al., 1984). In addition, free 
radical generating systems are promoters of cell 
transformation (Slaga et al., 1981; Zimmerman and 
Cerutti, 1984; Weitzman et al., 1985). 
1.13. Autoimmiinity 
The function of the immune system is to 
discriminate between self and non-self and mount 
responses to rid the body of potentially life threatening 
non-self, for example, viruses. However, this enormous 
recognition potential includes possible interactions with 
self components some of which appear to be essential for 
the regulation of immune function (Jerne, 1974), whereas 
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others can be pathogenic particularly if expressed at 
high levels. 
The potential for autoimmunity is present in normal 
individuals. Given the wrong circumstances, each 
individual can become autoimmune. Autoimmune disease is 
prevented because of the normal functioning of 
immunologic regulatory mechanisms. This regulation is 
mediated primarily by the interactions between various T 
lymphocyte subpopulations. Helper and suppressor T cells 
act together to establish an immunoregulatory balance, 
which, like a thermostat, determines the level of 
immunologic response to a particular antigen. A dis-
equilibrium resulting either in the generation of helper 
T cells, or in a deficiency of suppressor T cells, could 
trigger potentially autoreactive B cell clones to 
autoantibody production. Primary variations of the target 
organ can either be genetically determined changes of 
autoantigenic determinants or secondary alterations based 
on chemical, viral or other environmental influences. 
1.13.1. Self recognition 
Recognition of self is physiologic and 
fundamental to a network theory of immunologic control 
that is based upon interactions between idiotypes and 
membrane antigens related to the major histocompatibility 
complex (MHC). Among the MHC antigens, the la surface 
membrane components (products of immune response or Ir 
genes) are particularly essential for immunologic 
control. Self recognition far from being a forbidden 
event, now appears to be a major principle upon which the 
immune system is founded (Talal, 1981). 
Jerne (1974) proposed that immunologic regulation is 
mediated by a complementary network of membrane receptors 
which express idiotypic determinants of immunoglobulins. 
These idiotypes are individually unique antigenic regions 
on immunoglobulins which in general correspond 
functionally to the antibody combining sites. Idiotypes 
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are also present on the lymphocyte surface where they 
function as receptors for antigen. Idiotypic receptors 
exist on both B and T cells and interact with 
complementary anti-idiotypic structures on 
immunoglobulins and on lymphocyte membranes. The immune 
system is maintained in a complex state of homeostasis 
via this open ended network, until perturbed as by the 
introduction of foreign antigens. Table 2 shows the 
distinction between self recognition, autoimmunity and 
autoimmune disease. 
1.13.2. Etiology of autoimmune diseases 
Inspite of the enormous progress in the knowledge 
of the immune reaction, the cause of autoimmunity is 
still largely unknown. Many theories have been proposed 
to explain the origin of autoimmune response; for 
example, it has been postulated that immune responses 
against host antigens could result from genetic 
predisposition, exaggerated random B cell activity, cross 
reactivity between host and foreign antigens or 
modification of host proteins as a consequence of 
infection, inflammation, drug administration etc. (Davis 
et al., 1978; Koffler et al., 1971 a; Theofilopoulos and 
Dixon, 1985; Patel et al., 1986; Huang et al., 1988). 
Theories such as those invoking the release of previously 
sequestered antigens or the persistence of a forbidden 
clone have lost popularity since considerable data have 
accumulated suggesting that, at best, those theories 
could only apply to a very limited number of situations. 
1.13.3. Role of genetic factors 
It is well known that autoimmune diseases, in 
general, show a highly significant familial 
predisposition. Relatives of a patient with a given 
autoimmune diseases are known to be at high risk for 
developing the same disease, and the relevant 
autoantibodies are known to occur in a much higher 
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Table 2 
The Spectrxun of Response to Self* 
SELF-RECOGNITION >AUTOIMMUNITY >AUTOIMMUNE DISEASE 
Physiologic Pathologic Pathologic 
Idiotype network Potentially T cell disregulation 
reversible with decreased supp-
ression and increased 
help 
MHC antigens (la) Chronic Intrinsic polyclonal 
infections B cell activation 
Drug reactions Multifactorial-viral, 
hormonal 
Aging Strong genetic pre-
disposition 
Anti-receptor diseases 
Source: Talal, N. (1981) La Ricerca Clin. Lab. 11, 101-108, 
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frequency among patients relatives than in the general 
population (Arnett and Shulman, 1976; Hochberg, 1987; 
Arnett, 1992). The majority of genes which have been 
associated with autoimmune diseases map within the MHC of 
man, or HLA region. The MHC is comprised of three 
functionally distinct and polymorphic gene clusters: 
classes I, II and III. Most of the MHC associations with 
SLE, the prototype of autoimmune diseases, involve class 
II (HLA-DR and DQ alleles) and class III alleles 
especially null or deficiency alleles of the fourth 
component (C4) of complement (Goldstein and Arnett, 1987; 
Bias et al., 1986; Braun and Zachary, 1988; Deodhar, 
1992; Arnett and Moulds, 1991). 
1.13.4. T-helper/T-suppressor cell imbalance 
The immune response is controlled mainly by the 
regulatory influence of T-lymphocyte subsets, T-helper 
and T-suppressor cells. In normal individuals, the ratio 
of T-helper to T-suppressor cells in the peripheral blood 
tends to be approximately 2:1, whereas in almost all of 
the autoimmune diseases studied so far, this ratio is 
considerably greater, often approaching 10 or 15:1, 
particularly during the acute or active phase of the 
respective disease (Gray et al., 1987; Shivakumar et al., 
1989 ; Morimoto et al., 1987). In most autoimmune 
diseases, there is significant decrease in T-suppressor 
cell numbers and activity, and this accounts for the 
increased T-helper/T-suppressor ratio (Clough et al., 
1980; Fauci et al., 1978; Kumagai et al., 1981). 
1.13.5. Polyclonal B cell activation 
Polyclonal B cell activation has been proposed as 
one possible mechanism that may be responsible for the 
over-activation of B cells and production of 
autoantibodies in certain autoimmune diseases, 
particularly SLE (Dziarski, 1988; Klinman et al. , 1990; 
Steinberg et al., 1990; Steinberg, 1992). B cell hyper-
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responsiveness and polyclonal activation are significant 
in both SLE patients and animal models of SLE 
(Theofilopoulos and Dixon, 1985; Manny et al., 1979; 
Chused et al., 1987; Theofilopoulos et al., 1983; Jasin 
and Ziff, 1975; Budman et al., 1977). The sequence of 
events is postulated to be as follows: in autoimmune 
prone individuals, B cells are hyper-responsive to 
polyclonal activators and these B cells undergo initial 
activation, followed by expansion, including expansion of 
autoreactive clones, under the influence of exogeneous or 
endogeneous polyclonal activators (Tsokos and Balow, 
1984; Theofilopoulos and Dixon, 1981; Tsokos, 1992). 
1.13.6. Hormonal factors 
Autoimmune diseases occur far more commonly in 
females than do in males, with the ratio of female to 
male involvement often reaching 10:1 or greater in 
certain diseases (Inman, 1978; Talal, 1979) . There has 
been considerable evidence supporting the hypothesis that 
sex-related factors are involved in the pathogenesis of 
SLE (Steinberg et al., 1979; Dumont and Monier, 1983; 
Jungers et al., 1985; Talal and Ahmad, 1987; Talal, 1989; 
Carlsten et al., 1990; Counihan et al., 1991; Lahita, 
1992). It has been reported that testosterone and thymic 
hormones enhance CD8"^ T cell receptor function (Lahita 
and Kinkel, 1984), whereas estrogen may suppress this 
function (Talal and Ahmad, 1987). Also, female relatives 
of patients with certain autoimmune diseases have been 
reported to demonstrate a significant prevalence of 
autoantibodies and suppressor T cell defects (Miller and 
Schwartz, 1982). Estrogens have altered immune functions 
in both noirmal mouse and inbred lupus strains such as 
NZB/WFl hybrid (B/W) (Theofilopoulos and Dixon, 1986; 
Roubinian et al., 1978; Steinberg et al., 1979; Siiteri 
et al., 1980). 
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1.13.7. Viral factors 
Viruses are frequently associated with autoimmune 
diseases of humans and animals (Steinberg et al., 1990; 
Krieg and Steinberg, 1990; Krieg et al., 1989, 1991). 
Such infectious agents may be acquired by horizontal or 
vertical transmission, and they may promote autoimmune 
reactions by many and varied mechanisms. Among the human 
viruses, Epstein-Barr virus (EBV) has been most 
prominantly considered as a cause of autoimmune diseases 
because of its ubiquity, persistence and ability to act 
on the immune system. For example, EBV acts as a 
polyclonal B cell activator stimulating mitosis and 
immunoglobulin secretion as well as promoting 
autoantibody production, especially rheumatoid factor 
(Gregory et al., 1991). 
1.14. Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is considered a 
prototypic human autoimmune disease that manifests itself 
with a variety of fascinating clinical and immunological 
features. Sera of patients with SLE contain a variety of 
autoantibodies to intracellular proteins and nucleic 
acids, and in particular antibodies to double stranded 
DNA (ds DNA). Anti-DNA antibodies represent a significant 
autospecificity in SLE because they are essentially 
diagnostic of the disease and they contribute to 
pathogenesis through the formation of immune complexes 
which damage endothelial cells and other tissues by a 
cascade of events involving complement, leukocytes, 
platelets and vasoactive substances (Theofilopoulos and 
Dixon, 1982; Tan, 1982, 1989; Diamond et al., 1992). 
1.14.1. SLE autoantibodies to DNA 
Antibodies to DNA can be divided into three major 
groups on the basis of specificity: 
(i) Anti-native DNA antibodies: antigenic determinant 
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related to double helical structure of DNA (Arana 
and Seligmann, 1967; Stollar, 1986). 
(ii) Anti-native DNA antibodies reacting in identity 
with anti-single stranded DNA: antigenic 
determinant related to deoxyribose-purine-
pyrimidines, but not dependent on double helix or 
on purines and pyrimidines alone (Arana and 
Seligmann, 1967; Tan et al., 1966; Stollar, 1973, 
1981). 
(iii) Anti-single stranded DNA antibodies: antigenic 
determinant related to purines and pyrimidines. 
Also reactive with purines and pyrimidines in RNA 
(Stollar et al., 1962; Tan, 1967; Rubin et al., 
1986). 
Antibodies to DNA react with many different 
determinants in the DNA molecule. There have been a few 
sera described that appear to react with the double 
helical structure of native DNA and do not cross react 
with single stranded DNA. However, the majority of 
antinuclear antibodies that react with native DNA cross 
react in immunologic identity with single stranded DNA, 
suggesting that the reactive determinant in DNA is 
probably composed of deoxyribose-phosphate backbone 
either with or without the association of purines and 
pyrimidines (Stollar, 1973). 
Double stranded DNA may contain single stranded 
regions from breaks or gaps in the molecules; there may 
also be some breathing of structure with single stranded 
DNA regions occasionally revealed. Similarly ssDNA 
preparations, may have regions of dsDNA possibly from 
intramolecular hydrogen bonding and local duplex 
formation. These considerations suggest that the 
distinction between anti-double stranded and anti-single 
stranded DNA is operational although valuable because of 
the diagnostic utility of anti-double stranded DNA 
determination (Barnett, 1979; Stollar and Papalian, 
1980). Other subpopulations of anti-DNA antibodies may 
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also occur. They may, for example recognize the backbone 
of one strand and may be able to react with both native 
and denatured DNA. Some antibodies can be fractionally 
absorbed with synthetic and single stranded 
homopolydeoxyribonucleotides such as poly(dT) or poly(dC) 
(Koffler et al., 1971 b) . Some of them may be base 
specific; others may react with the backbone and thus 
with several polynucleotides. 
In viewing the many studies of specificity of anti-
DNA antibodies of SLE sera, it appears that there are 
indeed several populations. The distinction among them 
may be somewhat difficult as determinants may involve 
contribution from more than one part of the molecule. 
Nevertheless, some of the antibodies appear to react 
primarily with bases or stacked bases and react only with 
denatured DNA. Others may see backbone feature still 
unique to denatured DNA. Still others may recognize 
backbone features common to both native and denatured DNA 
with minor contribution from the bases and finally a 
small number show a high degree of preference for the 
backbone of double stranded DNA. 
1.14.2. Monoclonal anti-DNA autoantibodies 
The advent of monoclonal autoantibodies has 
provided new systems for elucidating the expression of 
anti-DNA antibodies and their pathogenetic role (Eilat, 
1982; Andrezejewski et al., 1980; Hahn et al., 1980; Tron 
et al., 1980; Lerner et al., 1981; Pisetsky et al., 1982; 
Lafer et al., 1981 b; Ali et al., 1985; Eilat, 1986). The 
first examples of anti-DNA monoclonal autoantibodies were 
from either NZB/NZW (Hahn et al. , 1980) or MRL-lpr/lpr 
(Andrezejewski et al., 1980) mice. The murine monoclonal 
hybridomas produce mainly IgG but also IgM and IgA 
antibodies. Most of them bind denatured DNA, but some 
bind native DNA very well and even preferentially (Tron 
et al., 1982; Ballard and Voss, 1982; Kubota et al., 
1986). Human monoclonal autoantibodies from either 
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hybridomas (Shoenfeld et al., 1983 a; Cairns et al., 
1984) or EBV-transformed cells (Sasaki et al., 1984) are 
nearly all IgM molecules that react with denatured DNA. 
A recurring finding has been that many monoclonal 
autoantibodies cross react with several synthetic 
polynucleotides (Shoenfeld et al., 1983 a; Andrzejewski 
et al., 1981; Lee et al., 1981; Kardost et al., 1982), so 
that the universe of antibodies is smaller than what 
would be required to provide a distinct specificity for 
each form of nucleic acid. However, immunization with 
synthetic polynucleotides usually leads to a specific 
antibody that does not show this degree of cross 
reactivity. A second recurring finding is the prominence 
of certain polynucleotides, particularly poly(dT) and 
poly(dG) or poly(l) as preferred reactants for both 
murine and human hybridoma products (Arnott et al., 
1974) . 
Serological assays reveal that some of the anti-DNA 
autoantibodies cross react even with structures that are 
not nucleic acids. The first such cross reaction to be 
noted was with phospholipids (Lafer et al., 1981 b). This 
is the property of some, but not the majority, of 
monoclonal anti-DNA antibodies (Koike et al., 1982). The 
cross reactivity of anti-DNA antibodies could result from 
their binding to antigens which are structurally distinct 
yet share particular epitopes (Schwartz and Stollar, 
1985; Carroll et al., 1985; Lafer et al., 1981 b). 
The cross reactions of nucleic acids and 
phospholipids can be reciprocal. Antibodies induced by 
cardiolipin react with DNA (Guarnieri and Eisner, 1974; 
Rauch et al., 1984), and can share idiotype with anti-DNA 
autoantibodies (Rauch et al., 1984; Stollar et al., 
1989) . 
Still other cross reactions have been observed with 
antibodies that were selected originally because of their 
anti-DNA activity. They include reaction with a cell 
surface glycolipid of platelets (Asano et al., 1985), 
30 
cell surface proteins of several types of cells (Jacob et 
al., 1985), and cytoskeletal proteins, notably vimentin 
(Andre-Schwartz et al., 1984), of animal cells. In 
addition, certain cross reactions with bacterial surfaces 
involve carbohydrate structures rather than phospholipid 
(Naparstek et al., 1985; DerSimonian 1987; Kabat et al., 
1986). Some anti-DNA autoantibodies bind to IgG (i.e. are 
rheumatoid factors) (Hannestad, 1969; Monestier et al., 
1986). 
1.14.3. Anti-idiotypic antibodies 
Alongside studies of antigen binding specificity 
have been those on the antibody structure, first at the 
level of idiotypes. Anti-idiotype antibodies have been 
prepared against monoclonal autoantibodies (Tron et al., 
1983; Rauch et al., 1982; Marion et al., 1982; Hahn and 
Ebling, 1984; Eilat et al., 1985). In addition very 
informative monoclonal anti-idiotypes were prepared 
against immunospecifically purified serum anti-DNA 
antibodies (Solomon et al., 1983). Private idiotypes of 
restricted expression have been dominant in some studies 
(Tron et al., 1983), but in several findings, recurrent 
idiotypes have been described (Rauch et al., 1984; Marion 
et al., 1982; Hahn and Ebling, 1984; Eilat et al., 1985; 
Mayus and Pisetsky, 1985; Takei et al., 1987; Morgan et 
al., 1985; Zouali and Eyquem, 1984). The later include 
idiotypes shared by different members of a strain or 
species (Rauch et al., 1982; Marion et al., 1982; Hahn 
and Ebling, 1984; Eilat et al., 1985; Solomon et al., 
1983), and idiotypes shared among different species 
(Mayus and Pisetsky, 1985; Takei et al., 1987; Morgan et 
al., 1985). Some of them have been measured in the sera 
of animals (Rauch et al., 1982; Marion et al., 1982; Hahn 
and Ebling, 1984; Eilat et al., 1985) or people (Davidson 
et al., 1987; Solomon et al., 1983; Zouali and Eyquem, 
1984; Harkis et al., 1987; Isenberg et al., 1984, 1985; 
Diamond and Solomon, 1983; Kaburaki and Stollar, 1987) 
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with active autoimmune disease and in the inflammatory 
lesions associated with the diseases (Isenberg and 
Collins, 1985; Miller et al., 1986), 
1.14.4. Natural autoantibodies 
Low concentrations of naturally occurring 
antibodies to nucleic acids and several proteins occur in 
normal human sera (Rubin and Carr, 1978; Guilbert et al., 
1982) and these antibody populations can be expanded by 
stimulation with polyclonal activators of B cells 
(Fournie et al., 1974; Dziarski, 1982). The purified 
human antibodies yield immunofluorescent staining of 
human cells, confirming that they are autoantibodies 
directed against conserved structures. Normal mouse sera 
also contain natural autoantibodies that cross react with 
antigens from different species (Lymberi et al., 1989; 
Martin and Martin, 1975). 
Both human and mouse natural autoantibodies tend to 
be cross reactive not only with one autoantigen from 
varying species, but also with varying kinds of antigen 
structures (Dighiero et al., 1982). A single mouse or 
human anti-DNA autoantibody can react with DNA, 
cytoskeleton, bacterial cell surfaces and purified 
phospholipids (Andrzejewski et al., 1981; Ternynck and 
Avrameas, 1986; Souroujon et al., 1988; Poncet et al., 
1988). Similarly certain human rheumatoid factors cross 
react with the dinitrophenyl hapten or denatured DNA 
(Hannestad, 1969), the nucleosome subunit of chromatin 
(Hannestad and Stellar, 1979) , or bromelain-modified 
erythrocytes (Cunliffe and Cox, 1980), and mouse 
rheumatoid factors cross react with a similar array of 
diverse substances (Rubin et al., 1984; Manheimer-Lory et 
al., 1986). 
1.14.5. Autoantibody encoding genes 
In both mice and humans, autoreactivity is 
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characteristic of a significant fraction of antibodies 
produced by immunized fetal or newborn subjects (Dighiero 
et al., 1985; Souroujon et al., 1988; Casali and Notkins, 
1989; Logtenberg et al., 1989 ; Bos et al., 1989; 
Striebich et al., 1990). In both species, certain 
autoantibodies are encoded by unmutated germ line Vj^  and 
H l segments (Trepicchio et al., 1987; Baccala et al., 
1989; Kasturi et al. , 1990; DerSimonian et al., 1987; 
Cairns et al., 1989; Siminovitch et al., 1989; Logtenberg 
et al., 1989; Sanz et al., 1989 a, b; Roudier et al. , 
1990; Pascual and Capra, 1991) and a large number are 
encoded by genes that differ by only a few bases from 
known germ line genes (Reininger et al., 1987; 
DerSimonian et al., 1990). Naturally occurring 
autoantibodies in unimmunized mice and humans have 
similar properties. They react with conserved structures 
of similar antigens, are similarly cross reactive, and 
are often encoded by unmutated germ line genes. 
Autoantibodies in mice, dogs and humans with autoimmune 
disease also have several properties in common (Eisenberg 
et al., 1987; Bonfa et al., 1988; Theof ilopoulos and 
Dixon, 1987; Lewis, 1974). Pathogenic autoimmunity may 
develop from similar origins of autoreactivity in diverse 
species. 
Autoantibody conservation is revealed through the 
sharing of idiotypes among autoreactive immunoglobulins 
not only of one species (Rauch et al., 1982; Marion et 
al., 1982; Lymberi et al., 1985; Shoenfeld et al. , 1983 
b; Solomon et al., 1983; Hahn and Ebling, 1984; Isenberg 
et al., 1984; Zouali and Eyquem, 1984) but of 
autoantibodies from different species including mice, 
dogs and humans (Morgan et al., 1985; Kalunian et al., 
1989; Takei et al., 1988; Zouali et al., 1988 a; Watts et 
al., 1990). Several auto antibodies are highly conserved 
within a species i.e. among humans of diverse origins or 
among different strains of mice (DerSimonian et al., 
1987; Matthyssens and Rabbitts, 1980; Chen et al., 1987; 
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Schroeder et al., 1987). 
Autoreactivity is maintained at a low background 
level in normal individuals, under controls that prevent 
a large scale anti-self response. The natural 
autoantibodies are prominant within this low background. 
In subjects with autoimmune disease, the regulation may 
be hindered so that the autoreactive background is both 
expanded and diversified. In this process, autoantigens 
may select diversified antibodies that react with unique 
features of the self species, and this diversification 
may include both descendants of primary autoantibodies 
and newly recruited antibodies encoded by genes that are 
not involved in the natural autoantibody repertoire 
(Stollar, 1991). 
1.15. Objectives of the Present Study 
The basic question of why anti-DNA autoantibodies 
are foirmed in SLE has not been answered. It is especially 
puzzling in the case of native DNA, which is not 
immunogenic in normal experimental animals even when 
usually injected with carriers that allow effective 
immunization with denatured DNA or other helical nucleic 
acids. It is not known whether some form of DNA, such as 
a product of viral infection or a fragment of chromatin 
or chemically modified DNA serves as immunogen. In view 
of the broad specificity of naturally occurring 
autoantibodies, the modified DNA as stimulus for the 
production of antibodies showing cross reactivity with B-
conformation and precipitating autoimmune process is 
being strengthened continuously (Stollar, 1989). In the 
present study, calf thymus DNA was modified with hydrogen 
peroxide in the presence of UV light of 254 nm. Chemical 
alterations to DNA mediated by hydroxyl radical under 
these conditions were detected by UV spectroscopy, 
thermal denaturation studies, sedimentation in alkaline 
sucrose density gradients, nuclease SI sensitivity and by 
fluorescence intensity measurements. The alterations like 
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changes in physico-chemical properties and single strand 
breaks in native DNA were the predominant reactions 
mediated by oxidising species like hydroxyl radical. In 
addition, ion exchange chromatography on DEAE Sephadex A 
25 column was used to reveal the modified base products 
in DNA which result from hydrogen peroxide exposure in 
presence of UV light. The antigenicity of modified 
polymer was probed by inducing antibodies in experimental 
animals. The repertoire of specificities of the induced 
antibodies was evaluated by assessing their binding using 
direct binding and inhibition ELISA. Antibodies were 
further characterized by quantitative precipitin and gel 
retardation assay. Finally, the specificity of binding of 
serum anti-DNA autoantibodies to native and reactive 
oxygen species modified DNA (ROS-DNA) was evaluated by 
direct binding and inhibition studies. The effect of 
polymer size on antibody binding was determined using 
native DNA fragments of increasing chain length (50-800 
bp) . Relative binding affinities of SLE IgG was 
evaluated by means of Langmuir analysis. 
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2 E X P E R I M E N T A L 
2.1. MATERIALS 
2.1.1. Chemicals 
Calf thymus DNA, nuclease SI (Aspergillus oryzae), 
poly-L-lysine, poly-L-glutamate, bovine serum albumin, 
agarose, Coomassie Brilliant Blue R 250, xylene cyanole 
FF, anti-IgG-alkaline phosphatase conjugate, 
trinitrobenzene sulphonic acid, ethidium bromide, 
Freund's complete and incomplete adjuvants, standard 
protein markers and fluorescent dye Hoechst 33258 were 
purchased from Sigma Chemical Company, U.S.A. Synthetic 
polynucleotides, micrococcal nuclease, Ox 174 RF DNA Hae 
III restriction nuclease digest, Sepharose 4B, DEAE 
Sephacel, DEAE Sephadex A 25, Sephadex G 200, agarose NA, 
Ficoll 400 were obtained from Pharmacia Fine Chemicals, 
Sweden. P-nitrophenyl phosphate, Folin-Ciocalteu reagent 
and Blue Dextran 2000 were purchased from C.S.I,R. Centre 
for Biochemicals, Delhi. 
Polystyrene microtitre flat bottom ELISA plates 
having 96 wells (7 mm in diameter) were obtained from 
Dynatech, U.S.A. Tween-20, acrylamide, N, N'-
methylenebisacrylamide, ammonium persulphate, N, N, 
N',N'-tetraethylmethylenediamine, hydroxy-apatite were 
from Bio-Rad Laboratories, U.S.A. Hydrogen peroxide, 
ninhydrin, sodium dodecyl sulphate and acetic anhydride 
were purchased from B.D.H. England. All other chemicals 
were of highest analytical grade available. 
2.1.2. Equipment 
Bausch and Lomb Spectronic-20, Fraction collector 
FRAC-100 (Pharmacia, Sweden), Shimadzu spectrophotometer 
UV-240 equipped with thermoprogrammer and controller 
unit, Shimadzu spectro-fluorophotometer RF-540, ELISA 
microplate reader MR-600 (Dynatech, U.S.A.) Beckman 
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ultracentrifuge model L860 M, Elico pH meter model Ll-
lOT, gel electrophoresis apparatus GNA-100 (Pharmacia, 
Sweden), short wavelength ultraviolet lamp (Spectroline 
R-51, Black Light Eastern Inc. U.S.A.) having maximum 
emission at 253.7 nm were the major equipment used in 
this study. 
2.2. METHODS 
2.2.1. Purification of Calf Thymus DNA 
Highly polymerized calf thymus DNA was purified 
free of proteins, RNA and single stranded regions as 
described by Ali et al. (1985). The DNA (2 mg/ml) in 0.1 
x SSC buffer (0.015 M sodium citrate, 0.15 M sodium 
chloride, pH 7.3) was extracted with a mixture of 
chloroform-isoamyl alcohol (24:1) in a stoppered 
measuring cylinder for one hr. DNA in aqueous layer was 
separated from organic layer and precipitated with two 
volumes of cold ethanol and thereafter collected on a 
glass rod. The extraction process was repeated and DNA 
was dissolved in 30 mM acetate buffer, pH 5.0 containing 
30 mM zinc chloride. The single stranded regions were 
removed by treatment with nuclease SI (200 units/mg DNA) 
at 37°C for 3 0 min. The reaction was stopped by the 
addition of one tenth volume of 0.2 M EDTA, pH 8.0. The 
extraction procedure was repeated as before and final 
preparation of DNA was dissolved in PBS (10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4). 
2.2.2. Isolation of DNA Fragments 
Purified DNA (2 mg/ml in 100 mM NaCl, 6 mM Tris, 2 
mM CaClj, pH 8.0) was subjected to controlled digestion 
with micrococcal nuclease (40 units/mg DNA) at 37°C for 
2.5 min to obtain fragments varying approximately from 70 
bp to 800 bp. The reaction was stopped by the addition of 
EDTA, pH 8.0, to a final concentration of 20 mM. The 
mixture was extracted twice with chloroform-isoamyl 
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alcohol and DNA fragments were precipitated with ethanol. 
This was followed by the removal of single stranded 
regions with nuclease SI digestion (200 units/mg DNA) at 
37°C for 3 0 min. The digested fragments were extracted as 
before, dissolved in TBS (10 mM Tris, 150 mM NaCl, pH 
8.0) and passed through a 2.06 cm x 57 cm column of 
Sepharose 4B equilibrated with TBS. Fractions of 4 ml 
were collected and monitored at 260 nm (Figure 2) , DNA 
fragments were analysed for size by slab gel 
electrophoresis (inset Figure 2). 
2.2.3. Colorimetric Estimation of DNA 
Concentration of DNA was determined by the method 
of Burton (1956) using diphenylamine reagent. 
2.2.3.1. Crystalization of diphenylamine 
Diphenylamine (2 g) was dissolved in 200 ml of 
boiling hexane. Approximately 0.5 g of activated animal 
charcoal was supplemented to the boiling mixture. The 
solution was filtered while hot and filtrate was kept 
overnight at 4°C. The crystals were separated by 
filtration and dried at room temperature. 
2.2.3.2. Preparation of diphenylamine reagent 
Recrystallized diphenylamine (750 mg) was 
dissolved in 50 ml of glacial acetic acid containing 0.75 
ml of concentrated sulphuric acid. 
2.2.3.3. Procedure 
To 1.0 ml of DNA was added 1.0 ml of IN 
perchloric acid. The tubes were incubated in a thermostat 
water bath at 70°C for 15 min. Hundred uL of 5.43 mM 
acetaldehyde was added to each tube followed by the 
addition of 2 ml of freshly prepared diphenylamine 
reagent. The contents were mixed and allowed to stand at 
room temperature for 16-20 hr. Absorbance was recorded at 
600 nm. The concentration of DNA in unknown sample was 
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Figure 2. Frac t iona t ion of ca l f thymus DNA on Sepharose 4B column 
digested b r i e f ly with micrococcal nuc lease . I n s e t i : The 
resu l t s of polyacrylamide gel e lec t rophores is of f r ac t iona ted 
DNA. Lanes (2-8) r ep resen t f r a c t i o n s 20-30. Lane 1 
represen t s na t ive DNA and lane 9 conta ined Hae I I I 
d iges t of px l74 RF DNA. 
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determined from the standard plot constructed by using 
0-100 ug of purified calf thymus DNA (Figure 3). 
2.2.4. Determination of Protein Concentration 
Protein was estimated colorimetrically by the 
method of Lowry et al. (1951). 
2.2.4.1. Folin-Ciocalteu reagent 
The reagent was purchased from C.S.I.R. Centre 
for Biochemicals, Delhi and diluted 1:4 before use. 
2.2.4.2. Alkaline copper reagent 
The components of alkaline copper reagent were 
prepared as follows: 
(a) 2% sodium carbonate in 0.1 N NaOH 
(b) 0.5% copper sulphate in 1.0% sodium potassium 
tartrate 
The working reagent was prepared fresh just before 
use by mixing components (a) and (b) in the ratio of 
50:1. 
2.2.4.3. Procedure 
To 1.0 ml of protein sample was added 5.0 ml of 
alkaline copper reagent. The contents were mixed and 
allowed to stand at room temperature for 10 min. Working 
Folin-Ciocalteu reagent (1 ml) was added to each tube, 
mixed immediately and left at room temperature for 3 0 
min. The absorbance was recorded at 660 nm. The 
concentration of unknown sample was evaluated from a 
standard plot constructed by using varying concentrations 
of bovine serum albumin (Figure 4). 
2.2.5. Irradiation of DNA 
Aqueous solutions of calf thymus DNA and DNA 
fragments of 300 bp (0.15 mM) in PBS, pH 7.4 were 
irradiated under 254 nm light for 30 min at room 
temperature in the presence of hydrogen peroxide. The 
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Figure 3 . S t anda rd plot for the colorimetrlc estLmation of DNA. 
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Figure 4. S t anda rd plot for the colorimetric es t imat ion of protein. 
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temperature during the irradiation period was kept 
constant by circulating tap water. The concentration of 
hydrogen peroxide, determined by titration with sodium 
thiosulphate (Ansari et al., 1985) was 15.1 mM. Excess of 
hydrogen peroxide after irradiation was removed by 
exhaustive dialysis against PBS, pH 7.4. Native DNA 
samples exposed to hydrogen peroxide or UV light alone 
were used as corresponding controls. 
2.2.6. Determination of Melting Temperature 
Thermal denaturation analysis of nucleic acids was 
accomplished in order to ascertain the degree of 
modification incurred on the nucleic acids by determining 
midpoint melting temperature (T^ )^ . 
The Tjjj of nucleic acid samples was determined by 
Shimadzu UV 240 spectrophotometer coupled with a 
temperature programmer and controller assembly (Hasan and 
Ali, 1990). The samples in PBS, pH 7.4 were heated at the 
rate of l°C per min initiating from 30°C upto 95°C. The 
absorbance was recorded at 260 nm and the percent 
denaturation evaluated with increase in temperature as 
follows: 
At - A30 
% denaturation = X ICQ 
^ a x " ^ 3 0 
where, A,p = Absorbance at a temperature T°C 
Ajjigjj = Final maximum absorbance on the completion 
of denaturation 
A3Q = Initial absorbance at 30°C 
2.2.7. Thermodynamic Analysis of Nucleic Acid 
Denaturation 
The thermal transition of nucleic acid from native to 
denatured state was characterized as single variable, fO, 
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the fraction of nucleic acid in the denatured state. The 
percent loss in absorbance was used as experimental 
variable to follow the transition. At any given point 
along the transition curve, the observed percent change 
in absorbance was related to the fraction of nucleic acid 
in the denatured state, by the following expression: 
(A)obs - (A)n 
fD = 
(A)d - (A)N 
where (A)obs' ^^^N (A) D represent the percent loss in 
absorbance in any observed, native and fully denatured 
states respectively. Since each experimental value of 
(A^obs ^iil give unique value of (A)^ ,^ the later was used 
to construct transition curves for the thermal 
denaturation of nucleic acid. 
By assuming that unfolding of the strands of nucleic 
acid is a two state process due to the presence of A-T 
and G-C regions respectively, the initial and final 
states of thermal denaturation of nucleic acids were 
related to apparent equilibrium constant, defined as: 
Kapp 
(A)obs -
(A)D - (A)obs 
The free energy change, A g , for the thermal 
reaction (native double stranded conformation to single 
stranded conformation) was calculated by using the 
following relationship: 
A G D ° = - R T I n app 
where, K^pp is the apparent equilibrium constant 
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2.2.8. Hydroxyapatite Column Chromatography 
Hydroxyapatite column chromatography was employed 
to discriminate nucleic acids endowed with different 
secondary structures. Modified and unmodified DNA samples 
were chromatographed on hydroxyapatite column before and 
after heat denaturation (Dardalhon and Averbeck, 1988). 
Three ml of DNA sample (100 ug/ml) in 10 mM sodium 
phosphate buffer pH 6.8 was loaded onto a hydroxyapatite 
column (1.5 cm x 14 cm) previously washed and 
equilibrated with 10 mM sodium phosphate buffer pH 6.8. 
The bound material was eluted with 0.125 M and 0.25 M 
potassium phosphate buffer, pH 6.8. Fractions of 3.0 ml 
were collected at a flow rate of 10 ml/hr and monitored 
at 260 nm. DNA samples were denatured by heating for 15 
min at 100°C, at a concentration of 100 ug/ml in 10 mM 
sodium phosphate buffer and fast cooled. 
2.2.9. Detection of Single Strand Breaks 
The damage to DNA mediated by hydroxyl radical was 
ascertained by sucrose density gradient centrifugation 
and polyacrylamide gel electrophoresis. 
2.2.9.1. Alkaline density gradient centrifugation 
Nucleic acid samples (0.15 ml) were treated by 
the addition of an equal volume of 0.2 N NaOH. After a 
ten min delay to permit denaturation of DNA, 0.2 ml of 
each sample was layered on top of a 3.8 ml alkaline 
sucrose gradient (5-20% sucrose in 0.1 N NaOH and 0.01 M 
EDTA) (Ali and Sauerbier, 1978). The gradients were 
centrifuged at 37,000 rpm for 10.5 hr at room temperature 
in the swinging bucket rotor of Spinco E, Beckman 
ultracentrifuge. Six drop fractions were collected and 
diluted to about 0.5 ml by the addition of 0.3 ml of 
double distilled water and their absorbance recorded at 
260 nm. 
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2.2.9.2. Polyacrylamide slab gel electrophoresis 
Electrophoresis of nucleic acid samples was 
performed with 7.5% acrylamide gels under denaturing and 
non-denaturing conditions according to the method of 
Sealey and Southern (1985). 
2.2.9.2.1. Electrophoresis under non-denaturing conditions 
(i) Following stock solutions were prepared 
A - 40% acrylamide in distilled water 
B - 2% bisacrylamide in distilled water 
C - Resolving gel buffer: 0.9 M Tris-borate, 25 mM EDTA 
(pH 8.3) 
D - TEMED 
E - 1.5% ammonium persulphate (freshly prepared) 
(ii) Recipe for the preparation of non-denaturing 
polyacrylamide gels 
Stock solution Amount in ml 
A 7.5 
B 7.5 
C 4.0 
D 0.025 
E 2.0 
Distilled water 19.0 
in a total volume of 40 ml and final polyacrylamide 
gel concentration of 7.5% 
(iii) Procedure 
The gel plates (19 cm x 16 cm) were cleaned by 
soaking them in chromic acid overnight, rinsed with water 
and then with ethanol. The bottom of the gel mould was 
sealed with 1% agarose. The gel mixture was prepared by 
adding the correct volumes of all componets, gently mixed 
and poured between the glass plates within 0.5 cm of the 
top. Immediately, a comb was inserted between the glass 
plates and the assembly left undisturbed for the gel to 
polymerise (30-50 min). DNA samples in buffer of low 
ionic strength and at concentration of 1 ug/uL were 
loaded directly onto the gels by adding one tenth volume 
of the ^stop mix' (30% Ficoll, 0.025% xylene cyanole FF, 
0.5 M EDTA, 10 times concentrated electrophoresis 
buffer). The gels (19 cm x 16 cm x 0.2 cm) were run for 
6-8 hr at 70 volts. After electrophoresis, the gels were 
stained directly by immersion in electrophoresis buffer 
containing 1 ug/ml ethidium bromide for 30-60 min and 
were viewed by illumination with UV light. 
2.2.9.2.2. Electrophoresis under denaturing conditions 
Electrophoretic fractionation of nucleic acids 
was carried out under denaturing conditions using urea as 
a denaturing agent. The composition of the stock 
solutions were same as for non-denaturing gels. The gels 
were prepared as non-denaturing gels except that the 
volume of distilled water was reduced to allow 16.8 g of 
urea to be added to give a final volume of 38.0 ml. 
Thereafter, 0.025 ml of solution D and 2.0 ml of solution 
E was added immediately before pouring the gel. The final 
gel mixture contained 7 M urea. Samples were prepared 
by adding urea (upto 7 M) and 0.025% of tracking dye 
xylene cyanole FF. To destroy any aggregates, the 
preparations were heated for 10 min at 90°C before their 
application onto the gel. The reservoir buffer contained 
7 M urea. The gels were run for 10-12 hr at 70 volts. 
Rest of the procedure was same as above. 
2.2.9.3. Isolation of DNA by diffusion 
After locating the bands, the gel was cut into 
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lanes. Each lane was sliced into 5 mm pieces and DNA 
extracted by diffusion. Elution by diffusion was carried 
out by placing intact piece of thin gel slice into a 0.5 
ml buffer consisting of 0.15 M NaCl, 10 mM Tris-HCl (pH 
8.0), 1 mM EDTA. The gel was gently macerated using a 
glass rod (Maxam and Gilbert, 1980). After overnight 
incubation (more than 12 hr) at 37°C, the mixture was 
centrifuged at 12,000 g for 10 min in a microfuge. The 
supernatant containing DNA was filtered through Millipore 
filter (0.45 mu). 
2.2.9.4. Fluorometric assay for DNA with ethidium bromide 
The fluorescence of ethidium bromide is enhanced 
on binding to DNA (Karsten and Wallenberger, 1972). 
Enhancement involves intercalation of molecules of the 
dye between the nucleic acid bases. 
2.2.9.4.1. Reagents 
(a) Phosphate-buffered saline (PBS) (170 mM NaCl, 3.3 mM 
KCl, 10 mM Na2 HPO4, 1.8 mM KH2 PO4, pH 7.4). 
(b) 100 ug/ml of ethidium bromide in PBS. 
2.2.9.4.2. Method 
To 0.2 ml of extracted DNA was added 2.2 ml of 
PBS, pH 7.4. The sample was treated with 0.1 ml of 
ethidium bromide solution and fluorescence intensity of 
ethidium-DNA complex ( ^ ex = 360 nm, Xeinit = 580 nm) was 
recorded with respect to free ethidium bromide of the 
same concentration. 
2.2.10. Nuclease 81 Sensitivity of Modified DNA Samples 
Twenty uL of sample containing approximately 2 ug 
DNA in acetate buffer (30 mM each of sodium acetate and 
zinc chloride, pH 5.0) was treated with 40 units of 
nuclease SI (Matsuo and Ross, 1987) . After 30 min 
incubation at 37°C, the reaction was stopped by the 
addition of one tenth volume of 0.2 M EDTA, pH 8.0. The 
A8 
digested sample was subjected to agarose gel 
electrophoresis. 
(a) Gel preparation 
Agarose (0.18 g) in 30 ml of TAE (40 mM Tris-acetate, 
pH 8.0 containing 2 mM EDTA) was dissolved by heating in 
boiling water bath. The solution was cooled to between 
50°C and 60°c. The solution was poured into the gel tray 
and left at room temperature for 30 min for complete 
solidification. 
(b) Sample preparation and loading 
The nuclease SI treated nucleic acid samples were 
prepared for loading onto the gels by adding one fifth 
volume of concentrated loading buffer (0.125% bromophenol 
blue, 30% Ficoll 400, 0.5 M EDTA and lOx electrophoresis 
buffer) . The samples were loaded in the wells of the 
submerged gel (0.4 cm thick) and electrophoresed for 2-3 
hr at 4 0 V. Ethidium bromide was incorporated both in 
the gel during its preparation and in the running buffer 
(0.5 ug/ml). 
2.2.11. Separation of Modified Bases 
The separation and quantification of modified 
bases in nucleic acid samples was carried out according 
to Hasan and Ali (1990). 
2.2.11.1. Acid hydrolysis of nucleic acid samples 
Modified DNA samples were precipitated with two 
volumes of cold ethanol, dessicated and dissolved in 
perchloric acid (70%) . The samples were heated at 100°C 
for 1 hr to release the bases. The solution was 
neutralized and chromatographed on DEAE Sephadex A 25 
column. 
2.2.11.2. DEAE Sephadex A 25 column chromatography 
The swollen ion exchanger was mixed with 
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starting buffer (1 mM Tris-HCl, pH 7.6) to form a fairly 
thick slurry. The ion exchanger suspension was poured 
into the column and gel was allowed to settle. In order 
to allow the system to reach equilibration and to 
stabilize the bed, about ten bed volumes of buffer were 
run through the ion exchanger bed. Three ml of sample was 
loaded onto the column (2.4 cm x 20 cm) preequilibrated 
with 1 mM Tris-HCl buffer and was eluted with Tris-HCl 
buffer using a linear gradient (1-20 mM) at a flow rate 
of 40 ml/hr. Fractions of 2.5 ml were collected and their 
absorbance recorded at 260 nm. The control experiments 
were carried out with equimolar mixture of individual 
bases and hydrolysed native DNA in order to locate the 
pattern of unmodified bases. The individual 
modified/unmodified bases were identified by their 
characteristic UV absorption profile. 
2.2.12. Immunization Schedule 
Antibodies against modified DNA were elicited in 
goat complexed with methylated BSA (MBSA, 0.5 ml each) 
and emulsified with 1.0 ml of Freund's complete adjuvant. 
Intramuscular injections were given for five weeks at 
weekly intervals with incomplete adjuvant (Ishaq and Ali, 
1984). The amount of antigen was 100 ug/injection. 
Booster dose was administered after the lapse of one 
month from the last injection. Blood was collected 
through jugular vein and serum separated. The separated 
serum was decomplemented by heating at 56°C for 30 min 
and stored in small aliquots at -20°C with 0.1% sodium 
azide as preservative. Preimmune sera were collected 
before immunization of the animals. 
Antibodies against ROS-DNA fragments of JOO bp were 
raised in rabbits after intramuscular injection with 50 
ug of antigen complexed with MBSA and emulsified with 
complete Freund's adjuvant. The rabbits received six 
similar injections but with incomplete Freund's adjuvant 
at weekly intervals. Animals were bled by cardiac 
ICQ 
puncture and serum separated, preserved in sodium azide 
(0.1%) and stored at 4°C. 
2.2.13. Isolation and Purification of IgG 
2.2.13.1. Precipitation of immunoglobulins 
To 6.5 ml of serum was added 3.5 ml of 
saturated ammonium sulphate gradually under continuous 
stirring to avoid local high concentrations leading to 
precipitation of contaminants. The solution was stirred 
for one hr at 4°C and centrifuged at low speed (15 min, 
4,000 g). The pellet was washed twice with 40% saturated 
ammonium sulphate, redissolved in buffer of same volume 
and reprecipitated. The precipitate was collected by 
centrifugation, dissolved in sodium phosphate buffer, pH 
8.0 and excess of salts were removed by dialysis. 
2.2.13.2. Purification of IgG on DEAE Sephacel 
Ion exchange chromatography was performed using 
DEAE Sephacel (Ali et al., 1991).' The resin was swollen 
in distilled water, treated with 0.1 N NaOH for 1 hr at 
room temperature and washed with distilled water till pH 
became neutral. It was then treated with 0.1 N HCl for an 
hr. The regenerated resin was washed extensively with 
distilled water and packed in a column (1.5 cm x 28 cm) 
and equilibrated with the operating buffer (0.01 M sodium 
phosphate, pH 8.0). The immunoglobulins were applied to 
the column and eluted with phosphate buffer using a 
linear gradient of 0.01 M-0.3 M. Fractions of 4 ml were 
collected and absorbance was monitored at 280 nm. The 
homogeneity of the isolated IgG was ascertained by SDS-
PAGE. 
2.2.13.3. Purification of IgG by gel filtration 
Gel filtration was performed on a Sephadex G 
200 column. About 10 g of gel was allowed to swell in 
distilled water for 5 hr in a boiling water bath. The 
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column (2.4 cm x 50 cm) was filled with the operating 
buffer upto 3 cm. An extension column was connected to 
the column and then degassed gel slurry was carefully 
poured into the column. The gel was left overnight at 
room temperature to settle under gravity. As the gel 
settled down, the flow rate was increased gradually to a 
value slightly higher than that was to be employed for 
elution. The column was equilibrated with operating 
buffer by passing a volume equal to 3 times of the total 
bed volume. Uniform packing of the column was checked by 
passing 0.2% w/v solution of Blue Dextran. 
Three ml of the sample containing 3 0 mg protein, was 
applied onto the column with the help of an applicator. 
The column outlet was opened slowly and the sample was 
allowed to percolate through the upper surface of the 
gel. The flow rate of the column was then adjusted to 20 
ml/hr and the column was connected to a reservoir 
containing operating buffer. After rejection of discarded 
volume, fractions of 4.0 ml were collected and absorbance 
monitored at 280 nm. 
2.2.13.4. Polyacrylamide gel electrophoresis 
The homogeneity of the IgG was probed by 
polyacrylamide slab gel electrophoresis according to the 
method of Laemmli (1970) . 
2.2.13.4.1. Stock solutions 
(1) Acrylamide-bisacrylamide (30:0.8) : prepared by 
dissolving 30 g of acrylamide and 0.8 g 
bisacrylamide in a total volume of 100 ml water. 
The solution was stored at 4°C in a dark bottle. 
(ii) TEMED: used as supplied. 
(iii) Ammonium persulphate (1.5%, w/v); 0.15 g of 
ammonium persulphate was dissolved in 10 ml water. 
The solution was made fresh just before use. 
(iv) SDS (10% w/v): prepared by dissolving 10 g SDS in 
water to 100 ml. 
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(v) Resolving gel buffer (3 M Tris-HCl, pH 8.8): 
prepared by dissolving 36 g Tris in 48.0 ml of 1 N 
HCl. The contents were mixed thoroughly, pH 
adjusted to 8.8 and the final volume brought to 100 
ml. 
(vi) Stacking gel buffer (0.5 M Tris-HCl, pH 6.8): Tris 
(6.05 g) was dissolved in 40 ml distilled water, 
titrated to pH 6.8 with 1 N HCl (around 48 ml) and 
the volume made upto 100 ml with water. 
(vii) Reservoir buffer (0.025 M Tris, 0.192 M glycine, 
0.1% SDS, pH 8.3): 3.03 g Tris, 14.4 g glycine and 
1.0 g SDS were dissolved in and made to one litre 
with water. 
(viii) Sample buffer 
(A) - Tris (6.0 g) was dissolved in 80.0 ml of water and 
pH adjusted to 6.8 with o-phosphoric acid. The 
volume was made to 100 ml with water. 
(B) - To 12.5 ml of was added 1.0 mg bromophenol blue 
and 12.5 ml glycerol. 
(C) - One part of B and four parts of sample were mixed 
and heated in a boiling water bath for 5 min just 
prior to electrophoresis. 
Recipe for 7.5% SDS-PAGE 
(Total volume 30.0 ml) 
Acrylamide-bisacrylamide 7. 5 ml 
Resolving gel buffer 3 . 75 ml 
10% SDS 0. 3 ml 
1.5% Ammonium persulphate 1. 5 ml 
Distilled water 16. 95 ml 
TEMED 15. 0 ul 
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Recipe for stacking gel 
(Total volume 10.0 ml) 
Acrylamide-bisacrylamide 1.25 ml 
Stacking gel buffer 2.5 ml 
10% SDS 0.1 ml 
1.5% Ammonium persulphate 0.5 ml 
Distilled water 5.65 ml 
TEMED 7.5 uL 
2.2.13.4.2. Procedure 
The resolving gel mixture was prepared by 
mixing the components in the volumes listed above and 
poured into the space between the glass plates leaving 
sufficient space (about 3.5 cm) at the top for a stacking 
gel to be polymerized later and sample wells formed. 
Samples were carefully loaded onto the gel surface using 
a microsyringe. The gels were electrophoresed at 60 V for 
6-8 hr and were stained with Coomassie Brilliant Blue R 
250. 
2.2.14, Detection and Quantitation of Antibodies 
2.2.14.1. Enzyme linked immunosorbent assay (ELISA) 
The anti-ROS DNA antibodies were detected and 
quantitated by ELISA on flat bottom 96 well microtitre 
plates according to the method of Aotsuka et al. (1979) 
with slight modification. 
2.2.14.1.1. Buffers and reagents 
(a) Tris buffer saline (TBS), pH 7.4 
10 mM Tris, 150 mM NaCl, pH 7.4 containing 0.02% 
sodium azide as preservative. 
(b) Tris buffer saline Tween-20 (TBS-T), pH 7.4 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl and 500 uL 
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Tween-2 0 
(c) Bicarbonate buffer, pH 9.6 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 
2 mM magnesium chloride, pH 9.6 containing 0.02% 
sodium azide as preservative. 
(d) Substrate 
Five hundred ug/ml p-nitrophenyl phosphate in 
bicarbonate buffer, pH 9.6. 
2.2.14.1.2. Procedure 
Polystyrene plates were preincubated with 100 
uL poly-D-lysine (50 ug/ml in water) for 30 min at room 
temperature. After washing three times with TBS, pH 7.4, 
the wells were coated with 100 uL of modified DNA 
antigens (2.5 ug/ml TBS) for 2 hr at room temperature and 
overnight at 4°C. The wells were emptied and washed three 
times with TBS-T, pH 7.4. Hundred uL of poly-L-glutamate 
(50 ug/ml TBS) was added to antigen coated wells for 2 
hr. The plates were washed three times with TBS-T and 
unoccupied sites were blocked with 150 uL of 2% BSA (in 
TBS) for 6 hr at room temperature. Antibodies (100 
uL/well) to be tested (dilution in TBS) were adsorbed for 
2 hr at room temperature and overnight at 4°C. The 
unbound material was washed four times with TBS-T and two 
times with distilled water. An appropriate anti-
immunoglobulin alkaline phosphatase conjugate was added 
to each well. The substrate was added and absorbance 
recorded at 410 nm on an automatic microplate reader 
after proper color development. Each sample was run in 
duplicate. The control wells were treated similarly but 
were devoid of antigen. Results were expressed as a mean 
^test ~ •^control-
2.2.14.2. Competition ELISA 
The specificity of the induced antibodies was 
ascertained by competition ELISA employing modified 
polymers and various synthetic polynucleotides as 
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inhibitors. Anti-ROS DNA antibodies (constant amount) 
were incubated with increasing amounts (0-10 ug) of 
modified polymers and synthetic polynucleotides. 
Following incubation for 2 hr at room temperature and 
overnight at 4°C, immune complexes were added to ROS-DNA 
coated plates and the direct binding ELISA was performed. 
Each inhibitor dilution was run in duplicate and 
corrected for nonspecific reactivity in control wells. 
Percent inhibition was calculated using the formula: 
^410 inhibited 
% inhibition = [ 1 - ] x lOO 
^410 uninhibited 
2.2.14.3. Quantitative precipitin titration 
The antigen-antibody interaction was 
investigated by performing precipitin analysis under 
equilibrium conditions. Increasing amounts of antigen 
(ROS-DNA) (0-50 ug) were added to a series of Eppendorf 
microfuge tubes containing equal amounts (100 ug) of 
immune IgG. The mixture was incubated at 37°C for two hr 
and then transferred to 4°C for a day. This was followed 
by the addition of anti-goat IgG to the assay mixture. 
The tubes were incubated at 37°C for 2 hr and overnight 
at 4°C. The precipitates thus formed were separated from 
the supernatant by centrifugation at maximum speed for 2 
min in a microfuge and both (precipitate and supernatant) 
were saved. The precipitate was washed twice with cold 
PBS, pH 7.4 and redissolved in a fixed volume of 1 N 
NaCl. The amount of bound and unbound antigen in the 
dissociated immune complex precipitate and supernatant 
respectively were determined colorimetrically using 
diphenylamine reagent (Burton, 1956). 
The affinity of the interaction was probed by 
Langmuir isotherm plot. A plot of 1/r versus l/[Ag] 
yielded a straight line. The results were analysed by 
least square fit method. Affinity constant was computed 
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from the slope of the plot. 
2.2.14.4. Gel retardation assay 
For the visual detection of antigen-antibody 
binding and formation of immune complexes, 
electrophoresis was performed with 1% agarose gels (Alam 
and Ali, 1992). 
(a) Electrode buffer 
40 mM Tris-acetate (pH 8.0) containing 2 mM EDTA. 
(b) Preparation of gel 
The gel tray was cleaned with water and a mild 
detergent, rinsed well with distilled water and 
dried. The ends of the gel tray were sealed with a 
tape and gel comb was placed in position. Agarose NA 
(0.3 g) in 30 ml of electrophoresis buffer was 
dissolved by heating in a boiling water bath. The 
solution was cooled (50°C-60°C) and poured into the 
gel tray. The gel was left at room temperature for 
complete solidification. After the gel was completely 
set, the comb and tape was carefully removed and gel 
mounted in the electrophoresis tank. 
(c) Sample preparation and loading 
Samples were prepared by incubating constant amounts 
of antigen and antibody in PBS, pH 7.4 for 2 hr at 
37°C and overnight at 4°C. One fifth volume of 
concentrated loading buffer (6x) containing 0.25% 
xylene cyanole and 15% Ficoll 400 were added to 
samples prior to loading them onto the gel. 
(d) Electrophoresis conditions 
The gels were run with 40 mM Tris-acetate buffer, pH 
8.0 at 30 V. 
(e) Staining 
The gels were stained with fluorescent dye ethidium 
bromide (l ug/ml) for 15-30 min. After staining, gels 
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were viewed by illumination with UV light. 
2.2.15. Serum Specimens 
Normal human sera were obtained from healthy 
laboratory personnel. Sera of patients with systemic 
lupus erythematosus were obtained from outdoor and indoor 
patients of Department of Medicine, All India Institute 
of Medical Sciences, New Delhi and J.N. Medical College 
Hospital, A.M.U., Aligarh. The samples were transported 
to the laboratory in ice sodium chloride mixture. 
Patients with this disease satisfied the American 
Rheumatism Association Criteria for the diagnosis of SLE 
(Tan et al., 1982). All sera were stored at -20°C with 
0.1 percent sodium azide as preservative until examined. 
Serum samples were heated at 56°C for 30 min before use 
to inactivate complement. 
2.2.16. Immunological Techniques 
2.2.16.1. Direct binding ELISA 
Antibodies in SLE sera were detected and 
quantitated by ELISA as described earlier (Aotsuka et 
al., 1979). Decomplemented sera were serially diluted in 
TBS-BSA and were added to antigen coated plates for 2 hr 
at room temperature and overnight at 4°C. Bound 
antibodies were assayed with anti-human IgG alkaline 
phosphatase conjugate (1:1500 dilution in TBS) using p-
nitrophenyl phosphate as substrate. The absorbance of 
each well was monitored at 410 nm on an automatic 
microplate reader. 
2.2.16.2. Inhibition ELISA 
Antibody specificity was evaluated by 
competitive binding assay (Hasan et al., 1991). Serum 
samples at a dilution of 1:100 were incubated with 
increasing amounts (0-10 ug) of competitors for 2 hr at 
room temperature and subsequently overnight at 4°C. 
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Duplicate aliquots of immune complexes were added to 
native DNA coated plates and direct binding ELISA was 
performed. Inhibition was expressed as the amount of 
inhibitor resulting in a 50% decrease in antibody binding 
to the solid phase antigen. 
2.2.17. Data Analysis 
Absorbance values obtained with sera of 20 normal 
healthy individuals were used for determining the cut off 
level for distinguishing antibody positive and negative 
samples. The mean and standard deviation (S.D.) of the 
absorbance values was calculated and a value of 2 S.D's 
above the mean 0.17 was chosen as a cut off value. A test 
sample was positive if the mean absorbance of duplicate 
measurements was greater than 0.17 and negative if the 
mean absorbance was lower. 
2.2.18. Isolation of IgG from SLE Servim 
IgG was isolated from SLE serum by the method of 
Ali et al. (1991) . IgG was precipitated as 40% of the 
total Y-globulin fraction by 35% ammonium sulphate 
fractionation. After dissolving the precipitate in 
minimal volume of 0.01 M sodium phosphate buffer, pH 8.0, 
the excess of salt was removed by dialysis. The sample 
was loaded on DEAE Sephacel column (1.5 cm x 28 cm) 
previously equilibrated with 0.01 M sodium phosphate 
buffer, pH 8.0. IgG was eluted with phosphate buffer, 
using a linear gradient (10-300 mM). Fractions of 4.0 ml 
at a flow rate of 18 ml/hr were collected and monitored 
at 280 nm. Three peaks emerged, the first, at about 20 mM 
phosphate, contained pure IgG with a yield of about 80%. 
2.2.19. Formation and Quantitation of Immune Complexes 
Antigen-antibody interaction was performed by 
precipitin analysis under equilibrium conditions in 
Eppendorf microfuge tubes. Increasing amounts of antigen 
(0-50 ug) were added to a constant amount of antibody 
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(100 ug SLE IgG) in a total volume of 250 uL. The mixture 
was incubated for 2 hr at room temperature and overnight 
at 4°C. The immune complexes were pelleted at maximum 
speed for 2 min, washed twice with cold PBS, pH 7.4 and 
dissolved in 250 uL of 1 N NaCl. The concentration of 
protein and DNA in each sample was determined by the 
colorimetric assay of Lowry (1951) and Burton (1956) 
respectively. 
2.2.20. Calculation of Antibody Affinity 
The data from immune precipitation reaction were 
used to estimate the quantity of bound antigen in an 
equilibrium mixture of antigen and antibody for the 
calculation of apparent antibody affinity by the method 
of Langmuir (1918). The results were analysed by least 
square fit method. Affinity constant was computed from 
the slope of the plot. 
2.2.21. Chemical Modification of Amino Groups of Anti-ROS 
DNA IgG 
2.2.21.1. Acetylation of IgG 
Acetylation of IgG to modify lysine residues 
was performed according to the method of Riordan and 
Vallee (1972) using acetic anhydride as an acetylating 
agent. A solution of IgG of known concentration in 0.06 M 
sodium phosphate buffer was taken and to this was added 
the required amount of acetic anhydride with continuous 
stirring. The reaction was performed at 4°C and the pH of 
the reaction mixture was maintained between 7.4 to 7.6 by 
adding 1 N NaOH. The reaction was allowed to proceed for 
40 min. The modified protein was then dialysed against 
0.06 M sodium phosphate buffer, pH 7.0. Keeping all the 
reaction conditions as above, the molar excess of acetic 
anhydride over protein was changed from 50 to 1000 to 
effect different degrees of modification. 
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2.2.22. Quantification of Modification 
The extent of lysine residue modification of 
anti-ROS DNA IgG was determined by treatment with 
trinitrobenzene sulphonic acid (TNBS) as described by 
Habeeb (19 66) and by ninhydrin reaction (Moore and Stein, 
1954) . 
2.2.22.1. Reaction with TNBS 
To 1.0 ml of protein solution (modified and 
native IgG) was added 0.1 ml of TNBS solution in water. 
The mixture was incubated at 4 0°C for 2 hr at room 
temperature and 1.0 ml of 10% (w/v) SDS was added to 
solubilize the protein and to prevent its precipitation 
on addition of 0.5 ml of 1 N hydrochloric acid. The color 
intensity was recorded after 10 min at 335 nm against a 
blank treated in the same way except that it contained 1 
ml of water instead of protein solution. The extent of 
modification was calculated from the straight line plots 
between amount of protein (in mg) and absorbance at 335 
nm, for modified and unmodified preparations by using the 
following equation: 
Percent modification = 100 ( 1 - m'/m ) (i) 
where m' and m represent the slopes of the straight lines 
for modified and unmodified preparations respectively. 
2.2.22.2. Ninhydrin reaction 
Estimation of free amino groups was 
accomplished by the method described by Moore and Stein 
(1954) . 
(a) Preparation of hydrindantin 
Hydrindantin was prepared by reducing ninhydrin with 
ascorbic acid (Moore and Stein, 1954) . One gram of 
ninhydrin was dissolved in 25 ml of water at 90°C. 
Five ml of 20% (w/v) ascorbic acid was added slowly 
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to ninhydrin solution with continuous stirring. The 
reaction was allowed to proceed for 30 rain and the 
contents were cooled under tap water. The 
hydrindantin crystals, thus formed were filtered and 
dried in a dessicator, under reduced pressure. Dried 
crystals were stored in the dark. 
(b) Preparation of ninhydrin reagent 
Three hundred mg of ninhydrin and 100 mg of 
hydrindantin were dissolved in 76 ml of methyl 
cellosolve. To this was added 24 ml of 4 M sodium 
acetate buffer, pH 5.5. The contents were mixed 
thoroughly and filtered through Whatman filter paper. 
The reagent thus obtained was stored at 4°C in an 
amber colored bottle. 
(c) Method 
Increasing amounts of protein (0.1 to 1 mg) were 
taken in a series of tubes and volume made upto 1 ml 
with water. One ml of 4 M sodium acetate buffer, pH 
5.5 was added to each tube followed by the addition 
of 1 ml ninhydrin reagent. The tubes were placed in a 
boiling water bath for exactly 20 min and then cooled 
under tap water. Five ml of 50% (v/v) ethanol was 
added to each tube. The contents were mixed and 
filtered through a Whatman filter paper. The 
absorbance was recorded at 570 nm against an 
appropriate blank. Absorbance values at 570 nm were 
plotted against protein concentration (in mg) and 
data analysed by least square analysis. The extent of 
modification was determined by using equation (i). 
2.2.23. Effect of Modification on the Reactivity of Anti-
ROS DNA IgG 
The reactivity of modified IgG was determined by 
direct binding ELISA on microtitre polystyrene plates. 
The unmodified anti-ROS DNA was used as control. 
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3 R E S U L T S 
3.1. Analysis of Irradiated Samples 
Solutions of calf thymus DNA and DNA fragments of 
300 bp (0.15 mM) in PBS pH 7.4 were irradiated at room 
temperature in the presence of hydrogen peroxide using 
254 nm UV light. The irradiated samples were dialysed 
extensively against PBS to remove excess of hydrogen 
peroxide. The absorption spectra of the irradiated 
nucleic acid samples (ROS-DNA) were run using Shimadzu UV 
240 spectrophotometer. Figures 5 and 6 show the 
absorption spectra of modified/unmodified calf thymus DNA 
and DNA fragments of 3 00 bp in the wavelength range from 
200 nm - 400 nm. The irradiated nucleic acid samples in 
presence of hydrogen peroxide showed a marked increase in 
absorbance at 260 nm. However, exposure of DNA to 
hydrogen peroxide or UV light alone resulted in a slight 
increase in absorbance at 260 nm. The increase in 
absorbance observed when DNA is irradiated in presence of 
hydrogen peroxide reflects the presence in the treated 
DNA of single stranded regions. 
3.2. Thermal Melting of DNA 
Thermally induced transitions were measured 
spectrophotometrically at 260 nm by heating nucleic acid 
samples at a rate of 1°C per min. Melting curves were 
collected at temperatures from 30°C to 95°C. Increase in 
UV absorption at 260 nm was taken as a measure of 
denaturation. Figure 7 shows the thermal denaturation 
profile of native DNA and DNA hydrogen peroxide complex 
without UV irradiation. As evident from the data the 
samples did not show any hyperchromicity before the sharp 
transition between 85°C and 90°C. The observed 
hypochromic transition is consistent with the thermal 
stability range of native DNA at different temperatures. 
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The melting temperature of native DNA and DNA hydrogen 
peroxide complex at which fifty percent of the double 
helical structure is lost was found to be 89°C and 88°C 
respectively. On the other hand, heating of DNA complexed 
with hydrogen peroxide and exposed to UV light showed a 
progressive denaturation starting from 40°C which 
persisted till 90°C. Further heating of the sample from 
90°C to 95°C showed an insignificant increase in percent 
denaturation. The midpoint of the transition was found to 
be 76°C (Figure 7). The results exhibit a net decrease of 
13°C in the Tm value for the modified DNA when compared 
to its unmodified native conformer. These findings 
indicate, therefore, that the decrease in Tm to the 
extent of 13°C is due primarily to a structural 
alteration of the DNA which occurs upon generation of 
single stranded breaks. The hyperchromism rate and Tm 
values corresponding to the midpoints of the melting 
curves are listed in Table 3. 
Thermal denaturation studies were also carried out 
for hydroxyl radical modified and native DNA fragments of 
around 3 00 bp in length. As illustrated in Figure 8, the 
melting curves for modified DNA fragments display a 
progressive increase in denaturation from about 30°C 
onward. The midpoint of the transition is at 47°C. Native 
fragments showed a Tm of 55°C (Figure 8) and underwent a 
27.7% of total hyperchromicity. The percent 
hyperchromicity of modified fragment was computed to be 
18.9 (Table 3). These results further indicate a partial 
destruction of the secondary structure of DNA as a 
consequence of 'OH induced modification. 
3.3. Thermodynamic Study 
Thermodynamic aspects of hydrogen peroxide and UV 
light interaction with DNA was investigated by thermal 
denaturation studies. The free energy of denaturation 
( A Gj-,°) for native DNA decreased linearly from 30°C to 
85°C. The A was found to be -1.798 k.cal.deg"^ at 
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TABLE 3 
Ultraviolet and Thermal Denaturation characteristics of Native 
and ROS-Modified Nucleic Acid Samples Under Identical 
Experimental Conditions 
N U C L E I C P A R A M E T E R 
A C I D 
P O L Y M E R A b s o r b a n c e P e r c e n t M e l t i n g O n s e t o f 
R a t i o a t H y p e r c h r o m i - T e m p e r a t u r e D u p l e x 
2 6 0 / 2 8 0 c i t y a t 9 5 ° C ( T m ^ C ) M e l t i n g 
1 . N a t i v e DNA 1 . 9 2 3 5 . 0 1 89 85 
2 . DNA h y d r o g e n 1 . 8 5 3 A . 0 5 8 8 80 
p e r o x i d e c o m p l e x 
w i t h o u t UV 
i r r a d i a t i o n 
3 . I r r 8 d i a t e d D N A 1 . 9 0 2 8 . 6 6 76 50 
h y d r o g e n p e r o x i d e 
c o m p l e x 
4 . N a t i v e D N A 1 . 9 0 2 7 . 7 55 'iO 
( 3 0 0 b p ) 
5 . M o d i f i e d D N A 1 . 8 0 1 8 . 9 47 30 
( 3 0 0 b p ) 
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40°C and -0.900 k.cal.deg"^ at 85°C. The high negative 
values of from 30°C to 85°C indicate the 
tremendous thermodynamic stability of the duplex. Further 
elevation in temperature from 85°C to 87°C showed 
positive A values. The positive values of A h e r e 
indicate the sharp transition from the native to 
denatured state. 
Exposure of DNA to UV radiation in presence of 
hydrogen peroxide decreased the thermodynamic stability 
of the duplex as evidenced from the changes in A 
values. The AG q° was computed to be 2.322 k.cal.deg"^ 
at 40°C which decreased to 0.969 k. cal. deg"^ at 68°C. 
The observed positive A GQ° values of modified DNA can 
be attributed to the hydrogen bond breaks and loss in 
base stacking. These thermodynamic parameters are 
depicted in Table 4. 
3.4. Chromatography of Nucleic Acids on Hydroxyapatite 
Column 
Nucleic acids with different secondary structures 
have more affinity for hydroxyapatite than flexible, 
disordered polymers. Fractionation of nucleic acid 
samples was carried out on the basis of this property of 
hydroxyapatite. 
Calf thymus DNA samples (modified and unmodified) in 
10 mM sodium phosphate buffer, pH 6.8, were loaded on 
hydroxyapatite column equilibrated with the same buffer. 
After washing the column with the equilibration buffer, 
elution was performed with 0.125 M and 0.25 M potassium 
phosphate buffer, pH 6.8. The chromatogram obtained with 
native DNA showed only one peak centered at 0.25 M Pi 
(Figure 9 A). The chromatographic pattern of DNA exposed 
to UV light in presence of hydrogen peroxide was slightly 
different from that of native DNA, since most of the 
material was eluted by 0.25 M Pi and smaller fraction was 
eluted by 0.125 M Pi (Figure 9 C) , indicating that the 
minor fraction might be produced due to the generation of 
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TABLE 4 
Thermodynamic Characteristics of Native and ROS-Modified Nucleic 
Acid Polymers 
NUCLEIC ACID POLYMERS 
Native DNA ROS-DNA 
Temperature A G Temperature A G 
(Abs) k.cal.deg"^ (Abs) k.cal.deg~^ 
313 -1.798 313 2.322 
318 -1.826 318 2 .008 
323 -1.890 323 1.766 
328 -1.236 328 1.591 
333 -1.255 333 1.361 
338 -1.115 337 0.915 
343 -1.131 341 0.969 
348 -0.887 345 1. 060 
353 -0.900 349 1.235 
358 -1.462 351 -1.396 
360 1.983 353 -0.539 
361 2 .457 357 -0.997 
363 -0.084 359 -2.479 
3 65 -0.854 363 2.594 
ICQ 
E 
c 
g 
uj u 
2 
< 
CD cr o 1/1 
CD < 
FRACTION NUMBER 
Figure 9. Chromatography of nucleic acicj s a m p l e s on 1.5 cmxl4 cr: 
h y d r o x y a p a t l t G columns. Stepwise e l u t i o n as performed 
with 0.125 N and 0.25 N potassium phospha te b u f f e r , pH r..^ 
(A) Native DNA, (B) U n i r r a d i a t e d DNA-hydrogen peroxide 
complex, (C) I r r a d i a t e d DNA-hydrogen peroxide (;omplex. 
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single strand breaks. In contrast, native DNA treated 
with hydrogen peroxide alone showed the same elution 
pattern as native DNA (Figure 9 B). 
Modified and native DNA samples denatured by heating 
for 15 min at 100°C, at a concentration of 100 ug/ml in 
10 itiM sodium phosphate buffer, pH 6.8 and fast cooled, 
showed a chromatographic behaviour as depicted in 
Figure 10. These samples were eluted in a single peak at 
0.125 M Pi. The properties of the main fraction of 
denatured DNA were those of single stranded DNA in that 
its melting curve showed a slow continuous increase of 
^260' ^ hyperchromicity of 10-15%. 
3.5. Single Strand Breaks 
3.5.1. Sedimentation behaviour 
Following exposure to UV irradiation in presence 
of hydrogen peroxide, calf thymus DNA samples were 
processed for alkaline gradient centrifugation. Samples 
were denatured by the addition of 0.2 N NaOH, transferred 
to top of 5-20% linear alkaline sucrose gradient and 
sedimented at 37,000 rpm for 10.5 hr. Absorbance was read 
at 260 nm and data were plotted as absorbance at 260 nm 
against fraction number. Figure 11 shows representative 
sedimentation profile for modified DNA from native DNA 
and DNA treated with hydrogen peroxide alone. Changes in 
molecular weight of DNA, due to single strand breaks by 
hydrogen peroxide following UV irradiation can be 
observed as a change in the sedimentation rate. Native 
DNA banded as a sharp symmetrical peak at fraction 3 
(Figure 11 A), while modified DNA gave a broader peak at 
fraction 10, By comparison of the position of the first 
moment of the modified DNA samples with that of control, 
it can be seen that hydrogen peroxide treatment in 
presence of UV light has produced a decrease in molecular 
weight. 
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Figure 10. Chromatography of ca l f thymus DNA p r e p a r a t i o n s on 
hydroxy a p a t i t e columns. Stepwise e lu t lon of (A) hea t 
d e n a t u r e d ca]f thymus DNA, (B) h e a t d e n a t u r e d DNA-
hydrogen peroxide complex wi thout UV i r r a d i a t i o n , 
(C) h e a t d e n a t u r e d ROS-DNA. 
ICQ 
0.65 
F R A C T I O N N U M B E R 
Figure 11. Sedimentation pa t t e rns of u n i r r a d i a t e d and i r r a d i a t e d 
ca l f thymus DNA. Samples were l ayered on sucrose 
g rad i en t s ( 5 - 2 0 7 o ) and sedimented at 3 7 , 0 0 0 rpm for 
10.5 hr at room tempera tu re . Native DNA (A), DNA-hydrogen 
peroxide complex without UV i r r a d i a t i o n (Bj and 
ROS-DNA (C). 
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3.5.2. Electrophoretic pattern 
The polyacrylamide gel electrophoresis pattern of 
native DNA irradiated with UV light in the presence of 
hydrogen peroxide is shown in Figure 12. Polyacrylamide 
gel electrophoresis was carried out in 7.5% 
polyacrylamide gels under non-denaturing conditions. As 
evident from the data, modified DNA band (lane 4) 
migrated with enhanced mobility as compared to native DNA 
(lane 1). This difference in migration may be due to the 
changes in the secondary structure of modified DNA as 
opposed to the native double helical DNA. No difference 
in the migration was noted when DNA was treated with 
hydrogen peroxide or UV light alone (Figure 12, lanes 2 
and 3). 
When electrophoresis was carried out in denaturing 
polyacrylamide gels containing 7.0 M urea, more 
degradation of DNA exposed to UV radiation in presence of 
hydrogen peroxide was noted, as the band migrated with 
mobility higher than the bands in control gel. Figure 13 
shows the gel patterns obtained after treatment with 
7.0 M urea of modified (lanes 3 and 4) and control DNA 
samples (lanes 1 and 2). These results indicate that 
hydrogen peroxide treatment in presence of 254 nm light 
caused alterations in the secondary structure of DNA. 
3.5.3. Fluorescence measurements 
The presence of single strand breaks in hydroxyl 
radical modified DNA was further ascertained by 
fluorescence intensity measurements of gel slices. Gels 
run under non-denaturing conditions were stained with 
ethidium bromide, located, sliced and DNA extracted by 
diffusion. The extracted DNA was treated with ethidium 
bromide and quantitated by fluorescence intensity 
measurement. A significant difference in the peak pattern 
was observed between the native and modified DNA. The 
later material produced a broader peak with DNA 
distribution in various fractions (Figure 14 A) , while a 
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Figure 12. Polyacrylamide gel e lect rophoret ic pa t t e rns of nat ive and 
modified DNA polymers obta ined on 7.5% acrylamide gels 
at pH 8 .3 . The e lec t rophores is was c a r r i e d out at 70 
vo l t s . Lanes 1-3 represen t na t ive DNA, DNA t r ea t ed with 
hydrogen peroxide and DNA t r ea t ed with UV l i gh t . Lane 
4 represen ts hydroxyl r ad ica l modified DNA. 
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Figure 13. Polyacrylamide gel e lec t rophores is of nucleic acid 
polyiners. Samples were dena tu red with 7,0 M urea and 
e lec t rophores is was run for 12 hr at 70 volts (7.5% ge l ) . 
Lanes 1 and 2 represen t u n i r r a d i a t e d contro] and nat ive 
DNA. Lanes 3 and 4 represen t hydroxyl r a d i c a l modified 
DNA. 
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sharp peak was observed in case of native DNA and DNA 
treated with hydrogen peroxide alone (Figure 14 B) . This 
broader distribution of DNA noted in modified fractions 
can be ascribed to the presence of single stranded 
regions in treated DNA. 
Fluorescence intensity profile of modified DNA 
extracted from denaturing gel slices is shown in Figure 
15. Modified samples showed pattern different from that 
of control denatured DNA samples as most of the material 
was distributed in large number of fractions. The control 
DNA samples were distributed in one symmetrical peak 
(Figure 15) . These results reflect the presence of single 
stranded breaks in hydroxyl radical modified DNA. 
3.6. Nuclease SI Digestion of Modified DNA 
Calf thymus DNA treated with hydrogen peroxide and 
exposed to 254 nm light was digested with nuclease SI 
(20 units/ug DNA). The residual DNA was detected by 
agarose gel electrophoresis. Control experiments were 
carried out with native DNA and nuclease SI treated 
native DNA and DNA hydrogen peroxide complex without UV 
irradiation. Figure 16 shows the nuclease SI 
susceptibility of modified and unmodified DNA samples. In 
case of modified DNA, there is a major loss of double 
strandedness as indicated by the enhanced, mobility of DNA 
band (lane 4), whereas native DNA and DNA hydrogen 
peroxide complex are essentially unaffected (Figure 16, 
lanes 2 and 3). Hydrogen peroxide in presence of UV light 
therefore created sufficient structural alterations in 
DNA to be substrate for single strand specific nuclease 
SI. 
3.7. Hydrogen Peroxide Induced Modification of 
Pyrimidine and Purine Bases 
In order to separate the modified bases, hydrogen 
peroxide treated and UV light exposed DNA solutions were 
subjected to acid hydrolysis. The neutralized hydrolysate 
ICQ 
cn z LU 
T — 
2 
IL/ o 
2 LU (J UJ cr o o 
16 0 4 
F R A C T I O N N U M B E R 
Figure 14. Fluorescence in tens i ty profi le showing s ing le s t r a n d 
breaks i n ROS-DNA ex t rac ted from no n - d e n a t u r i n g 
polyacrylamide gels . (A) ROS-DNA ( ) and nat ive DNA 
( - O - ) . (B) DNA-hydrogen peroxide complex without UV 
i r r a d i a t i o n ( - O - ) . 
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Figure 15. Fluorescence in tens i ty profi le showing s ing le s t r a n d 
b reakage in ROS-DNA ex t rac ted ft-om dena tu r ing 
poly acryl amide gels . ROS-DNA ( -it- ) , na t ive DNA ( - 0 - ) 
and u n i r r a d i a t e d contro] ( - • - ) . 
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Figure 16. Nuclease SI suscep t ib i l i ty of nucleic acid polymers as 
detected by hor izontal agarose gel e lec t rophores i s . Lanes 
1-3 r ep resen t nat ive DNA, SI t r e a t ed DNA and SI t r ea ted 
DNA-hydrogen peroxide complex. Lanes 4 and 5 represen t 
SI t r ea t ed and un t rea ted ROS-DNA respec t ive ly . 
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was applied to a DEAE Sephadex A 25 column and eluted by 
a linear concentration gradient of 1 mM - 20 mM Tris-HCl 
buffer. Control experiments were carried out with 
equimolar mixture of individual bases and hydrolysed 
native DNA. A typical elution profile of four bases is 
shown in Figure 17. Peaks 1,2,3 and 4 represent cytosine, 
thymine, adenine and guanine respectively. The peak 
fractions of 1,2,3 and 4 peaks of the chromatogram showed 
maxima at 264 nm, 262 nm, 258 nm and 272 nm, the 
characteristics corresponding to the samples of cytosine, 
thymine, adenine and guanine respectively. The elution 
pattern of hydrolysed calf thymus DNA was similar to the 
pattern obtained with individual bases (Figure 18). 
Exposure of DNA to hydrogen peroxide in presence of 
UV light resulted in the formation of six base products. 
Figure 19 illustrates the ion exchange profile obtained 
with hydrolysate of modified DNA. The products were 
identified spectrophotometrically and by comparison of 
the chromatographic patterns with standard bases. The 
first peak collected from the column represents cytosine. 
The second and third peak collected corresponds to 
modified and unmodified thymine respectively, while 
fourth and fifth peak represents modified and unmodified 
adenine. Guanine was eluted in a single peak (sixth). The 
extent of modification was determined by measuring the 
peak areas of the modified and their corresponding 
unmodified bases (as control). Thymine was found to be 
modified to the extent of 54%, while adenine around 20%. 
These results are shown in Table 5. 
A similar distribution of base products was obtained 
with hydrogen peroxide treated and UV exposed DNA 
fragments of around 300 bp. Figure 20 shows the elution 
pattern of hydroxyl radical modified DNA fragments. The 
profile indicates the modification of adenine and thymine 
to the extent of 21.7% and 48% respectively. No 
modification was observed in cytosine and guanine 
residues. These results indicate that the thymine was the 
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F igu re 17. F r ac t i ona t i on of equimolar mixture of p u r i n e and 
pyr imid ine bases on DEAE Sephadex A 25 column. Peaks 
1,2, 3 and 4 r e p r e s e n t cy tos ine , thymine , adenine and 
g u a n i n e r e s p e c t i v e l y . 
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Figure 18. F rac t iona t ion of acid hydro lysed na t ive ca l f thymus DNA 
on DEAE Sephadex A 25 column. Peaks 1 , 2 , 3 and 4 
r e p r e s e n t cy tos ine , thymine , adenine and guanine 
r e s p e c t i v e l y . 
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Figure 19. Chromatographic proHle of acid h y d r o l y s a t e of ROS-DNA 
on DEAE Sephadex A 25 column. The modified bases have 
been s h a d e d . 
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TABLE 5 
Modification of Bases in DNA Exposed to Hydroxyl Radical 
BASE 
PERCENT MODIFICATION 
Native DNA DNA fragments of 3 00 bp 
Cytosine 
Adenine 
Thymine 
20 
54 
21.7 
48 
Guanine 
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Figure 20. Chromatography of an acid hydroJysa te of 
bp on DEAE Sephadex A 25 column. The 
have been s h a d e d . 
ROS-DNA of 300 
modified bases 
ICQ 
major modified base product. 
3.8. Antigenicity of Modified DNA 
The antigenicity of hydroxyl radical modified DNA 
was probed by inducing antibodies in goat. In order to 
evaluate the repertoire of specificities of these 
antibodies, their binding was assessed by direct binding 
and inhibition ELISA. Gel retardation and quantitative 
precipitin assays were also employed to further 
characterize the binding of induced antibodies. 
3.8.1. Evaluation of antibody response 
Direct binding ELISA for the detection of anti-
modified DNA antibody was used to characterize the immune 
goat serum. The antiserum showed a titre greater than 
1:25600 (Figure 21). Preincubation of the serum with 
10 ug/ml modified DNA inhibited 79% of the antibody 
binding to the immunogen. Preimmune goat serum as control 
did not show any binding with the modified DNA. 
3.8.2. Purification and binding characteristics of 
immune IgG 
Immunoglobulin G was isolated from immune and 
preimmune goat serum by DEAE Sephacel column 
chromatography of 35% saturated ammonium sulphate 
precipitated y-globulin fraction (Figure 22). The ion 
exchange purified IgG was further passed through a 
Sephadex G 200 column (Figure 23) . The result of the 
purification was evaluated by SDS-polyacrylamide gel 
electrophoresis in the absence of reducing agent. The 
purified IgG migrated as a single band upon 
electrophoresis as shown in Figure 24. 
The activity of Sephadex G 200 purified IgG was 
evaluated by direct binding ELISA. Figure 25 shows the 
representative results from the studies of the binding of 
purified antibodies to modified and native polymer. The 
immune IgG exhibited a strong binding to immunogen. 
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F igure 21. Binding of immune I 
an t ibodies to ROS-DNA. 
and preimmune ( - O - ) serum 
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Figu re 22. Elut ion profiJe of immune IgG on DEAE Sephacel column. 
The IgG was e lu ted with phospha te b u f f e r , pH 8 .0 us ing 
a l i n e a r g r a d i e n t of 0.01 M - 0 .3 M. 
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Figure 23. Elution prof i le of immune IgG on Sephadex G 200 column. 
The column (2.4 cm x 50 cm) was e q u i l i b r a t e d with 
M phosphate b u f f e r , pH 8 .0 . Approximately 10 mg of 
was appl ied onto the column. The column was r u n 
at a flow ra t e of 15 ml hr ^ . 
0.15 
IgG 
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Figure 24. SDS-po]yacry] amide gel e lec t rophores is of Sephadex G 200 
pur i f ied immune IgG. Lanes (1-4) r ep re sen t f r ac t ions 
24-27 of Sephadex G 200 chrom atogram. Lane 5 represents 
s t a n d a r d protein marker . 
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Figu re 25. Binding of anti-ROS DNA IgG to ROS-DNA ( - * - ) and 
na t ive DNA ( - e - ) . The b ind ing of prelmmune goa t leG 
to e i the r of the an t igens ( - O - ) . 
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Besides iminunogen, the antibodies also showed effective 
binding with native DNA. Preiminune IgG as control showed 
negligible binding to either of these antigens 
(Figure 25), 
3.8.3. Specificity of induced antibodies 
The specificity of the induced antibodies for 
antigenic determinants on modified DNA was evaluated by 
competitive binding assays. A maximum of 87% inhibition 
was recorded at an inhibitor concentration of 5 ug/ml 
(Figure 26). The concentration of the competitor required 
for fifty percent inhibition was 0.2 ug/ml. 
3.8.4. Immune cross reactivity of anti-ROS DNA 
antibodies 
The anti-ROS DNA antibodies exhibited a broad 
spectrum of reactivity as demonstrated by its binding to 
a variety of nucleic acid antigens. Competition 
experiments with native DNA showed a considerable 
inhibition in antibody activity. Preincubation of immune 
antibodies with native DNA inhibited the binding of this 
antibody to modified DNA by 62% at 10 ug/ml (Figure 26). 
Fifty percent inhibition was achieved with 1.0 ug of 
native DNA. Antibody was inhibited in its binding to 
modified DNA by heat denatured DNA, producing a maximum 
of 60% inhibition at an inhibitor concentration of 
10 ug/ml (Figure 27) , The amount of heat denatured DNA 
that caused 50% inhibition was 2.2 ug/ml. Antibody 
recognition of poly(rG). poly(dC), a polymer known to be 
present in A-/analogous conformation, resulted in 40% 
elimination of antibody binding with 10 ug of inhibitor. 
Binding of antibodies to homopolymers poly(dG), poly(dA), 
poly(dT) and poly(dC) was also characterized by 
competition experiments. None of these polymers showed 
more than 15% inhibition in antibody binding (Figure 27). 
The contribut ion of sugar moiety was evaluated by binding 
to RNA. Total RNA from buffalo thymus was an ineffective 
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Figu re 26. I n h i b i t i o n of an t ibody b ind ing by ROS ( - O - ) and na t ive 
DNA ( — ) . The microt i t re pl.ates were coated with 
ROS-DNA (2 .5 ug/ml) and IgG was used a t a c o n c e n t r a -
t ion of 4 .0 ug /ml . 
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Figure 27. I n h i b i t i o n of anti-ROS DNA an t ibody b ind ing to ROS-DNA 
by nucleic acid polymers. Competitors were: hea t 
d e n a t u r e d DNA from ca l f thymus ( -•#- ) , poly (rGK 
poly(dC) ( - 0 - ) ; poly(dA) ( -t^!- ); poly(dT) (-•)f-) and 
poly(dC) ( - ik- ) . 
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inhibitor for anti-ROS DNA antibodies. Competition ELISA 
with calf thymus DNA brominated in high salt 
concentration showed poor inhibition of antibody binding. 
Fifty percent inhibition data summarized for all the 
competitors are given in Table 6. 
3.8.5. Inhibition studies by polynucleotides 
To further define the structural determinants 
recognized by anti-ROS DNA antibodies, their interaction 
with various synthetic polydeoxyribonucleotides was 
studied. These right handed helical double stranded 
polynucleotides differ slightly from the average B-DNA 
helix and can be used as probes for specificity analysis. 
Figure 28 depicts the inhibition of the binding of anti-
ROS DNA antibodies to modified polymer coated plates by 
poly(dA-dU).poly(dA-dU), poly(dG-dC).poly(dG-dC) and 
poly(dA-dG).poly(dC-dT). Fifty percent inhibition was 
achieved with 5.5 ug poly (dA-dU) . poly (dA-dU) and 5.0 ug 
of poly(dG-dC).poly(dG-dC) and poly(dA-dG).poly(dC-dT) 
respectively. Figure 29 shows representative competition 
assays in which poly(dA-dT).poly(dA-dT), 
poly(dG).poly(dC) and poly(dl-dC).poly(dl-dC) were 
employed as inhibitors. Here, the strong cross reaction 
with poly(dA-dT).poly(dA-dT) was observed; 1.05 ug of 
this polymer was required for 50% inhibition. Maximum 
inhibition obtained was 65% at an inhibitor concentration 
of 10 ug/ml. The amount of poly(dG).poly(dC) that caused 
50% inhibition was 5.0 ug/ml, while 50% inhibition could 
not be achieved with poly (dl-dC) . poly (dl-dC) at the 
concentrations tested. These data suggest that for the 
synthetic polydeoxyribonucleotides, the sugar phosphate 
moiety was relevant to the antigenic determinants of 
induced antibodies. Table 7 lists the results for all 
synthetic polynucleotides in terms of the amount of 
competitor required for 50% inhibition. 
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TABLE 6 
Inhibition of Anti-ROS DNA Antibody Binding to ROS-DNA by a 
Variety of Nucleic Acid Polymers 
Competitor 
Concentration Maximum Percent Percent Relative 
for 50% Inhibi- Inhibition at Affinity 
tion^ (ug/ml) 10 ug/ml 
Modified DNA 0.20 87 100 
Native DNA 1. 00 62 20 
ssDNA 2 .20 60 9. 09 
Poly(rG).poly(dc) NIL 40 -
Poly(dA) NIL NIL -
Poly(dG) NIL NIL -
Poly(dT) NIL NIL -
Poly(dC) NIL NIL -
RNA NIL NIL -
Br-DNA NIL NIL -
a) Anti-ROS DNA antibody at 4.0 ug/ml was preincubated for 2 hr 
with increasing concentrations of polynucleotides and assayed 
for residual binding to ROS-DNA 
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Figure 28. Inh ib i t i on of antL-ROS DNA antntx»dy binding by 
polynucleot ides . The ant ibody was incuba ted with 
i n c r e a s i n g amounts of polynucleotides and then tes ted for 
r e s i d u a l b inding to ROS-DNA. Poly (dA-dU). poly(dA-dU) 
( - A - ) ; poly(dG-dC).poly(dG-dC) ( - 4 - ) and poly(dA-dG). 
poly(dC-dT) ( - O - ) . 
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Figure 29. Inh ib i t ion of binding of anti-ROS DNA antibodies to 
ROS-DNA by polynucleot ides . Competitors were: poly(dA-dT), 
poly(dA-dT) ( 
po ly (d I -dC) .po ly (d I -dC) 
poly(dG).poly(dC) 
- o - ) . - A - ) and 
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TABLE 7 
Inhibition of the Binding of Anti-ROS DNA Antibodies by 
Synthetic Polynucleotides 
Polynucleotide 
Amount of Poly-
nucleotide (ug/ml) 
Producing 50% 
Inhibition^ 
Percentage 
Inhibition 
Poly(dA-dU).poly(dA-dU) 5.5 55 
PoIy(dG-dC).poly(dG-dC) 5. 0 58 
Poly(dA-dG).poly(dC-dT) 5.0 60 
Poly(dA-dT).poly(dA-dT) 1. 05 65 
Poly(dG).poly(dC) 5.0 59 
Poly(dl-dC).poly(dl-dC) >10. 0 35 
a) Where 50% inhibition was not reached, a sign is employed 
followed by the highest amount of polynucleotide tested 
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3.8.6. Quantitative precipitin analysis 
Antigen-antibody interactions were quantitated by 
precipitin titration. Increasing amounts of hydroxyl 
radical modified DNA were added to a fixed amounts of 
immune IgG. The resulting immune complexes were 
precipitated by the addition of anti-goat IgG. The amount 
of bound DNA in immune complexes was determined 
colorimetrically (Burton, 1956). Preimmune goat IgG was 
used as anti-DNA antibody negative control. Figure 30 
shows the binding of the antigen to immune antibodies in 
precipitin titration assay. At the point of maximum 
binding, 10 ug of modified DNA was bound. The total input 
of DNA was 20 ug and this indicates that at most 50% of 
the antigen was apparently bound to immune IgG. Half 
maximal binding occurred when approximately 5 ug of 
antigen was added. No significant binding of preimmune 
goat IgG was demonstrated when it was supplemented with 
modified antigen (Figure 30) . 
Langmuir isotherm plot was used to evaluate the 
antibody affinity. The affinity constant of immune IgG 
for modified DNA was in the order of 1.142 x 10~® M. 
3.8.7. Binding of anti-ROS DNA antibodies to modified 
and native DNA fragments 
Modified and native DNA fragments of 3 00 bp were 
used to determine how the formation of complexes between 
these fragments and immune antibodies affect the 
migration of DNA in agarose gels. Constant amounts of 
modified and native DNA fragments were incubated with 
immune IgG for 2 hr at room temperature and overnight at 
4°C. The electrophoretic separation of these fragments 
from their protein bound counterparts was achieved in 1% 
agarose gels, buffered with TAE pH 8.0, that were run at 
room temperature for 2 hr at 30 V. The addition of immune 
IgG resulted in a slower migration of DNA bands. The 
modified DNA fragments were shifted to a slower migrating 
form at an antibody concentration of 25 ug/ml (Figure 31, 
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Figure 30. Binding cu rves i l l u s t r a t i n g the amount of ROS-DNA bound 
to immune IgG in a q u a n t i t a t i v e p r e c i p i t i n a s s a y . 
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Figure 31. Gel r e t a r d a t i o n a s s a y of the b ind ing of immune IgG to 
na t ive and ROS-DNA f r a g m e n t s . Lanes 1, 2 and 4 
con ta ined modified an t igen (5 u g ) , immune IgG (25 ug) 
and na t ive DNA (300 bp, 5 ug) r e s p e c t i v e l y . Lanes 3 
and 5 con ta ined immune IgG (25 ug and 30 ug) alongv-^ith 
5 ug each of ROS and na t ive DNA f r a g m e n t s . 
101 
lane 3), whereas native fragment was slowed at a slightly 
higher antibody concentration of 30 ug/ml. These results 
demonstrate the identification of differential 
interactions of anti-ROS DNA antibodies with modified and 
native fragments of 300 bp. Normal goat IgG did not show 
immune complex formation. 
3.9. Antigenicity of ROS-DNA Fragments of 3 00 bp 
To investigate the immunogenicity of anti-ROS DNA 
antibodies, female rabbits were immunized with modified 
fragments of 300 bp. The specificity of the induced 
antibodies was determined by various immunological 
techniques including direct binding ELISA, inhibition 
ELISA and gel retardation assay. 
3.9.1. Direct binding studies 
Rabbit antiserum was tested by direct binding 
ELISA using ROS-DNA as coating antigen. The antiserum 
demonstrated a positive titre greater than 1:3200 
(Figure 32). Normal rabbit serum under these conditions 
failed to show any binding. At a serum dilution of 1:100, 
preincubation of the serum with 10 ug/ml ROS-DNA 
inhibited 80% of the binding activity of the serum. 
Preincubation of the serum with native DNA caused 55% 
inhibition of the antibody binding. These results are 
given in Table 8. 
Immune IgG was precipitated from rabbit serum and 
isolated by DEAE Sephacel column chromatography. Isolated 
IgG was further subjected to purification on Sephadex 
G 200 column (Figure 33). The purity of the isolated IgG 
was determined by SDS-PAGE under non-reducing conditions. 
The eluted fractions contained a single protein band 
(Figure 34). 
Direct binding ELISA was used to determine the 
activity of purified IgG. As shown in Figure 35, immune 
IgG exhibited high binding to ROS-DNA fragments. Besides 
immunogen, antibodies showed effective binding with 
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F igure 32. Binding of anti-ROS DNA ant ibodies to ROS-DNA. 
Immune ( - O - ) and preimitiune ( ) s e r a . 
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TABLE 8 
Binding Characteristics of Anti-ROS DNA Antibody 
Competitor 
Absorbance 
at 410 nm 
Percent 
Inhibition at 10 ug/ml 
1.15 
ROS-DNA fragment 
(300 bp) 
0.230 80 
Native DNA fragment 
(300 bp) 
0. 517 55 
A 1:100 dilution of rabbit serum was preincubated for 2 hr at 
room temperature with selected inhibitors 
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Figure 33. Elution profiJe of immune IgG on Sephadex G 200 column. 
buf fer p r s . o " ' ' with 0.15 M phospha te 
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Figure 34. Polyacry] amide gel e lec t rophoredc pa t t e rn of anti-ROS 
DNA IgG. The sample was run on 7 . 5 7 o SDS-poly aery] amide 
gels at pH 8 ,3 . Lanes (2-6) r ep resen t peak f rac t ions 
(12-16) of Sephadex G 200. chrom atogram. Lane 1 
represen ts s t a n d a r d protein marker . 
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Figure 35. Direct b ind ing of anti-ROS DNA ant ibody with ROS ( - O - ) 
and na t ive DNA of 300 bp ( ) . Preimmune IgC with 
e i the r of the an t igens ( - X - ) . 
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native double stranded DNA. Normal rabbit IgG under these 
conditions did not show any significant binding with 
either of the antigens (Figure 35). 
3.9.2. Inhibition studies 
To determine the specificity of induced 
antibodies, competition ELISA was performed by employing 
modified polymer as an inhibitor. Figure 36 shows the 
competitive curve for modified DNA of 300 bp that was 
able to inhibit the binding of induced antibodies to ROS-
DNA coated wells. The incubation of 10 ug/ml of modified 
fragments with antibody inhibited the binding of this 
antibody by 89%. Fifty percent inhibition was recorded at 
an inhibitor concentration of 0.01 ug/ml. Besides 
immunogen, induced antibodies were inhibited in their 
binding to modified fragments by native double stranded 
fragments, inhibiting upto 60% of the antibody binding. 
The amount of native DNA required for 50% competition was 
0.04 ug (Figure 36). While native DNA proved to be an 
effective inhibitor, total RNA from buffalo thymus showed 
poor inhibition of anti-ROS DNA antibody binding. 
However, heat denatured DNA showed significant inhibition 
in antibody binding. A maximum of 62% inhibition was 
recorded at an inhibitor concentration of 10 ug/ml, while 
0.1 ug of the polymer caused 50% reduction in antibody 
binding (Figure 37) . Binding of antibodies to various 
synthetic homopolymers poly(dT), poly(dA) and poly(dG) 
was also evaluated by competition studies. All these 
polymers were found to be ineffective inhibitors, showing 
not more than 20% inhibition in antibody binding 
(Figure 37). Poly(rG).poly(dC), a polymer known to be 
present in A-/analogous conformation, inhibited the 
binding of antibodies to ROS-DNA fragment upto 40% at an 
inhibitor concentration of 10 ug/ml (Figure 37). 
Relatively higher amount (20 ug/ml) was required for 50% 
inhibition. Competition ELISA with brominated calf thymus 
DNA showed poor inhibition of antibody binding. These 
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Figure 36. Competition b inding experiments with anti-ROS DNA 
ant ibodies from rabb i t s immunized with ROS-DNA of 300 
bp . The percent inh ib i t ion of b ind ing to modified 
f r agment is shown as a funct ion of the amount of nucleic 
acid added as competitor in ELISA. Modified DNA ( - # - ) 
and nat ive DNA ( - O - ) . 
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Figure 37. Inh ib i t ion of antibody binding by nucleic acid poiymers. 
The pla tes were coated with ROS-DNA of 300 bp (2.5 ug/ 
m]) and IgG was used at a concent ra t ion of 10 ug/ml . 
The inh ib i to r s \<icre: heat dena tured calf thymus DNA 
( - # - ) ; i ^ ly ( rG) .po ly(dC) ( O ); i.x^ly(dA) ( -tA^ - ); 
poly(dT) ( -A.- ) and poly (dG) ( ). 
antibody binding characteristics of purified IgG are 
depicted in Table 9. 
3.9.3. Competition studies by polynucleotides 
Multiple cross reactions were found between 
induced antibodies and various right handed helical 
double stranded polydeoxyribonucleotides which differ 
slightly from average B-DNA helix. Figure 38 shows the 
inhibition of antibody binding to ROS-DNA fragments by 
poly(dA-dG).poly(dC-dT), poly(dA-dU).poly(dA-dU) and 
poly(dC).poly(dC). All these polynucleotides effectively 
inhibited the antigen - antibody interaction. The amounts 
of poly(dA-dG).poly(dC-dT), poly(dA-dU).poly(dA-dU) and 
poly(dG).poly(dC) that caused 50% inhibition were 0.4 ug, 
5.0 ug and 4.0 ug respectively. Figure 39 shows the 
results when poly(dA-dT).poly(dA-dT), poly(dG-
dC).poly(dG-dC) and poly(dl-dC).poly(dl-dC) were used to 
inhibit ROS-DNA antibody reaction. Poly(dA-dT).poly(dA-
dT) was more effective than poly(dG-dC) ,poly(dG-dC) and 
poly(dl-dC).poly(dl-dC) as competitors producing a 
maximum inhibition of 63% at an inhibitor concentration 
of 10 ug/ml. Poly(dG-dC).poly(dG-dC) and poly(dI-
dC).poly(dl-dC) at concentration of 10 ug/ml produced a 
maximum of 56% and 40% inhibition of antibody binding. 
Fifty percent inhibition required 5.0 ug of poly(dG-
dC) . poly(dG-dC) , while 50% inhibition could not be 
achieved with poly(dl-dC).poly(dl-dC). Table 9 gives the 
summarized data on the binding of these polynucleotides 
to anti-ROS DNA antibodies. 
3.9.4. Gel retardation assay 
Antibody binding to modified and native DNA 
fragments (average size 300 bp) was studied in 1% agarose 
gels. When mixtures of antibody and DNA fragments were 
subjected to agarose gel electrophoresis, the antigen-
antibody complexes showed a significant decrease in 
mobility. Figure 40 shows that ROS-DNA fragments are 
110 
TABLE 11 
I n h i b i t i o n o f Rabbi t A n t i - R O S DNA Ant ibody B i n d i n g t o ROS-DNA 
(300 bp) by a V a r i e t y o f S y n t h e t i c P o l y n u c l e o t i d e s 
Competitive 
Inhibitor 
A m o u n t o f P o l y -
n u c l e o t i d e ( u g / m l ) 
P r o d u c i n g 50% 
Inhibition 
M a x i m u m P e r c e n t 
I n h i b i t i o n a t 
10 u g / m t 
P e r c e n t 
Relative 
A f f i n i t y 
R O S - D N A o f 300 bp 0.01 89 100 
N a t i v e DNA o f 300 bp 0 .04 6 0 25 
P o l y ( d A - d G ) . p o l y ( d C - d T ) 0 . -i 0 58 2 . 5 
P o l y ( d A - d U ) . p o l y ( d A - d U ) 5 . 0 56 
p o l y ( d G ) . p o l y ( d C ) 4 . 0 58 
SSDNA 0 . 1 62 1 0 
p o l y ( r G ) . p o l y ( d C ) 50 
RNA N I L N I L 
B r - D N A N I L N I L 
p o l y ( d A - d T ) . p o l y { d A - d T ) 1 . 0 63 
p o l y ( d G - d C ) . p o l y ( d G - d C ) 5 . 0 56 
p o l y C d l - d C ) . p o l y ( d I - d C ) N I L 40 
po I y ( d T ) 
p o I y ( d A ) 
N I L 
N I L 
N I L 
N I L 
po I y ( d G ) N I L N I L 
I n h i b i t i o n a t 20 u g / m l 
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COMPETITOR CONCENTRATION (ug/ ml) 
Figure 38. Competitive immunoassay of anti-ROS DNA ant ibodies with 
po lynuc leo t ides . The an t ibodies were i ncuba t ed with 
v a r i o u s polynucleot ides and then t e s t ed for r e s idua l 
b ind ing to ROS-DNA. Poly( dA-dG). poly( dA-dG) ( ) ; 
poly{dA-dU).po]y(dA-dU) ( - O - ) and po]y(dG) .poly(dC) 
( -A- ). 
z o 
S i z 
a 
UJ a. 
Figure 39. I nh ib i t i on of 
po lynuc leo t ides , 
were Incuba ted 
t r a n s f e r r e d to 
COMPETITOR CONCENTRATION ( jjg/ml ) 
anti-ROS DNA an t ibody b ind ing by 
Various concen t r a t ions of pxilynucleotides 
with the an t ibody and the mixture was 
- -- modified DNA of 300 bp coated wells 
Po]y(dA-dT) .po]y(dA-dT) ( O - ); poly( dG-dC). poly( dG-dC) 
) and poly ( d l - d C ) . p o ] y ( d l - d C ) ( ) . 
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bound by a n t i b o d i e s at a p r o t e i n c o n c e n t r a t i o n o f 
25 ug/ml (lane 4) and are s h i f t e d to a s lower migrat ion 
form. Nat ive DNA species i s bound by the antibody at a 
h igher concentrat ion of 50 ug/ml ( F igu re 40, lane 5 ) . 
F igu re 41 shows the formation of complexes between 
immunized ant ibodies and nat ive DNA fragments of 300 bp. 
When inc reas ing amount of antibody p r o t e i n was added to 
n a t i v e DNA f ragment s , the a n t i g e n - a n t i b o d y complexes 
showed d i f f e r e n t degree of r e t a r d e d m o b i l i t y . W i t h 
i n c r e a s i n g c o n c e n t r a t i o n of a n t i b o d y , the amount of 
immune complexes was found increased as judged by t h e i r 
f luorescence i n t e n s i t y , whereas the amount of unbound DNA 
f ragments i n d i c a t e d p r o p o r t i o n a l decrease i n t h e i r 
concentrat ion (lane 1 to 5) . The nat ive DNA fragments 
were completely slowed at an antibody concentrat ion of 
100 ug/ml ( F igu re 41, lane 5 ) . 
3.10. Characterization of Human Anti-DNA Autoantibodies 
Sera f rom twe lve p a t i e n t s w i t h s y s t e m i c l u p u s 
erythematosus having high t i t r e anti-DNA ant ibodies w i t h 
preference f o r nat ive DNA were tes ted f o r i t s b inding 
w i t h ROS-DNA. Such ant ibodies were found i n 10 out of 12 
SLE p a t i e n t s w i t h v a r i o u s t i t r e s . I n c o n t r a s t , no a n t i -
ROS DNA ant ibodies could be demonstrated i n the sera of 
20 normal s u b j e c t s (Table 10) . DNA binding was defined by 
absorbance values of >2 S .D . above the mean of 0.17 f o r 
20 normal human serum c o n t r o l s . 
3.10.1. Reactivity of SLE sera with native and modified 
DNA 
The b i n d i n g p a t t e r n o f serum a n t i b o d i e s to 
modif ied and nat ive DNA from twelve p a t i e n t s w i t h SLE was 
determined by E L I S A . Serum responses to modif ied and 
nat ive DNA were detected f o r 10 out of 12 p a t i e n t s . The 
r e s u l t s of d i r e c t b inding of these SLE autoant ibodies 
showed that a l l these ant ibodies had s t ronger b ind ing to 
modif ied DNA (F igu re 42) . For a l l the sera tes ted , an 
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DNA ant ibodies 
as ana lysed by 
ug) f ragments (5.0 
to nat ive DNA 
gel r e t a rda t i on 
were incubated 
Figure 41. Binding of anti-ROS 
fragments of 300 bp 
a s say . Native DNA 
with buffer ( lane 1) and i nc rea s ing concentra t ions of 
anti-ROS DNA antibodies (25 ug - l ane 2; 50 ug - l ane 3; 75 
ug - l ane 4 and 100 ug - l ane 5) for 2 hr at room 
temperature and ove rn igh t at 4°C. Electrophoresis was 
ca r r i ed out with 1% agarose gels for 2 hr at 40 volts . 
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TABLE 10 
Nat ive and ROS-DNA B ind ing Capacity of Sera from Normal Sub jects 
and P a t i e n t s w i t h Systemic Lupus Erythematosus 
Sera 
From 
Number of Sera 
Tested 
Number of Sera 
P o s i t i v e 
Percent 
P o s i t i v e 
Normal sub ject s 20 
SLE 12 10 83.33 
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F igure 42. Binding of anti-DNA 
with d i f f e r e n t levels 
( ) , ( ) and 
au toan t ibod ies to ROS-DNA. SLE s e r a 
of an t ibody ac t i v i t y ( - * - ) , ( - A - ) , 
an t ibody nega t ive cont ro l ( -A- ). 
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approximately 30% increase i n mean absorbance value was 
observed f o r modif ied DNA as compared to nat ive DNA. 
These r e s u l t s are presented i n Table 11. 
3.10.2. Specificity of SLE autoantibodies 
I n an attempt to f u r t h e r c h a r a c t e r i z e the 
ant ibod ies , competit ion experiments of the binding of 
v a r i o u s S L E s e r a to n a t i v e and m o d i f i e d DNA were 
employed. Twelve sera were used f o r these as says . Native 
as w e l l as modif ied polymer was used as i n h i b i t o r . These 
r e s u l t s presented i n F igu re 43, ind icate that modif ied 
DNA i s the best i n h i b i t o r i n ten sera out of 12 s tud ied. 
I n c o n t r a s t , nat ive DNA competes l e s s e f f i c i e n t l y . Only 
i n one case did nat ive DNA possess an important competing 
e f f i c i e n c y as i t was able to i n h i b i t 70% of the react ion . 
As shown i n Table 12, there was a wide range i n the 
double s t randed DNA c o n c e n t r a t i o n r e q u i r e d f o r f i f t y 
percent i n h i b i t i o n i n the EL ISA vary ing from 0 .5 ug to 
10 .0 ug/ml. The amount of modif ied DNA requ i red f o r 50% 
i n h i b i t i o n of b inding to nat ive DNA was approximately 
0 .2 ug/ml, f o r each of the ant ibodies te s ted . These data 
ind icate that SLE autoant ibodies showed a 2 . 5 - 5 0 f o l d 
preference f o r modif ied DNA over double stranded nat ive 
DNA. 
3.10.3. Preferential binding of human anti-DNA 
autoantibodies to modified DNA fragments 
I n o rde r to determine the a n t i g e n i c i t y of 
hydroxy l rad ica l modif ied DNA fragments (300 bp), the 
b inding of anti-DNA antibody p o s i t i v e and negative sera 
to ROS-DNA was measured by d i r e c t b i n d i n g E L I S A 
( F i g u r e 4 4 ) . Se ra f rom ten S L E p a t i e n t s showed h i g h 
b inding to modif ied polymer, wh i le s i g n i f i c a n t l y lower 
b i n d i n g was observed a g a i n s t n a t i v e DNA f r a g m e n t s . 
F i g u r e 45 shows that modi f icat ion of double stranded DNA 
w i t h hydrogen peroxide i n presence of UV l i g h t , induced a 
s i g n i f i c a n t i n c r e a s e i n serum b i n d i n g f rom a mean 
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TABLE 11 
Human Anti-DNA Autoantibody B ind ing to Nat ive and ROS-DNA 
T E S T ANTIGENS Percent 
PATIENT Reduced B ind ing 
NATIVE DNA ROS-DNA w i t h nDNA 
1. 0 .740 1.062 30.3 
2. 0.698 0.989 30 .0 
3. 0.684 0.949 27.9 
4. 0.628 0.884 28 .9 
5. 0 .576 0.826 30.2 
6. 0 .820 0 .819 
7. 0 . 5 2 1 0 . 7 3 1 28.7 
8. 0 . 4 5 1 0.673 32 .9 
9. 0.394 0.568 30.6 
10. 0.368 0.525 29.9 
The t e s t ant igens (2 .5 ug/ml) were bound to po ly s ty rene p la tes 
and then incubated w i t h 1:100 d i l u t i o n of each serum. The values 
represent absorbance measurement at 410 nm. 
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COMPETITOR CONCENTRATION ( j u g / m l ) 
F igure 4 3 . I n h i b i t i o n of anti-DNA an t ibody b i n d i n g by na t ive 
( ), (-*-), ( -O- ) and ROS ( -A- ), (-X-) 
DNA. The p la tes were coated vs?ith na t ivg DNA (2.5 ug/tnl) 
and al l the th ree an t ibodies were from SLE s e r a . 
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TABT.K 12 
I n h i b i t i o n of B ind ing of ST.E Autoant ibodies by Nat ive and ROS-DNA 
PATIENT 
INHIB ITORS 
Nat ive DNA ROS -DNA 
1. 2.0^ (60)b 0.20^ (74)^ 
2 . 5 .0 (53) 0. 10 (76) 
3 . 10. 0 (50) 0 .20 (72) 
4 . 5 ,0 (55) 0 .20 (75) 
5. 0 .5 (70) 0. 15 (70) 
6. 4 . 0 (60) 0. 15 (72) 
7 . 2 . 0 (58) 0. 12 (68) 
8 . 5 .0 (52) 0 .20 (71 .5) 
9. 7 .5 (54 .5 ) 0 .20 (65 .0) 
10. 5 .0 (58) 0. 10 (71 .0) 
a) Amount o f compet i to r r e q u i r e d to i n h i b i t 50% o f r e a c t i o n 
(ug/ml) 
b) Percentage inhibition at the maximal concentration of 
competitor (10 ug/ml) 
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F igure 44. Binding of anti-DNA ant ibodies to na t i ve ( - X - ) , ( - •X- - ) , 
( - A - ) and modified ( ) , ( - O ) , ( - A - ) DNA 
f ragmen t s of 300 bp. Antibody nega t ive control ( - O - ) . 
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Figure 45. Direct b i n d i n g of SLE serum an t ibod ies to na t i ve ( 
and ROS-modifled ( C3 ) DNA of 300 b p . Normal human 
serum with e i t he r of the an t igens ( GIS3 ) . 
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absorbance of 0 .68 f o r nat ive DNA to a mean of 0 .96 f o r 
ROS-DNA, represent ing a 30% increase. Of the ten p a t i e n t s 
s tud ied, only i n one sample the serum binding remained 
unchanged. As c o n t r o l , 20 normal human sera f a i l e d to 
bind nat ive and ROS-DNA. 
3 . 1 0 . 4 . B ind ing s p e c i f i c i t y of SLE autoant ibodies 
The s p e c i f i c i t y of each SLE sera f o r modif ied and 
nat ive DNA fragments was next evaluated i n i n h i b i t i o n 
as says . I n t h i s t e s t , the antibody was f i r s t incubated 
w i t h the p u t a t i v e i n h i b i t o r s and then assayed f o r 
r e s i d u a l b inding to double stranded DNA. F i g u r e 46 shows 
the r e s u l t i n g i n h i b i t i o n curves i n which e i t h e r nat ive or 
ROS-DNA was used as compet i to r of the b i n d i n g of 
autoant ibodies . I n a l l cases ROS-DNA competed bet te r 
than double stranded nat ive fragments. I n 10 SLE sera the 
i n h i b i t i o n i n antibody b inding was more than 70% by ROS-
DNA fragments. By comparison, b inding of SLE sera were 
blocked by l e s s than 60% by nat ive DNA fragments. For 
on ly one serum nat ive DNA i n h i b i t e d b inding by > 60%. 
M o d i f i e d f ragments caused 50% i n h i b i t i o n i n ant ibody 
b i n d i n g at a c o n c e n t r a t i o n o f a p p r o x i m a t e l y 0 . 5 to 
1 . 0 ug/ml . I n case of n a t i v e f ragments c o n s i d e r a b l y 
h igher concentrat ions were requ i red f o r s i m i l a r l e v e l of 
competi t ion. Representat ive examples of these s t u d i e s are 
summarized i n Table 13. 
3 . 1 0 . 5 . E f f e c t of DNA s i z e on antibody b ind ing 
DNA f ragments of i n c r e a s i n g cha in l e n g t h 
(50-800 bp) were used to determine the e f f e c t of polymer 
s i z e on anti-DNA antibody b ind ing. The SLE ant ibod ies , as 
determined by i n h i b i t i o n exper iments, showed a preference 
f o r ROS-DNA fragments as compared to nat ive fragments. 
There were marked increases i n antibody e f f i c i e n c y as 
fragment s i z e increased from an average of 50 bp to 
800 bp. The s m a l l e s t react ive fragments were between 
50-70 bp i n length. The preincubat ion of 10 ug/ml of the 
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F igure I n h i b i t i o n of anti-DNA ant ibody b i n d i n g by na t ive ( t V J, 
( - O - ), ( -><•- j and modified ( ) , { - A - ) , 
DMA of 300 bp . The SLE an t ibod ies were i n c u b a t e d with 
va r ious concen t r a t ions of na t i ve and modified DNA for 2 
hr at room tempera tu re and o v e r n i g h t at and then 
tes ted for r e s idua ] b ind ing to na t ive DNA. 
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TABLE 11 
Competitive Inhibition of Naturally Occurring SLE Autoantibodies 
by Native and ROS-DNA of 3 00 bp 
SLE Serum 
Amount of Polymer (ug/ml) 
50% I n h i b i t i o n ^ 
Producing 
Native DNA^ Modif ied DNA^ 
1. 4 .0 0 .5 
2 . 7 . 0 0 .5 
3 . 7 . 0 0 .6 
4 . 5 .0 0 .7 
5. 7 . 5 0 .7 
6. 8 .5 0 .8 
7. >10. 0 1 .0 
8. 7 .5 1 .0 
9. >10.0 1 .5 
10. 1 .6 1 .6 
a) Where 50% i n h i b i t i o n was not reached a s i g n i s employed 
fo l lowed by the h ighes t amount of i n h i b i t o r tes ted 
b) The s i z e of nuc le ic acid was 300 bp 
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fragments w i th SLE ant ibodies i n h i b i t e d the b inding of 
nat ive DNA by 50-55%. S i m i l a r concentrat ion of nat ive 
f ragments of 5 0 - 7 0 bp showed an i n h i b i t i o n o f 30%. 
M o d i f i e d DNA f ragments o f 200 -300 bp were much more 
e f f e c t i v e c o m p e t i t o r s i n h i b i t i n g the b i n d i n g o f 
autoant ibodies by 70-72% at an i n h i b i t o r concentrat ion of 
10 ug/ml. I n c o n t r a s t , nat ive DNA fragments of s i m i l a r 
chain length i n h i b i t e d the binding by 50-60%. I n h i b i t i o n 
obtained w i th modif ied fragments of 600-800 bp was 78% at 
10 ug/ml , w h i l e s i m i l a r c o n c e n t r a t i o n s o f n a t i v e 
fragments i n h i b i t e d 60% of antibody b ind ing. Fragments of 
<50 bp i n length produced no i n h i b i t i o n of the nat ive DNA 
b i n d i n g o f the a u t o a n t i b o d i e s at the c o n c e n t r a t i o n 
tes ted. Table 14 summarizes the r e s u l t s of competit ive 
immunoassay of S L E serum w i t h n a t i v e and m o d i f i e d 
fragments of inc reas ing chain length. 
3.10.6. Formation and quantitation of immune complexes 
SLE serum was f ract ionated by ammonium su lphate 
p r e c i p i t a t i o n and chromatographed on DEAE Sephacel 
( F igu re 47 ) . Almost 80% of the IgG was e luted i n the 
f i r s t peak which contained no other serum c o n s t i t u e n t as 
shown by S D S - p o l y a c r y l a m i d e g e l e l e c t r o p h o r e s i s 
( F i g u r e 4 8 ) . Normal human serum was f r a c t i o n a t e d 
s i m i l a r l y . 
a 
SLE IgG was tes ted w i th nat ive and modif ied DNA by 
q u a n t i t a t i v e p r e c i p i t i n a n a l y s i s . I nc reas ing amounts of 
nat ive and modif ied DNA fragments were added to 100 ug 
SLE IgG. The amount of bound DNA and p r o t e i n i n immune 
complexes was determined c o l o r i m e t r i c a l l y . The b inding of 
SLE IgG to nat ive and ROS-DNA fragments i s shown i n 
F i g u r e 49 . The r e s u l t s i n d i c a t e t h a t as the curve 
approached cond i t ions of antigen excess , the amount of 
IgG t h a t was bound decreased c o n c o m i t a n t l y w i t h the 
decrease i n the amount of antigen bound. A maximum of 
18 ug/ml of modif ied fragment was bound by 46 ug of IgG 
and h a l f maximal b i n d i n g occur red when a p p r o x i m a t e l y 
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TABLE 14 
I n h i b i t i o n of ST.E 
of Vary ing S i z e 
Antibody B ind ing to Nat ive DNA by DNA Fragments 
S i z e of 
Competitor (bp) 
Percentage I n h i b i t i o n 
Nat ive DNA ROS-DNA 
Nat ive DNA 60 75 
800 58 76 
603 55 78 
300 65 72 
194 50 70 
120 60 72 
70 30 55 
50 30 50 
<50 N I L 20 
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F igure 47. I so l a t ion of IgG from an SLE p a t i e n t serum on DEAE 
Sephacel column. The bound IgG was e lu t ed by a p p l y i n g 
a l i n e a r g r a d i e n t of 0 .01 M - 0 .3 M phospha te b u f f e r , 
pH 8 .0 . ^ 
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Figure 48. SDS-polyacryl amide ge] e l ec t rophore t i c p a t t e r n of SLE 
IgG. The sample was ana lysed by e lec t rophores i s on 7 .51 
SDS-polyacryl amide gel . Proteins were v i sua l i zed by 
s t a i n i n g the gel with Coom ass ie Blue R 250. Lanes (2-5) 
r e p r e s e n t peak f r a c t i o n s (25-28) of DEAE Sephacel 
chrom atogram and l ane 1 r ep re sen t s s t a n d a r d protein 
m a r k e r . 
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Figure 49: Binding of SLE IgG to 300 bp nat ive ( ) and ROS-DNA 
{ - O - ). Amount of ant igen bound (A) and amount of 
antibody prec ip i ta ted (B). Normal human IgG was used 
as negat ive control with both ant igens ( ) , ( - 0 - ) . 
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15 ug of the antigen was added (F igu re 49 B ) . Wi th nat ive 
DNA fragments, at the point of maximum b ind ing, 13 ug of 
antigen was bound by 40 ug of IgG. The t o t a l input of IgG 
was 100 ug, i n d i c a t i n g t h a t a lmos t 40% o f IgG was 
s p e c i f i c f o r a n t i - d o u b l e s t randed DNA. C o n t r o l 
experiments were ca r r ied out w i t h normal human IgG. No 
s i g n i f i c a n t b inding was observed w i t h e i t h e r of the two 
ant igens ( F igu re 49) . 
The a f f i n i t y constants of SLE IgG against nat ive and 
ROS-DNA fragments were determined by Langmuir i sotherm 
p l o t as shown i n F igu re 50. The a f f i n i t y constant va lues , 
calculated as the r e c i p r o c a l s of the s lopes of the l i n e a r 
r e g r e s s i o n , are l i s t e d i n Table 15. The a f f i n i t y of SLE 
IgG f o r modif ied fragment was approximately 1.53 f o l d 
that of nat ive fragment. 
3 . 1 1 . Mod i f icat ion of L y s i n e Res idues 
I n order to i n v e s t i g a t e the c o n t r i b u t i o n of l y s i n e 
r e s i d u e s to the immunochemical r e a c t i v i t y of ant i -ROS DNA 
ant ibod ies , the f ree amino groups of l y s i n e r e s i d u e s were 
m o d i f i e d w i t h a c e t i c anhydr ide . D i f f e r e n t degrees o f 
mod i f icat ion were achieved by changing molar excess of 
acet ic anhydride over p r o t e i n (from 50 -1000) . The extent 
o f m o d i f i c a t i o n was determined by t r i n i t r o b e n z e n e 
su lphonic acid (Habeeb, 1966) and by n i n h y d r i n method 
(Moore and S t e i n , 1 9 5 4 ) . Absorbance v a l u e s f o r each 
modif ied (and nat ive) IgG were p lo t ted against p r o t e i n 
concentrat ion and are shown i n F igu re 51. The data were 
f i t t e d i n t o s t r a i g h t l i n e s by l e a s t square a n a l y s i s 
method and the s l o p e s of the l i n e s were used f o r 
c a l c u l a t i n g the extent of modi f icat ion by f i t t i n g these 
va lues i n equation: 
% modi f icat ion = (1 - m'/ii^) x 100 
Where m' and m represent the s lopes of the s t r a i g h t l i n e s 
f o r modif ied and unmodified preparat ions r e s p e c t i v e l y . 
132 
[Ag] UNBOUND 
Figure 50: Eva lua t ion of a f f i n i t y constrants of human anli-DNA 
autoantribodies by Langmuir isotherm plo t . Antigens were 
na t ive DNA ( - O - ) and ROS-DNA ( ). 
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TABLE 15 
A f f i n i t y Constants of Human Anti-DNA Autoant ibodies 
ANTIGEN 
ANTIBODY A F F I N I T Y 
SLE IgG Normal Human IgG 
Nat ive DNA 
Modif ied DNA 
4.07 X 10 ® M 
6.26 X 10"® M 
0 
0 
The a f f i n i t y constant was determined by q u a n t i t a t i v e p r e c i p i t i n 
t i t r a t i o n . The s i z e of DNA was 300 bp and the data expressed as 
the molar concentrat ion of ant igens tes ted. 
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Figure 51. Plots for 
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A progressive increase in percent modification was 
observed with increased molar excess of acetic anhydride 
(Figure 52) . The initial increase in modification was 
slow upto 200 molar excess, followed by a pronounced 
increase on further acetylation with 1000 molar excess. 
The maximum extent of modification achieved was 74%. 
These results are presented in Table 16. 
3.12. Effect of Lysine Modification on the Binding of 
Anti-ROS DNA Antibodies 
The ability of acetylated IgG to react with 
hydroxyl radical modified DNA was investigated by direct 
binding ELISA. Figure 53 shows that the activity of 
modified antibody protein decreased slowly, followed by a 
significant decrease with increase in percent 
modification. With 10% modified lysine residues, there 
was no loss in antibody binding. However, after 
acetylation of 55% and 65% of lysine residues, fairly 
considerable changes in antibody binding were observed as 
reflected by a decrease in absorbance at 410 nm to the 
extent of 30-40% respectively. Acetylation of 74% of 
lysine residues resulted in approximately 50% loss of 
antibody binding. Table 17 gives the summarized data on 
the percent decrease in antibody binding as a consequence 
of lysine modification. 
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TABLE 11 
Chemical Modification of Lysine Residues of anti-ROS DNA IgG 
Acetic Anhydride Percent 
Concentration (M) Modification* 
50** 10 
100 28 
200 45 
400 54 
600 66 
800 70 
1000 74 
Reaction Conditions: 40 minutes at 4°C, pH 7.4 to 7.6 
* Obtained by trinitrobenzene sulphonic acid method 
** Denotes molar excess of the reagent over protein 
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TABLE 11 
Effect of Lysyl Residue Modification on Anti-ROS DNA Antibody 
Binding 
Acetic Anhydride 
Concentration 
Percent 
Acetylated 
Lysine Residues 
Percent Decrease 
in Antibody 
Binding 
50 
100 
200 
400 
600 
800 
1000 
0 
10 
28 
45 
54 
66 
70 
74 
0 
0 
12.5 
20.2 
30 
40 
51 
50 
* Denotes molar excess of the reagent over protein 
The microtitre plates were coated with ROS-DNA (2.5 ug/ml) 
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4 D I S C U S S I O N 
Active oxygen species, the generation of which is 
triggered by a variety of chemical or biochemical 
mechanisms leading to monoelectronic reductions of ground 
state oxygen, as well as by physical agents (e.g. 
radiation ) or biological processes (e.g. inflammation) 
have been implicated as important causative agents in the 
pathogenesis of several human degenerative diseases 
(Ames, 1983; Cerutti, 1985; Marx, 1987; Vuillaume, 1987; 
Meneghini, 1988). In particular, their relevance in the 
induction and development of cancer is well documented, 
and the interplay between oxidative mechanisms and the 
host antioxidant system appears to affect multiple steps 
of carcinogenesis process (Hochstein and Atallah, 1988; 
Ames, 1986; Pryor, 1986). Among the reactive 
intermediates that may be generated under various types 
of oxidative stress, hydroxyl radicals are considered 
extremely dangerous species reacting with very high rate 
constants with a wide range of biological substances 
(Farhataziz and Ross, 1977; Pryor, 1988; Willson, 1979; 
Hutchinson, 1985). The hydroxyl radicals are formed in 
biological systems via ionizing radiation or through the 
Haber-Weiss or Fenton reactions (Fong et al., 1976; 
Czapski and Ilan, 1978; Mello-Filho and Meneghini, 1984). 
DNA of living cells is considered to be the 
principal target for reactive oxygen species and damage 
occurs at the site where the reduced metal bound to DNA 
reacts with hydrogen peroxide (Czapski, 1984; Que et al., 
1980; Gutteridge and Halliwell, 1982; Goldstein and 
Czapski, 1986; Marshall et al., 1981). Hydroxyl radical 
generated at the metal binding site may attack DNA at 
either the sugar or the base (Hutchinson, 1985; Schulte-
Frohlinde and Von Sonntag, 1985) ultimately leading to 
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DNA strand breaks. Such single stranded DNA breaks 
accumulate during exposure of bacteria and mammalian 
cells to hydrogen peroxide, superoxide radical, gamma 
radiation, or ozone (Ananthaswamy and Eisenstark, 1977; 
Mello-Filho and Meneghini, 1985; Birnboim and Kanabus-
Daminska, 1985; Seeberg and Steinum, 1980; Ward et al., 
1985; Hagansee and Moses, 1986). Near UV radiation and a 
variety of antitumor drugs also form single strand breaks 
in DNA (Dugue and Meunier, 1985; Ley et al., 1978). 
Hydrogen peroxide induced degradation of DNA in 
vitro and in vivo has been demonstrated by decrease in 
DNA viscosity (Massie et al., 1972), increase in both 
single strand (Massie et al. , 1972 ; Meneghini and 
Hoffmann, 1980; Lesko et al., 1980; Repine et al., 1981; 
Mello-Filho and Meneghini, 1984; Ward et al., 1985) and 
double strand DNA breaks (Massie et al., 1972), formation 
of ammonia and inorganic phosphate (Scholes and Weiss, 
1953) and base release (Rhaese and Freese, 1968) . In 
addition to these alterations within the sugar phosphate 
backbone of DNA, hydrogen peroxide or its reactive 
radical byproducts are reported to react with DNA bases 
resulting in the formation of altered bases (Lewis and 
Adams, 1985; Rhaese et al., 1968; Demple and Linn, 1982; 
Kasai and Nishimura, 1984). Apart from hydroxyl radical 
mediated direct DNA damage several indirect effects of 
extracellular hydrogen peroxide have been described 
(Hyslop et al., 1986; Schraufstatter et al., 1986 a,b). 
In the present study, the reaction of hydrogen 
peroxide with DNA in presence of UV radiation (254 nm) 
resulted both in single strand breakage and modification 
of DNA bases. The chemically predominant reaction was 
breakage of sugar phosphate backbone. The absorption of 
DNA increased at 260 nm during the reaction with hydrogen 
peroxide plus UV light (254 nm) at pH 7.4 when compared 
to its native double stranded DNA analog. Treatment of 
DNA with hydrogen peroxide or UV light alone did not 
result in any significant increase in absorption. The 
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observed hyperchromicity in ROS-DNA may be caused by the 
formation of single strand breaks in DNA. 
Thermal denaturation of treated DNA resulted in a 
considerable decrease in melting temperature (13°C) 
indicating the presence of single stranded regions in the 
modified DNA. Such breaks can be revealed when the 
hydrogen bonds holding the two strands together are 
disrupted by heating. The secondary structure of modified 
DNA was affected by a change in temperature from 40°C to 
90°C; .higher temperature favours progressive non-
cooperative unstacking of the bases in single stranded 
nucleic acids (Casperson and Voss, 1983). Thus the 
decrease in Tm in ROS-DNA was due to destabilization of 
the base stacking interactions. On the other hand, native 
DNA showed a Tm of 89°C which is typical of double 
helical calf thymus DNA. In this case, absorption at 260 
nm changed abruptly when a critical degree of 
denaturation was reached, suggesting a cooperative 
transition phenomenon. Treatment of DNA with hydrogen 
peroxide alone did not lead to any change in melting 
temperature. Comparison of Tm values for modified and 
native DNA leads to the conclusion that treatment of DNA 
with hydrogen peroxide plus UV light results in 
structural alterations of DNA which occur due to the 
simultaneous scission of the phosphodiester backbone and 
the generation of single stranded regions. The 
experimental observations on short DNA fragments of 300 
bp also indicate that changes in its structure precede 
strand separation. In this case too hydrogen peroxide and 
UV light treatment decreased the duplex melting 
temperature by almost 8°C relative to the fully paired 
parent duplex DNA of 300 bp. 
Thermodynamics of the interaction of hydrogen 
peroxide and UV radiation with DNA was also studied using 
thermal denaturation. Hydrogen peroxide and UV treatment 
decreased the thermodynamic stability of the duplex as 
evidenced from decrease in Tm and changes in A 
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values (Table 4). The positive change in free energy and 
its distribution over a wide range of temperature shows 
that energetically unfavourable structure is predominant 
in this modified polymer at relatively lower temperature 
(below 50°C). The opening of the helix as characterized 
by values is sluggish in between 40°C and 85°C, 
thereby suggesting that binding of hydrogen peroxide and 
UV light resulted in hydrogen bond breakage and loss in 
base stacking. In contrast, native DNA displayed a large 
negative value for AG,^®. The results speculate the 
tremendous stability exhibited by double helical native 
DNA. Disruption of the Watson-Crick base pairing between 
the two strands was evident above 85°C, which was 
inferred from the negative scale towards the positive 
side. The positive A Gq° values above 85°C suggest the 
sharp transition of double helical nucleic acid from 
native to denatured state. 
Changes in the physico-chemical characteristics of 
ROS-DNA as reflected through absorption spectroscopy and 
melting studies, were further observed by sedimentation 
density gradient method. The presence of single strand 
breaks in native DNA can be measured only after 
separation of the strands by denaturation. The DNA 
samples were irradiated in presence of hydrogen peroxide 
and treated with alkali before sedimentation. By 
comparing the sedimentation rate of the modified DNA with 
that of the control, included in parallel gradients, it 
was observed that hydrogen peroxide treatment has 
produced a decrease in molecular weight. The modified DNA 
sedimented with peak producing a broader distribution 
than did the unmodified DNA's. This broadening may be 
indicative of the single strand breaks in DNA produced by 
hydrogen peroxide in presence of UV light. These data are 
compatible with the chemical studies implicating hydroxyl 
radicals as mediators of strand breakage (Meneghini and 
Hoffmann, 1980; Hoffmann et al., 1984). The possible 
mechanism of hydrogen peroxide induced formation of DNA 
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lesions has been studied by Meneghini and co-workers in 
several mammalian cell lines (reviewed by Meneghini, 
1988). They found that reproductive cell killing by 
hydrogen peroxide correlated well with DNA strand break 
(as determined by alkaline sucrose gradient 
sedimentation), both of which could be inhibited by the 
addition of a strong iron chelating agent o-
phenanthroline. They proposed that the formation of 
hydrogen peroxide induced alkali labile site (including 
strand breaks) as well as sister chromatid exchanges are 
mediated by hydroxyl radical damage produced by the iron 
catalyzed Haber-Weiss reaction taking place in the 
nucleus, catalyzed by chromatin bound iron (Meneghini and 
Hoffmann, 1980; Mello-Filho and Meneghini, 1984; 
Larramendy et al., 1987; Imlay et al., 1988). 
The observed effects on the mobility of DNA under 
non-denaturing conditions may also suggest that a 
difference in the migration between native and modified 
DNA may be a consequence of hydrogen peroxide exposure. 
Electrophoresis under denaturing conditions showed severe 
degradation of DNA modified with hydroxyl radical 
compared to its corresponding control. The resulting 
electrophoretic patterns were characterized by fast 
(modified) and slow (native) moving components, possibly 
representing DNA breakage. Thus hydrogen peroxide in 
presence of UV light seems to affect the secondary 
structure of DNA. Previously it has been shown that 
incubation of supercoiled covalently closed circular DNA 
with hydrogen peroxide results in the formation of single 
strand breaks converting the supercoiled into open 
circular and eventually linear forms as demonstrated by 
neutral agarose gel electrophoresis (Tachon, 1989) . A 
similar observation has been made by Aiyar et al. (1990) 
upon addition of chromium to PBR322 DNA in presence of 
hydrogen peroxide and glutathione. 
Additional evidence for the structural alterations 
in native DNA as a result of hydrogen peroxide exposure 
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was revealed by analysing the fluorescence intensity 
profiles of DNA extracted from denaturing and non-
denaturing acrylamide gels. The modified samples were 
distributed in various fractions producing a broader peak 
in comparison to control samples, thereby suggesting that 
hydrogen peroxide has induced fragmentation in native DNA 
in presence of UV radiation. 
Several previous studies have demonstrated that 
various forms of DNA damage create structural distortion 
in DNA large enough to be recognized by single strand 
specific nucleases (Kato and Fraser, 1973; Shishido and 
Ando, 1974 ; Slor and Lev, 1973 ; Yamasaki et al., 1977). 
Over a wide range of concentrations of nuclease, complete 
digestion of single strand DNA was achieved with little 
effect on double stranded DNA (Cleaver et al., 1985). 
Present results with single stranded specific nuclease SI 
are consistent with these findings (Figure 16) . When 
native DNA complexed with hydrogen peroxide and exposed 
to UV light was subjected to nuclease SI digestion, the 
single stranded regions in double stranded DNA were 
selectively removed leaving small amounts of double 
stranded DNA. Thus hydroxyl radicals appeared to generate 
sufficient distortions in DNA to act as substrates for 
nuclease SI. Both native DNA and DNA-hydrogen peroxide 
complex (without UV exposure) were resistant to nuclease 
SI digestion. 
In addition to the alterations within sugar 
phosphate backbone, hydroxyl radical was also found to 
produce DNA base modifications. The ion exchange 
chromatography experiments with ROS-DNA revealed the 
formation of well defined products of thymine and 
adenine. These results are consistent with earlier 
observations that among the bases, the thymine moiety is 
the most susceptible to the modifying effects of hydroxyl 
radical (Hutchinson, 1985), while singlet oxygen is 
known to modify guanines predominantly (Friedmann and 
Brown, 1978; Cadet et al., 1983). In order to determine 
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the participation of bydroxyl radical in mediating 
alteration in thymine residue, the UV spectrum of the 
latter was compared to that of thymine dimer. The pattern 
of UV absorption spectra of the modified thymine product 
was clearly distinct from that obtained for thymine dimer 
(Setlow, 1961), thereby suggesting that hydroxyl radical 
and not the UV radiation was responsible for the damage. 
The reduced yields of hydrogen peroxide induced products 
to background levels in DNA in absence of UV light 
indicate that hydrogen peroxide alone has no measurable 
reactivity with DNA, in terms of base product 
modification. 
Antibodies against modified DNA were induced in both 
goat and rabbits by immunization with ROS-DNA and ROS-DNA 
of 300 bp complexed with methylated bovine serum albumin. 
The hydroxyl radical modified DNA was a particularly 
potent immunizing stimulus, inducing high titre 
antibodies. These results are consistent with the fact 
that antibodies to helical nucleic acids are generally 
sensitive to alterations in the sugar phosphate backbone 
(Lee et al., 1984 ; Sundquist et al,, 1987; Santella et 
al., 1985; Lafer et al., 1981 b). Moreover, native B-DNA 
is a poor immunogen (Stollar, 1986). Double stranded RNA, 
RNA-DNA hybrid, triple helical RNA and DNA analogues, and 
double helical polydeoxyribonucleotides that differ from 
average B-DNA structure have been found to be immunogenic 
(Stollar, 1973, 1975, 1986; Anderson et al., 1988). This 
conformational variance from the B-form appears to be a 
pre requisite for the induction of an antibody response, 
although the reason for this is unclear (Braun and Lee, 
1988) . 
Specificity of purified anti-ROS DNA IgG for 
antigenic determinants on modified DNA was assessed by 
direct and inhibition ELISA. In a direct assay, the 
antibodies demonstrated strong binding for ROS-DNA which 
was confirmed by inhibition ELISA indicating that the 
concentration of modified DNA required for 50% inhibition 
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of anti-ROS DNA antibody binding was 0.2 ug/ml. In 
addition to ROS-DNA, the immunogen, both the antibodies 
showed a considerable recognition of native DNA. This 
reactivity probably can be explained by the recognition 
of an antigenic determinant common to both modified and 
double stranded native DNA. Previous studies have shown 
that immunization with polynucleotides produce antibodies 
that cross react with native DNA (Lee et al., 1985). A 
monoclonal IgM antibody selective for native DNA was 
obtained by Huang et al. (1985) from a mouse that was 
immunized with DNA and several different synthetic DNA 
analogues. Immunization with cardiolipin can produce 
anti-DNA antibodies in both rabbits and mice (Guarnieri 
and Eisner, 1974 ; Rauch et al , , 1984). It has been 
suggested that phosphate-sugar-phosphate moiety of 
cardiolipin mimics the backbone of DNA, thus explaining 
the cross reactivity of antibodies to both antigens 
(Rauch et al., 1984). Jacob and colleagues (1982 and 
1985) have reported that antibodies induced in response 
to deoxyribonucleotide-protein conjugates gave a cross 
reaction with native DNA. 
The linear deoxyribose phosphate backbone was 
relatively unimportant to binding by immunized antibodies 
in that single stranded homopolymers such as poly(dT), 
poly(dG), poly(dC) and poly(dA) inhibited poorly. Total 
RNA from buffalo thymus also failed to inhibit modified 
DNA binding by induced antibodies, suggesting that the 
purine and pyrimidine bases did not play an important 
role in antibody-DNA interaction. However, competition 
ELISA with poly(rO).poly(dC), a polymer known to attain 
A-/analogous conformation, showed appreciable inhibition 
in antibody activity. The ability of ROS-DNA to induce 
some antibody that cross reacted with this polymer, 
indicate that some features of A-helix are present in 
this antigen in solution. Nucleic acid A-helices, such as 
poly(I).poly(C) (Guigues and Leng, 1976) and 
poly(A).poly(U) (Stollar, 1975) are immunogenic. It has 
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been reported that antibodies induced to A-helices do 
cross react with double stranded DNA (Guigues and Leng, 
1976) . Antibodies elicited by ROS-DNA had no reactivity 
towards brominated calf thymus DNA which has been shown 
to attain Z-/analogous conformation on bromination in 
high salt (Hasan and Ali, 1990). 
To further define the structural determinant 
recognized by the anti-ROS DNA antibodies, their 
interaction with various synthetic polynucleotides was 
studied. These compounds present a more limited set of 
determinants than natural DNA and can be used as probes 
for specificity analysis. The induced antibodies reacted 
efficiently with various synthetic polynucleotides as 
judged by the results of polynucleotide and immunized 
antibody inhibition studies (Figures 28, 29 and 38). 
Poly(dA-dT).poly(dA-dT) whose secondary structure is very 
similar to double stranded DNA (Arnott et al., 1974; 
Shindo and Zimmerman, 1980; Viswamitra et al., 1982) was 
a very potent inhibitor producing 50% inhibition at a 
concentration of 1.05 ug/ml. Poly(dG).poly(dC) was also 
an effective inhibitor of modified DNA binding than were 
either of its substituent single stranded homopolymers 
(poly(dG) and poly(dC)) alone. Poly(dG).poly(dC), in 
solution exhibits immunologic properties of both A- and 
B- forms in that (i) it is immunogenic and does not cross 
react with double stranded DNA (Stollar, 1975) and (ii) 
anti-double stranded DNA antibodies from human SLE sera 
may be inhibited by poly(dG).poly(dC) (Stollar and 
Papalian, 1980). Other helical double stranded 
polydeoxyribonucleotides such as poly(dG-dC).poly(dG-dC), 
poly(dA-dU).poly(dA-dU) and poly(dA-dG).poly(dC-dT) which 
are stable as B-DNA at low salt concentrations were also 
effective inhibitors of ROS-DNA binding producing a 50% 
inhibition at 5 ug/ml. However, 50% inhibition could not 
be achieved with poly(dl-dC).poly(dl-dC). 
The polyspecific behaviour of the induced antibodies 
in a way resembles the binding characteristics of SLE 
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anti-DNA autoantibodies. Analysis of binding data 
indicates that the various polynucleotides with which 
they react share a common antigenic determinant or 
epitope. The logical candidate for this shared epitope is 
a sugar-phosphate backbone that occurs in all 
polynucleotides. This conclusion appears to be consistent 
with the others who have suggested that the 
multispecificity of lupus autoantibodies can be explained 
by recognition of the sugar phosphate backbone of nucleic 
acids (Lafer et al., 1981 b; Shoenfeld et al., 1983 a; 
Rauch et al., 1985). Many monoclonal anti-DNA 
autoantibodies have been found to react with a number of 
seemingly unrelated antigens such as phospholipids 
(Shoenfeld et al., 1983 a; Rauch et al., 1984), vimentin 
(Andre-Schwartz et al., 1984), rheumatoid factor (Rubin 
et al., 1984), proteoglycon (Faaber et al., 1984) and 
cell surface proteins (Jacob et al., 1984). These cross-
reactions are likely to be due, in some cases, to the 
sharing of common epitopes such as the phosphodiester 
links (Lafer et al; 1981 b) . The binding diversity of 
lupus autoantibodies seems even greater when different 
nucleic acids and their modified preparations are used as 
test antigens (Ali et al., 1991; Alam and Ali, 1992; Ara 
et al., 1992; Ara and Ali, 1992; Alam et al., 1992). 
In order to facilitate the identification of the 
interaction between immunized antibodies with modified 
DNA antigens of short stretches (300 bp), gel retardation 
assay was used to separate protein free DNA from DNA-
protein complexes. These results revealed a high affinity 
of anti-ROS DNA antibodies to their antigen. Besides the 
ROS-modified antigen, a specific binding was observed to 
native DNA fragments. These results reiterate that 
induced antibodies react with antigenic determinants 
common to both forms of DNA. 
Chemical modification of different amino acid 
residues of proteins has successfully been used in 
studying their structure- function relationship (Cohen, 
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1970) . The role of amino acid residues in maintenance of 
three dimensional structure (Habeeb, 1971; Shio et al., 
1972), in ligand binding (Brodersen et al., 1977), in 
sequence analysis (Delange et al., 1969), in sensing 
buried and exposed groups (Glazer, 1976) and in the 
biological function of proteins (Shaw, 1970; Kaiser et 
al., 1985) have been investigated. Changes in biological 
activity after chemical modification may be taken as an 
evidence of direct involvement of the modified residue in 
catalytic function (Kaiser et al., 1985). 
The biological role of lysine residues in several 
enzymes has been demonstrated by chemical modification 
techniques. The disrupting influence of lysine 
modification depends on the folded stability and on how 
necessary the lysine residues are for the formation of 
ordered structures. The acetylation of anti-ROS DNA IgG 
was carried out to assess the role of lysine residues in 
the antigen binding characteristics of the protein. This 
substitution results in the elimination of positive 
charge of the ammonium group. A few important 
observations of considerable significance were: 
(i) Modification of 10% of lysine residues induced no 
detectable change in antibody binding. 
(ii) Further modification of the residues to the extent 
of 74% exhibited distinct but gradual change in 
antibody activity. 
Thus the modification of lysine residues paralleled 
loss in antibody activity to the extent of 50%, implying 
that such residues might be involved in the antigen 
binding site of the immunoglobulin molecule. However, 
almost 50% reactivity was retained as a result of 74% 
modification of lysine residues of IgG, thereby 
suggesting that not all the lysyl residues are involved 
in antigen binding. 
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Systemic lupus erythematosus (SLE) is a highly 
variegated and pleomorphic autoimmune disease 
(Andrzejewski et al., 1980). Although much is understood 
about the pathogenesis of SLE, the variable expression of 
disease among affected subjects has not been adequately 
explained. It is possible that common pathogenetic 
mechanisms may be uniquely expressed in different-
individuals. Alternatively, it is conceivable that SLE 
represents simply a clinical syndrome emerging from 
distinct types of immunopathological disturbances (Balow, 
1986) . A wide variety of antibodies are found in the 
serum of patients with SLE. Among those, and because of 
their clinical importance, the most extensively studied 
have undoubtedly been the antibodies directed against 
DNA, and it has become increasingly obvious that, with 
respect to several properties, these antibodies are 
extremely heterogeneous (Glass and Schur, 1977). Antigen 
binding specificity of anti-double stranded DNA 
antibodies has been studied primarily through cross 
reactions with various nucleic acids (Gilliam et al., 
1980; Stollar and Papalian, 1980; Andrzejewski et al., 
1981). Such antibodies may specifically bind only double 
stranded DNA or may cross react with single stranded DNA 
(Cohen et al., 1971; Casperson and Voss, 1980), or with 
synthetic helical polymers of DNA (Stollar, 1979). Anti-
double stranded DNA binding has been shown to be 
dependent on secondary DNA structure (Papalian et al., 
1980) . Recently it has been reported that DNA after 
exposure to ROS presents a more discriminating antigen 
than native DNA for the binding of SLE autoantibodies 
(Blount et al., 1989, 1990). 
In the present studies, anti-DNA antibodies from SLE 
sera showed appreciably enhanced binding to ROS-DNA than 
to corresponding untreated antigen. Of 12 SLE patients, 
10 possessed native and hydroxyl radical modified DNA 
reactive antibod ies. When DNA fragments of 300 bp were 
used as antigen, of the 10 anti-DNA antibody positive SLE 
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sera only one exhibited similar binding to both native 
and modified DNA. All the sera in this series showed an 
approximately 30% increase in mean absorbance value for 
ROS-DNA as compared to native DNA (Table 11). No antibody 
activity was found in a group of 20 normal human sera. 
Native DNA exposed to hydrogen peroxide or UV light alone 
did not show enhanced reactivity with SLE anti-DNA 
antibodies. 
To determine whether the antibodies analysed reacted 
preferentially with modified DNA, sera were preincubated 
with native and ROS-DNA before their addition to native 
DNA coated microtitre plates. These results indicate that 
the modified DNA displaying greater antigenicity by 
direct binding were also the most effective inhibitors, 
but quantitative discrepancy was observed with one 
sample, showing a significant difference in binding to 
ROS-DNA as compared to native DNA. ROS-DNA caused 50% 
inhibition in antibody binding at a concentration of 
approximately 0.5 to 1.0 ug/ml, whereas a wide range in 
the double stranded DNA concentration was required for 
similar level of competition. These observations 
therefore, indicate that DNA modified by hydrogen 
peroxide plus UV light serves as a better antigen for 
antibodies found in SLE sera than native DNA. It is known 
that treatment of double stranded DNA with the 
superoxide-generating system xanthine-xanthine oxidase 
transforms the DNA into an immunogenic state (Jansson, 
1985). Similarly, ROS appears to increase the 
antigenicity of DNA. 
The size of antigenic determinant recognized by the 
antibodies was assessed by analysis of reactivity with 
graded length of DNA fragments. It was found that SLE 
anti-native DNA antibodies can indeed bind relatively 
small helical fragments. Testing fractions of narrow size 
distribution, it was found that the smallest reactive 
fragments were 50-70 bp in length, causing 50-55% 
competition with SLE sera when present at a concentration 
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of 10 ug/ml. There was a transition to markedly increased 
reactivity with fractions between 200-300 bp in size. 
Previous reports have also shown SLE plasma DNA to be 
between 100 and 200 bp in size, largely double stranded 
but with single stranded regions and to contain 
nucleotide base sequences most or all of which are 
present in human genome (Steinman, 1984; McCoubrey-Hoyer 
et al., 1984 ; Rumore and Steinman, 1990). One of these 
reports describes a 300 bp species of DNA from sera of 
one SLE patient (Morimoto et al., 1982). In addition, the 
apparent antibody affinity on the basis of 50% inhibition 
in antibody binding (Table 14) showed that ROS-DNA 
fragments were manifold more efficient inhibitors than 
unmodified fragments. 
Studies on the specificity of antibodies have 
demonstrated that DNA itself was not always the most 
reactive antigen, even for antibodies that were 
originally identified in a screening assay employing 
native DNA (Tan, 1982; Stollar, 1989). The origin of 
these antibodies remains obscure although modified DNA 
appears to be a causative factor. According to recent 
concept on the origin of anti-DNA antibodies in SLE, 
these might have been formed as a result of some other 
antigen but not patients' own DNA. Modified DNA could be 
a plausible candidate for the origin of anti-DNA 
antibodies in SLE (Stollar, 1986; Zouali et al., 1988 b; 
Hasan et al., 1991). Further, it has been proposed that 
in chronic inflammatory diseases, potentially damaging 
free radicals released from activated phagocytic cells at 
the site of injury may penetrate cellular membranes and 
react with nuclear DNA (Stollar, 1981; Lunec et al., 
1987; Allan et al., 1988). It is therefore, possible that 
in SLE, chronic inflammation may generate sufficient 
reactive oxygen species to degrade DNA such that an 
immune response is induced and autoantibodies to a self 
antigen are produced. 
153 
5 R E F E R E N C E S 
Adouard, V., Dante, R,, Niveleau, A., Delain, E., 
Revet, B. and Ehrlich, M. (1985) Eur. J. Biochem. 
152, 115-121. 
Aiyar, J., Berkovits, H.J., Floyd, R.A. and Wetterhahn, 
K.E. (1990) Chem. Res. Toxicol. 3, 595-603. 
Alam, K. and Ali, R. (1992) Biochem. Int. 26, 597-605. 
Alam, K. , Islam, N. , Hasan, R. , Ali, A. and Ali, R. 
(1992) Microbiol. Immunol. 36, 1003-1007. 
Alcover, A., Izquierdo, M. , Stellar, B.D., Kitagawa, 
Y., Miranda, M. and Alonso, C. (1982) Chromosoma 87, 
263-277. 
Ali, A., Hasan, R. and Ali, R. (1991) Biochem. Int. 23, 
111-118. 
Ali, R., DerSimonian, H. and Stollar, B.D. (1985) Mol. 
Immunol. 22, 1415-1422. 
Ali, R. and Sauerbier, W. (1978) Biophys. J. 22, 393-
411. 
Allan, I.M., Vaughan, A.T.M., Milner, A.E., Lunec, J. 
and Bacon, P.A. (1988) Br. J. Cancer 58, 34-37. 
Ames, B.N. (1983) Science 221, 1256-1264. 
Ames, B.N. (1986) Carcinogenesis and anticarcino-
genesis. In: Antimutagenesis and anticarcinogenesis 
mechanisms (Shankel, D.M., Hartman, P.E., Kada, T. 
and Hollaender, A. Eds.) pp 7-35. Plenum press, New 
York 
Ames, B.N., Magaw, R. and Gold, L.S. (1987) Science 
236, 271-280. 
Ananthaswamy, H.N. and Eisenstark, A. (1977) 
J.Bacterid. 130, 187. 
Anderson, W.F., Cygler, M. , Braun, R.P. and Lee, J.S. 
(1988) Bio Essays 8, 69-74. 
Andre-Schwartz, J., Datta, S.K., Shoenfeld, Y., 
Isenberg, D.A., Stollar, B.D. and Schwartz, R.S. 
(1984) Clin. Immunol. Immunopathol. 31, 261-271. 
Andrzejewski, C. , Rauch, J., Lafer, E. , Stollar, B.D. 
and Schwartz, R.S. (1981) J. Immunol. 126, 226-231. 
154 
Andrzejewski, C. , Stollar, B.D., Lalor, T.M. and 
Schwartz, R.S. (1980) J. Immunol. 124, 1499-1502. 
Ansari, A.S., Khan, I.A. and Ali, R. (1985) J. Radiat. 
Res. 26, 321-329. 
Aotsuka, S., Okawa, M. , Ibeke, K. and Yakohari, R. 
(1979) J. Immunol. Methods 28, 149-162. 
Ara, J., Ali, A. and Ali, R. (1992) Immunol. Invest. 
21, 553-563. 
Ara, J. and Ali, R. (1992) Immunol. Lett. 34, 195-200. 
Arana, R. and Seligmann, M. (1967) J. Clin. Invest. 46, 
1867-1870. 
Armato, U., Andreis, P.G. and Romanano, F. (1984) 
Carcinogenesis 5, 1547-1555. 
Arnett, F.C. (1992) Clin. Immunol. Immunopathol. 63, 4-6, 
Arnett, F.C. and Moulds, J.M. (1991) Clin. Exp. Rheum. 
9, 289. 
Arnett, F.C. and Shulman, L.E. (1976) Medicine 55, 313. 
Arnott, S., Chandrasekaran, R., Hall, I.H. and 
Puigjaaner, L.C. (1983) Nucleic Acids Res. 11, 4141-
4151. 
Arnott, S., Chandrasekaran, R., Hukins, D.W.L., Smith, 
P.J. and Watts, L. (1974) J. Mol. Biol. 88, 523-533. 
Asano, T. , Furie, B.C. and Furie, B. (1985) Blood 66, 
1254-1260. 
Aust, S.D., Morehouse, L.A. and Thomas, C.E. (1985) J. 
Free Rad. Biol. Med. 1, 3-25. 
Baccala, R., Quang, T.V., Gilbert, M., Ternynck, T. and 
Avrameas, S. (1989) Proc. Natl. Acad. Sci. USA 86, 
4624-4628. 
Ballard, D.W. and Voss, E.W., Jr. (1982) Mol. Immunol. 
19, 793-799. 
Balow, J.E. (1986) Clinics Immunol. Allergy 6, 353-366. 
Barnett, E.V. (1979) J. Immunol. Methods 27, 1-8. 
Benovic, J., Tillman, T. , Cudd, A. and Fridovich, I. 
(1983) Arch. Biochem. Biophys. 221, 329-353. 
155 
Biaglow, J.E., Varnes, M.E., Epp, E.R. and Clark, E.P. 
(1987) The role of thiols in response to radiation 
and drugs. In: Anticarcinogenesis and radiation 
protection (Cerutti, P., Nygaard, O.F. and Simic, 
M.G. Eds.) pp. 387-397. Plenum press, New York 
Bias, W.B., Beaty, T.L.H., Meyers, D.A. and Arnett, 
F.C. (1986) Am. J. Hum. Genet. 39, 584-602. 
Birnboim, H.C. (1982) Can. J. Physiol. Pharmacol. 60, 
1359-1366. 
Birnboim, H.C. and Kanabus-DaminsKa, M. (1985) Proc. 
Natl. Acad. Sci. USA 82, 6820-6824. 
Blakely, W.F., Fuciarelli, A.F., Wegher, B.J. and 
Dizdaroglu, M. (1990) Radiat. Res. 121, 338-343. 
Blount, S., Griffiths, H.R,, Emery, P. and Lunec, J. 
(1990) Clin. Exp. Immunol. 81, 384-389. 
Blount, S., Griffiths, H.R. and Lunec, J. (1989) FEBS 
Lett. 245, 100-104. 
Bonfa, E., Marshak-Rothstein, A., Weissbach, H., Brot, 
N. and Elkon, K. (1988) J. Immunol. 140, 3434-3437. 
Borek, C. and Troll, W. (1983) Proc. Natl. Acad. Sci. 
USA 80, 1304-1307. 
Borg, D.C. and Schaich, K.M. (1984) Isr. J. Chem. 24, 
38-53. 
Bos, N.A., Meeuwsen, C.G., Van Wijngaarden, P.V. and 
Benner, R. (1989) Eur. J. Immunol. 19, 1817-1822. 
Boveris, A., Oshino, N. and Chance, B. (1972) Biochem. 
J. 128, 617-630. 
Bradley, M.O. and Erickson, L.C. (1981) Biochim. 
Biophys. Acta 654, 135-141. 
Braun, R.P. and Lee, J.S. (1988) J. Immunol. 141, 2084-
2089 . 
Braun, W.E. and Zachary, A. (1988) The HLA 
histocompatibility system in autoimmune states. In: 
Autoimmune diseases, clinics in laboratory medicine 
(Deodhar, S.D. Ed.) pp 351-372. Philadelphia: W.B. 
Saunders 
Brawn, M.K. and Fridovich, I. (1981) Arch. Biochem. 
Biophys. 206, 414-419. 
156 
Brodersen, R. , Sjodin, T. and Sjoholm, I. (1977) J. 
Biol. Chem. 252, 5067-5072. 
Budman, D.R., Merchant, E.B., Steinberg, A.D. et al 
(1977) Arth. Rheum. 20, 829-833; 
Busen, W. , Amabis, J.M., Leoncini, 0., Stollar, B.D. 
and Lara, F.J.S. (1982) Chromosoma 87, 247-262. 
Burton, K. (1956) Biochem. J. 62, 315-323. 
Buxton, G.V., Greenstock, C.L., Helman, W.P. and Ross, 
A.B. (1988) Phys. Chem. Ref. Data 17, 513-886. 
Cadet, J., Decarroz, C., Wang, S.Y. and Midden, W.R. 
(1983) Isr. J. Cheim. 23, 420-429. 
Cairns, E., Block, J. and Bell, D.A. (1984) J. Clin. 
Invest. 74, 880-887. 
Cairns, E., Kwong, P.C., Misener, V., Ip, P., Bell, 
D.A. and Siminovitch, K.A. (1989) J. Immunol. 143, 
685-691. 
Cantoni, 0., Murray, D. and Meyn, R.E. (1986) Biochim. 
Biophys. Acta 867, 135-143. 
Carlsson, J. and Carpenter, V.S. (1980) Ibid 142, 319. 
Carlsten, H., Tarakowski, A., Holmdahl, R. and Nilsson, 
L.A. (1990) Clin. Exp. Immunol. 80, 467-473. 
Carroll, P., Stafford, D., Schwartz, R.S. and Stollar, 
B.D. (1985) J. Immunol. 135, 1086-1090. 
Casali, P. and Notkins, A.L. (1989) Ann. Rev. Immunol. 
7, 513-535. 
Casperson, G.F. and Voss, E.W., Jr. (1980) J. Immunol. 
Methods 36, 293-308. 
Casperson, G.F. and Voss, E.W., Jr. (1983) Mol . 
Immunol. 20, 573-580. 
Cerutti, P. (1985) Science 227, 375-381. 
Chapman, J.D. and Gillespie, C.J. (1981) Adv. Radiat. 
Biol. 9, 143. 
Chaudhuri, S., Bhattacharyya, N.P. and Bhattacharjee, 
S.D. (1992) J. Electron-Microsc-Tokyo, 41, 57-59. 
Chen, P.P., Robbins, D.L., Jirik, F.R., Kipps, T.J. and 
Carson, D.A. (1987) J. Exp. Med. 166, 1900-1905. 
157 
Chused, T.M., McCoy, K.L., Lai, R.B. et al.(1987) 
Concepts Immunopathol. 4, 129-143. 
Cleaver, J.E., Killpack, S. and Gruenert, D.C. (1985) 
Environ. Health perspect. 62, 127-134. 
Clough, J.D., Frank, S.A., Calabrese, L.H. (1980) Arth. 
Rheum. 23, 24-29. 
Cohen, L.A. (1970) In: The enzymes (Boyr, P.D. Ed.) 
Vol. 1, pp 147-211. Academic press, New York 
Cohen, S.A., Hughes, G.R.V., Noel, G.L. and Christian, 
C.L. (1971) Clin. Exp. Immunol. 8, 551-561, 
Counihan, K.A., Vertosic, F.T. and Kelly, R.H. (1991) 
Immunol. Invest. 20, 317-331. 
Cunliffe, D.A. and Cox, K.O. (1980) Nature 286, 720-
722 . 
Czapski, G. (1984) Isr. J. Chem. 24, 29-32. 
Czapski, G. and Goldstein, S. (1986) Free Rad. Res. 
Commun. 3, 157-161. 
Czapski, G. and Ilan, Y.A. (1978) Photochem. Photobiol. 
28, 651-653. 
Dardalhon, D. and Averbeck, D. (1988) Int. J. Radiat. 
Biol. 54, 1007-1020. 
Davidson, A., Shefner, R. , Livneh, A. and Diamond, B. 
(1987) Ann. Rev. Immunol. 5, 85-108. 
Davis, J.S., Godfrey, S.M. and Winfield, J.B. (1978) 
Arth. Rheum. 21, 17-22. 
Delange, R.T., Fambrough, D.M., Smith, E.L. and Bonner, 
J. (1969) J. Biol. Chem. 244, 319-334. 
Demple, B. and Linn, S. (1982) Nucleic Acids Res. 10, 
3781-3789. 
Deodhar, S.D. (1992) Clin. Biochem. 25, 181-185. 
DerSimonian, H. (1987) The structural basis of SLE 
anti-DNA autoantibodies, molecular analysis using 
human hybridomas. Thesis, Tufts University 
DerSimonian, H. , Long, A., Rubinstein, D. , Stollar, 
B.D. and Schwartz, R.S. (1990) Int. Rev. Immunol. 5, 
253-264. 
158 
DerSimonian, H., Schwartz, R.S., Barrett, K.J. and 
Stollar, B.D. (1987) J. Immunol. 139, 2496-2501. 
Diamond, B., Katz, J.B., Paul, E., Aranow, C., 
Lustgarten, D. and Scharff, M.D. (1992) Ann. Rev. 
Immunol. 10, 731-757. 
Diamond, B. and Solomon, G. (1983) Ann. N.Y. Acad. Sci. 
418, 379-385. 
Dickerson, R.E., Drew, H.R., Conner, B.N., Wing, R.M. , 
Fratini, A.V. and Kopka, M.L. (1982) Science 216, 
475-485. 
Diekmann, S. and Zarling, D.A. (1987) Nucleic Acids 
Res. 15, 6063-6074. 
Dighiero, G., Guilbert, B. and Avrameas, S. (1982) J. 
Immunol. 128, 2788-2797. 
Dighiero, G., Lymberi, P., Holmberg, D., Landquist, I., 
Coutinho, A. and Avrameas, S. (1985) J. Immunol. 
134, 765-771. 
Diguiseppi, J. and Fridovich, I. (1984) Grit. Rev. 
Toxicol. 12, 315-342. 
Dizsdaroglu, M. , Nackerdien, Z., Chao, B.C., Gajewski, 
E. and Roa, G. (1991) Arch. Biochem. Biophys. 285, 
388-390. 
Dizdaroglu, M. and Simic, M.G. (1981) Hydroxycyclohexa-
dienyl peroxy radicals. In: Oxygen and oxy-radicals in 
chemistry and biology (Rodgers, M.A.J, and Powers, E.L. 
Eds.) pp 619-621. Academic press. New york 
Dugue, B. and Meunier, B. (1985) Biochem. Biophys. Res. 
Commun. 133, 15-22. 
Dumont, F. and Monier, J.C. (1983) Clin. Immunol. 
Immunopathol, 29, 306-317. 
Dziarski, R, (1982) J. Immunol. 128, 1026-1030. 
Dziarski, R. (1988) Immunol. Today 9, 340-342. 
Ehrlich, M. , Ehrlich, K. and Mayo, J. (1975) Biochim. 
Biophys. Acta 395, 109-111. 
Eilat, D. (1982) Mol. Immunol. 19, 943-955. 
Eilat, D. (1986) Clin. Exp. Immunol. 65, 215-222. 
Eilat, D., Fischel, R. and Zlotnick, A. (1985) Eur. J. 
Immunol. 15, 368-375. 
159 
Einck, L, , Dibble, R. , Frado, L.Y. and Woodcock, C.L. 
(1982) Exp. Cell. Res. 139, 101-110. 
Eisenberg, R.A., Craven, S.Y., Warren, R.W. and Cohen, 
P.L. (1987) J. Clin. Invest. 80, 691-697. 
Estervig, D. and Wang, R.J. (1984) Photochem. 
Photobiol. 40, 333-336. 
Faaber, P., Capel, P.J.A., Rjike, G.P.M., Vierwinden, 
G., Van Der Putte, L.B.A. and Koene, R.A.P. (1984) 
Clin. Exp. Immunol. 55, 502-508. 
Farhataziz and Rodges, M.A.J. (Ed.) (1987) In: 
Radiation chemistry VCH, New York 
Farhataziz and Ross, A.B. (1977) Natl. Std. Ref, Data 
Ser. Natl. Bur. Stand. No. 59. 
Fauci, A.S., Steinberg, A.D., Haynes, B.F. and Whalen, 
G. (1978) J. Immunol. 121, 1473. 
Fenton, H.J.H. (1893) Proc. Chem. Soc. 9, 113. 
Fiorani, M. , Fumo, M. , Sestili, P., Cattabeni, F. and 
Cantoni, 0. (1990) Chem. Biol. Interact. 76, 129-
139 . 
Flaegstad, T., Fredriksen, K. , Dahl, B. , Traavik, T. 
and Rekvig, O.P. (1988) Proc. Natl. Acad. Sci. USA 
85, 8171-8175. 
Fong, K.L., McCay, P,B., Poyer, J.L., Misra, H.P. and 
Keele, R.B. (1976) Chem. Biol. Interact. 15, 77. 
Forman, H.J. and Boveris, A. (1982) Superoxide radical 
and hydrogen peroxide in mitochondria. In: Free 
radicals in biology (Pryor, W.A. Ed.) Vol. V, pp 65-
90. Academic press. New York 
Fournie, G.J., Lambert, P.H. and Miescher, P.A. (1974) 
J. Exp. Med. 140, 1189-1206. 
Frenkel, K. and Chrzan, K. (1987 a) Carcinogenesis 8, 
455-460. 
Frenkel, K. and Chrzan, K. (1987 b) Radiation like 
modification of DNA and H2O2 formation by activated 
human polymorphonuclear leukocytes (PMNs) In: 
Anticarcinogenesis and radiation protection 
(Cerutti, P., Nygaard, 0., Simic, M. Eds.) pp 97-
102. Plenum press, New York 
Frenkel, K. , Chrzan, K. , Troll, W. , Teebor, G.W. and 
Steinberg, J.J. (1986) Cancer Res. 46, 5533-5540. 
160 
Fridovich, I. (1978) Ann. Rev. Biochem. 4, 147-152. 
Friedmann, T. and Brown, D.M. (1978) Nucleic Acids Res. 
5, 615-622. 
Getzoff, E.D., Tainer, J.A., Weiner, P.K., Kollman, 
P.A., Richardson, J.S. and Richardson, J.C. (1983) 
Nature 306, 287-289. 
Gilkeson, G.S., Grudier, J.P., Karounos, D.G. and 
Pisetsky, D.S. (1989) J. Immunol. 142, 1482-1486. 
Gilliam, A.C., Lang, D. and Lo Spalluto, J.J. (1980) J. 
Immunol. 125, 874-885. 
Glass, D. and Schur, P.H. (1977) In: Autoimmunity: 
Genetic, Immunologic, virologic and clinical aspects 
(Talal, N. Ed.) Academic press. New York 
Glazer, A.N. (1976) In: The proteins (Neurath, H. Ed.) 
3rd edition, pp 1-103. Academic press. New York 
Goldstein, B.D. and Witz, G. (1990) Free Rad. Res. 
Commun. 11, 3-10. 
Goldstein, B.D., Witz, G., Amoruso, M., Stone, D.S. and 
Troll, W. (1981) Cancer Lett. 11, 257-262. 
Goldstein, R. and Arnett, F.C. (1987) Rheum. Dis. Clin. 
North. Am. 13, 487. 
Goldstein, S. and Czapski, G. (1984) Int. J. Radiat. 
Biol. 46, 725-729. 
Goldstein, S. and Czapski, G. (1986) J. Am. Chem. Soc. 
108, 2244-2250. 
Goodman, S.D. and Nash, H.A. (1989) Nature 341, 251-
254 . 
Gray, J.D., Lash, A., Bakke, A.C., Kitridou, R.C. and 
Horwitz, D.A. (1987) Clin. Exp. Immunol. 67, 556-
564 . 
Gregory, C.D., Dive, C. , Henderson, S., Smith, C.A., 
Williams, G.T., Gordon, J. and Rickinson, A.B. 
(1991) Nature 349, 612-614. 
Gruenewald, R. and Stollar, B.D. (1973) J. Immunol. 
Ill, 106-113. 
Guarnieri, M. and Eisner, D. (1974) Biochem. Biophys. 
Res. Commun. 58, 347-353. 
161 
Guerrero, I., Villasante, A., Corcer, V. and Pellicer, 
A. (1984) Science 225, 1159-1162. 
Guigues, M. and Leng, M. (1976) Eur. J. Biochem. 69, 
615-624. 
Guilbert, B. , Dighiero, G. and Avrameas, S. (1982) J. 
Immunol. 128, 2779-2787. 
Gupta, S.S. and Bhattachar jee, S.B. (1988) Int. J. 
Radiat. Biol. 53, 935-942. 
Gutteridge, J.M.C. (1986) Free Rad. Res. Commun. 1, 
173 . 
Gutteridge, J.M.C. (1988) In: Oxygen radicals and 
tissue injury, proceedings of an upjohn symposium 
(Halliwell, B. Ed.) p 9. Allen press, Lawrence, 
Kansas 
Gutteridge, J.M.C. and Halliwell, B. (1982) Biochem. 
Pharmacol. 31, 2801-2805. 
Habeeb, A.F.S.A. (1966) Anal. Biochem. 14, 328-335. 
Habeeb, A.F.S.A. (1971) In: Chemistry of cell interface 
(Brown, H.D. Ed.) Academic press. New York 
Haber, F. and Weiss, J. (1934) Proc. R. Soc. London 
Ser. A 147, 332-351. 
Hagansee, M.E. and Moses, R.E. (1986) J. Bacterid. 
168, 1059. 
Hagen, F.K., Zarling, D.A. and Jovin, T.M. (1985) EMBO 
J. 4, 837-844. 
Hahn, B.H. and Ebling, F.M. (1984) J. Immunol. 133, 
3015-3019. 
Hahn, B.H., Ebling, F., Freeman, S., Clevinger, B. and 
Davie, J. (1980) Arth. Rheum. 23, 942-945. 
Halliwell, B. (1978) FEBS Lett. 92, 321-326. 
Halliwell, B. (1987) FASEB J. 1, 358-364. 
Halliwell, B. and Gutteridge, J.M.C. (1984) Biochem. J. 
219, 1-14. 
Halliwell, B. and Gutteridge, J.M.C. (1985) Mol. 
Aspects Med. 8, 89. 
Halliwell, B. and Gutteridge, J.M.C. (1986) Arch. 
Biochem. Biophys. 246, 501-514. 
162 
Halliwell, B. and Gutteridge, J.M.C. (1988) Hum. 
Toxicol, 7, 7-13. 
Halliwell, B. and Gutteridge, J.M.C. (1989) In: Free 
radicals in biology and medicine. 2nd edition, 
Oxford University press (Clarendon) Oxford 
Halliwell, B. and Gutteridge, J.M.C. (1990) Methods 
Enzymol. 186, 1-85. 
Hanau, L.H., Santella, R.M., Grunberger, D, and 
Erlanger, B.F. (1984) J. Biol. Chem. 259, 173-178. 
Hannestad, K. (1969) Ann. N.Y. Acad. Sci. 168, 63-75. 
Hannestad, K. and Stollar, B.D. (1979) Nature 275, 671. 
Harkis, G.D., Hendrie, F. and Nuki, G. (1987) Clin. 
Immunol. Immunopathol. 44, 283-296. 
Hart, E.J. (1972) Radiat. Res. Rev. 3, 285-304. 
Hasan, R., Ali, A. and Ali, R. (1991) Biochim. Biophys. 
Acta 1073, 509-513. 
Hasan, R. and Ali, R. (1990) Biochem. Int. 20, 1077-
1088 . 
Hassan, H.M. and Fridovich, I. (1977) J. Biol. Chem. 
252, 7667-7672. 
Hayes, R.C., Petrutti, L.A., Huang, H. , Wallace, S.S. 
and LeClere, J.E, (1988) J. Mol. Biol. 201, 239-246. 
Hertzberg, R.P. and Dervan, P.B. (1984) Biochemistry 
23, 3934-3945. 
Hill, H.A.O. (1981) Philos, Trans. R. Soc. London Ser. 
B 294, 119-128. 
Hochberg, M.C. (1987) J. Rheumatol. 14, 867-869. 
Hochstein, P. and Atallah, A. (1988) Mut. Res. 202, 
363-375. 
Hoffmann, M.E., Mello-Filho, A.C. and Meneghini, R. 
(1984) Biochim. Biophys. Acta 781, 234-238. 
Hoffmann, M.E. and Meneghini, R. (1979 a) Photochem. 
Photobiol. 29, 299-303. 
Hoffmann, M.E. and Meneghini, R. (1979 b) Photochem. 
Photobiol. 30, 151-155. 
163 
Hoheisel, J.D. and Pohl, F.M. (1987) J. Mol. Biol. 193, 
447-464, 
Hoskins, J.A. and Davis, L.J. (1988) J. chromatography 
426, 155-161. 
Huang, C.M., Huang, H.J.S., Glembourlt, M. , Liu, C.P. 
and Cohen, S.N. (1985) In: Rapid detection and 
identification of infectious agents (Kingsbury, D.T. 
and Falkow, S. Eds.) pp 257-279. Academic press, 
Orlando 
Huang, Y.P., Perrin, L.H., Miescher, P.A. and Zubler, 
R.H. (1988) J. Immunol. 141, 827-833. 
Hughes, G.R.V. (1986) In: Copeman's textbook of the 
rheumatic diseases (Scott, T. Ed.) 6th edition, p 
1337. Churchill Livingstone 
Hutchinson, F. (1985) Prog. Nucleic Acid Res. Mol. 
Biol. 32, 115-154. 
Hyslop, P.A., Hinshaw, D.B., Schraufstatter, I.U., 
Sklar, L.A., Spragg, R.G. and Cochrane, C.G. (1986) 
J. Cell. Physiol. 129, 356-366. 
Imlay, J.A., Chin, S.M. and Linn, S. (1988) Science 
240, 640-642. 
Imlay, J.A. and Linn, S. (1986) J. Bacterid. 166, 519-
527 . 
Imlay, J.A. and Linn, S. (1988) Science 240, 1302-1309. 
Inman, R.D. (1978) Arth. Rheum. 21, 849-854. 
Isenberg, D.A. and Collins, C. (1985) J. Clin. Invest. 
76, 287-294. 
Isenberg, D.A., Shoenfeld, Y., Madaio, M.P., Rauch, J., 
Reichlin, M. , Stollar, B.D. and Schwartz, R.S. 
(1984) Lancet 2, 418-421. 
Isenberg, D.A., Shoenfeld, Y., Walport, M., Mackworth-
Young, C., Dudeney, C., Todd-Pokropek, A., Brill, S. 
and Weinberger, A. (1985) Arth. Rheum. 28, 999-1007. 
Ishaq, M. and Ali, R. (1984) Immunol. Commun. 13, 447-
455. 
Jacob, A. and Jacob, T.M. (1982) Nucleic Acids Res. 10, 
6273-6280. 
Jacob, A. and Jacob, T.M. (1985) FEBS Lett. 189, 81-84. 
164 
Jacob, L. , Lety, M.A., Louvard, D. and Bach, J.F. 
(1985) J. Clin. Invest. 75, 315-317. 
Jacob, L. , Tron, F., Bach, J.-F. and Louvard, D. (1984) 
Proc. Natl. Acad. Sci. USA 81, 3843-3845. 
Jansson, G. (1985) Free Rad. Res. Commun. 1, 119-122. 
Jasin, H.E. and Ziff, M. (1975) Arth. Rheum. 18, 219-
228 . 
Jerne, N.K. (1974) Ann. Immunol. (Inst. Pasteur) 125, 
373-389, 
Joenje, H. (1989) Mut. Res. 219, 193-208. 
Jones, D.P. (1985) The role of oxygen concentration in 
oxidative stress; hypoxic and hyperoxic models. In: 
Oxidative stress (Sies, H. Ed.) pp 151-195. Academic 
press, London 
Jovanovic, S.V. and Simic, M.G. (1986) J. Am. Chem. 
Soc. 108, 5968-5972. 
Jungers, P., Kuttenn, F. , Liote, F. , Pelissier, C., 
Athea, N. , Laurent, M.C., Viriot, J., Dougados, M. 
and Bach, F.J. (1985) Arth. Rheum. 28, 1243-1250. 
Kabat, E.A., Nickerson, K.G., Liao, J., Grossbard,. L., 
Osserman, E., Glickman, E., Chess, L. , Robbins, 
J.B., Schneerson, R. and Yang, Y. (1986) J. Exp. 
Med. 164, 642-654. 
Kaburaki, J. and Stollar, B.D. (1987) J. Immunol. 139, 
385-392. 
Kaiser, E.T., lawrence, D.S. and rokita, S.E. (1985) 
Anal. Rev. Biochem. 54, 565-595. 
Kalunian, K., Panosian-Sahakian, N., Ebling, F.M., 
Cohen, A.H., Louie, J.S., Kaine, J. and Hahn, B.H. 
(1989) Arth. Rheum. 32, 513-522. 
Karam, L.R. and Simic, M.G. (1988) Anal. Chem. 60, 
1117-1119 . 
Karam, L.R. and Simic, M.G. (1989) Environ. Health 
Perspect. 82, 185-190. 
Kardost, R.R.P., Billing, P.A. and Voss, E.W., Jr. 
(1982) Mol. Immunol. 19, 645-650. 
Karsten, V. and Wallenberger, A. (1972) Anal. Biochem. 
77, 464. 
165 
Kasai, H. and Nishimura, S, (1984) Nucleic Acids Res. 
12, 2137-2145. 
Kasturi, K.N., Mayer, R. , Bona, C.A., Scott, V.E. and 
Sidman, C.L. (1990) J. Immunol. 145, 2304-2311. 
Kato, A.C. and Fraser, M.J. (1973) Biochim. Biophys. 
Acta 312, 645-655. 
Keizer, H.G., Van Rijn, J., Pinedo, H.M. and Joenje, H. 
(1988) Cancer Res. 48, 4493-4497. 
Kennard, 0. (1983) In: Nucleic acids; The vectors of 
life (Pullman, B. and Jortner, J. Eds.) pp 33-48. 
Reidel Publishing Company, Dordrecht 
Kennedy, A.R., Troll, W. and Little, J.B. (1984) 
Carcinogenesis 5, 1213-1218. 
Kensler, T.W., Bush, D.M. and Kosumbo, W.J. (1983) 
Science 221, 75-77. 
Ketterer, B., Coles, B. and Meyer, D.J. (1983) Environ. 
Health perspect. 49, 59-69. 
Ketterer, B. and Meyer, D.J. (1989) Mut. Res. 214, 33-
40. 
Ketterer, B., Meyer, D.J. and Clark, A.G. (1988) 
Glutathione transferases. In: Glutathione 
conjugation (Sies, H. and Ketterer, B. Eds. ) pp 74-
135. Academic press. New York 
Kirkland, J.B. (1991) Biochim. Biophys. Acta 1092, 319-
325. 
Klein, S.M., Cohen, G. , Lieben, C.S. and Caderbaum, 
A.I. (1983) Arch. Biochem. Biophys. 223, 425-432. 
Klinman, D.M., Eisenberg, R.A. and Steinberg, A.D. 
(1990) J. Immunol. 144, 506-511. 
Koffler, D., Agnello, V. and Kunkel, H.G. (1971 a) Am. 
J. Pathol. 74, 109. 
Koffler, D.R., Carr, R. , Agnello, V., Thoburn, R. and 
Kunkel, H.G. (1971 b) J. Exp. Med. 134, 294-312. 
Koike, T. , Tomioka, H. and Kumagai, A. (1982) Clin. 
Exp. Immunol, 50, 298-302. 
Krieg, A.M., Gause, W.C., Gourley, M.F. and Steinberg, 
A.D. (1989) J. Immunol. 143, 2448-2451. 
166 
Krieg, A.M., Gourley, M.F. and Steinberg, A.D. (1991) 
J, Immunol. 146, 3002-3005. 
Krieg, A.M. and Steinberg, A.D. (1990) J. Clin. Invest. 
86, 809. 
Kubota, T., Akatsuka, T. and Kanai, Y. (1986) Immunol. 
Lett. 14, 53-58. 
Kuchino, Y., Mori, F., kasai, H., Inoue, H., Iwai, S., 
Miura, K. , Ohtsuka, E. and Nishiitiura, S. (1987) 
Nature 327, 77-79. 
Kumagai, S., Steinberg, A.D. and Green, I. (1981) J. 
Immunol. 127, 1643-1651. 
Lacour, P., Nahon-Merlin, E. and Michelson, M. (1973) 
Curr. Top. Microbiol. Immunol. 62, 1-39. 
Laemmli, U.K. (1970) Nature 227, 680-685. 
Lafer, E.M., Moller, A. , .,Nordheim, A., Stollar, B.D. 
and Rich, A. (1981 a) Proc. Natl. Acad. Sci. USA 78, 
3546-3550. 
Lafer, E.M., Rauch, J., Andrzejewski, C. Jr., Mudd, D., 
Furie, B., Furie, B. , Schwartz, R.S. and Stollar, 
B.D. (1981 b) J. Exp. Med. 153, 897-909. 
Lafer, E.M. and Stollar, B.D. (1984) J. Biomol. Struc. 
Dyn. 2, 487-494. 
Lafleur, M.V.M., Retel, J. and Loman, H. (1988) Rad. 
Phys. Chem. 32, 329-333. 
Lahita, R.G. (1992) Clin. Immunol. Immunopathol. 63, 
17-18. 
Lahita, R.G. and Kunkel, H.G. (1984) Arth. Rheum. 27, 
S65. 
Land, E.J., Simic, M.G. and Swallow, A.J. (1971) 
Biochim. Biophys. Acta 226, 239-240. 
Langmuir, I. (1918) J. Am. chem. Soc. 40, 1361. 
Larramendy, M. , Mello-Filho, A.C., Leme Martins, E.A. 
and Meneghini, R. (1987) Mut. Res. 178, 57-63. 
Laval, F. (1988) Mut. Res. 201, 73-79. 
Lee, J.S., Latimer, L.J,P. and Woodsworth, M.L. (1985) 
FEBS Lett. 190, 120-124. 
167 
Lee, J.S., Lewis, J.R., Morgan, A.R., Mosmann, T.R. and 
Singh, B. (1981) Nucleic Acids Res. 9, 1707-1721. 
Lee, J.S., Woodsworth, M.L. and Latimer, L.J.P. (1984) 
Biochemistry 23, 3277-3281. 
Lerner, E.A., Lerner, M.R., Janeway, C.A. Jr., Steitz, 
J.A. (1981) Proc. Natl. Acad. Sci. USA 78, 2737-
2741. 
Lesko, S.A., Drocourt, J.L. and Yang, S.U. (1982) 
Biochemistry 21, 5010-5015. 
Lesko, S.A., Lorentzen, R.J. and Ts'O, P.P. (1980) 
Biochemistry 19, 3023-3028. 
Levine, L. , Murakami, W.T., Van Vunakis, H. and 
Grossman, L. (1960) Proc. Natl. Acad. Sci. USA 46, 
1038-1043 , 
Lewis, J.G. and Adams, D.O. (1985) Cancer Res. 45, 
1270-1275. 
Lewis, R.M. (1974) Int. Rev. Exp. Pathol. 13, 55. 
Ley, R.D., Sedita, B.A. and Boye, E. (1978) Photochem. 
Photobiol. 27, 323-328. 
Logtenberg, T., Young, F.M., Van Es, J.H., Gmelig-
Meyling, F.H.J, and Alt, F.W. (1989) J. Exp. Med. 
170, 1347-1355. 
Lorentzen, R.J. and Ts'O, P.P. (1977) Biochemistry 16, 
1467-1473 . 
Loschen, G., Azzi, A., Richter, C. and Flohe, L. (1974) 
FEBS Lett. 42, 68-72. 
Lunec, J., Griffiths, H.R. and Blake, D.R. (1987) ISI 
Atlas Sci. 1, 45-58. 
Lymberi, P., Blancher, A., Calvas, P. and Avrameas, S. 
(1989) J, Autoimmunity 2, 283-295. 
Lymberi, P., Dighiero, G. , Ternynck, T. and Avrameas, 
S. (1985) Eur. J. Immunol. 15, 702-707. 
Madaio, M.P., Hodder, S., Schwartz, R.S. and Stollar, 
B.D. (1984) J. Immunol. 132, 872-876. 
Malfoy, B., Rousseau, N. and Leng, M. (1982) 
Biochemistry 21, 5463-5467. 
168 
Manheimer-Lory, A.J., Monestier, M. , Bellon, B. , Alt, 
F.W. and Bona, C.A. (1986) Proc. Natl. Acad. Sci. 
USA 83, 8293-8297. 
Manny, N. , Datta, S.K. and Schwartz, R.S. (1979) J. 
Immunol. 122, 1220-1227. 
Marion, T.N., Lawton, A.R. Ill, Klarney, J.F. and 
Briles, D.E. (1982) J. Immunol. 128, 668-674. 
Marshall, C.J., Vousden, K.H. and Philips, D.H. (1984) 
Nature 310, 586-589. 
Marshall, L.E., Graham, D.R., Reich, K.A. and Sigma, 
D.S. (1981) Biochemistry 20, 244-250. 
Martin, S.E. and Martin, W.J. (1975) Proc. Natl. Acad. 
Sci. USA 72, 1036-1040. 
Marx, J.L. (1987) Science 235, 529-531. 
Massie, H.R., Samis, H.V. and Baird, M.B. (1972) 
Biochim. Biophys. Acta 272, 539-548. 
Matsuo, N. and Ross, P.M. (1987) Biochemistry 26, 2001-
2009. 
Matthyssens, G. and Rabbitts, T.H. (1980) Proc.Natl. 
Acad. Sci, USA 77, 6561-6565. 
Maxam, A. and Gilbert, W. (1980) In: Methods in 
enzymology (Grossman, L. and Moldave, K. Ed.) Vol. 
65, p 499. Academic press. New York and London 
Mayus, J.L. and Pisetsky, D.S. (1985) Clin. Immunol. 
Immunopathol. 34, 3 66-378. 
McCord, J.M. and Day, E.D. (1978) FEBS Lett. 86, 139-
142. 
McCord, J.M. and Fridovich, I. (1968) J. Biol. Chem. 
243, 5753-5760. 
McCoubrey-Hoyer, A.T., Okarma, B. and Holman, H.R. 
(1984) Am. J. Med. 77, 23-34. 
Mello-Filho, A.C., Hoffmann, M.E. and Meneghini, R. 
(1984) Biochem. J. 218, 273-275. 
Mello-Filho, A.C. and Meneghini, R. (1984) Biochim. 
Biophys. Acta 781, 56-63. 
Mello-Filho, A.C. and Meneghini, R. (1985) Biochim. 
Biophys. Acta 847, 82-89. 
169 
Meneghini, R. (1988) Mut. Res. 195, 215-230, 
Meneghini, R. and Hoffmann, M.E. (1980) Biochim. 
Biophys. Acta 608, 167-173. 
Michell, B. (1984) Trends Biochem. Sci. 8, 117-118. 
Miller, F.D., Jorgenson, K.F., Winkfein, R.J., Van de 
Sande, J.H., Zarling, D.A., Stockton, J. and 
Rattner, J.B. (1983) J. Biomol. Struct. Dyn. 1, 611-
620. 
Miller, j.A., Dowd, P.M., Dudeney, C. and Isenberg, 
D.A. (1986) J. Roy. soc. Med. 79, 365-367. 
Miller, K.B. and Schwartz, R.S. (1982) Adv. Intern. 
Med. 27, 281-313. 
Misra, H.P. and Fridovich, I. (1976) Arch. Biochem. 
Biophys. 776, 577. 
Monestier, M., Manheimer-Lory, A., Bellon, B., Painter, 
C., Dang, H., Talal, N., Zanetti, M., Schwartz, 
R.J., Pisetsky, D., Kuppers, R., Rose, N., Brochier, 
J., Klareskog, L., Holmdahl, R., Erlanger, B. , Alt, 
F. and Bona, C. (1986) J. Clin. Invest. 78, 753-759. 
Moore, S. and Stein, W.H. (1954) J. Biol. Chem. 211, 
907-913. 
Moorhouse, C.P., Halliwell, B., Grootveld, W. and 
Gutteridge, J.M.C. (1985) Biochim. Biophys. Acta 
843, 265-268. 
Morgan, A., Isenberg, D.A., Naparstek, Y., Rauch, J., 
Duggan, D., Khiroya, R., Staines,N.A. and Schattner, 
A. (1985) Immunology 56, 393-400. 
Morimoto, C., Sano, H., Abe, T., Homma, M. and 
Steinberg, A.D. (1982) J. Immunol. 139, 1960-1965. 
Morimoto, C., Steinberg, A.D., Letvin, N.L., Hagen, M., 
Takeuchi, T. , Daley, J., Levine, H. and Schlossman, 
S.F. (1987) J. Clin. Invest. 79, 762-768. 
Muller, R. and Rajewsky, M.F. (1980) Cancer Res. 40, 
887-896. 
Nackerdien, Z., Kasprzak, K.S., Roa, G., Halliwell, B. 
and Dizdaroglu, M. (1991) Cancer Res. 51, 5837-5842. 
Nakamura, Y., Colburn, N.H. and Gindhart, T. (1985) 
Carcinogenesis 6, 229-235. 
170 
Naparstek, Y., Duggan, D., Schattner, A., Madaio, M.P., 
Stollar, B.D., Kabat, E.A. and Schwartz, R.S. (1985) 
J. Exp. Med. 161, 1525-1538. 
Neta, P., Dizdaroglu, M. and Simic, M.G. (1983) Isr. J. 
Chem. 24, 25-28. 
Ng, M.L., Pedersen, J.S., Toh, B.H. and Westaway, E.G. 
(1983) Arch. Virol. 78, 177-190. 
Nohl, H. and Jordan, W. (1986) Biochem. Biophys. Res. 
Commun. 138, 533-539. 
Nohl, H., Jordan, W. and Youngman, R. (1986) Adv. Free 
Rad. Biol. Med. 2, 211-279. 
Nordheim, A., Lafer, E.M., Peck, L.J., Wang, J.C., 
Stollar, B.D. and Rich, A. (1982) Cell 31, 309-318. 
Nordheim, A. and Rich, A. (1983) Nature 303, 674-679. 
O'Neil, P. (1983) Radiat. Res. 96, 198-210. 
Otwinowski, Z., Schevitz, R.W., Zhang, R.-G., Lawson, 
C.L., Joachimiak, A., Marmorstein, R.Q., Luisi, B.F. 
and Sigler, P.B. (1988) Nature 335, 321-329. 
Papalian, M. , Lafer, E., Wong, R. and Stollar, B.D. 
(1980) J. Clin. Invest. 65, 469-477. 
Parshad, R., Sanford, K.K., Jones, G.M. and Tarone, R. 
E. (1978) Proc. Natl. Acad. Sci. USA 75, 1830-1833. 
Pascual, V. and Capra, J.D. (1991) Adv. Immunol 49, 1-
74. 
Patel, G.V., Satam, M.N., Nadkarni, G.R. and Nadkarni, 
J.J. (1986) Cancer Immunol. Immunother. 23, 51-55. 
Patton, S.E., Rosen, G.M. and Rauckman, E.J. (1980) 
Mol. Pharmacol. 18, 588-593. 
Pechenaya, V.I. (1993) Biopolymers 33, 37-44. 
Peskin, A.V. and Shlyahova, L. (1986) FEBS Lett. 194, 
317-321. 
Philips, B.J., James, T.E.B., Anderson, D. (1984) Mut. 
Res. 126, 265-271. 
Pisetsky, D.S., Caster, S.A.(1982) Mol. Immunol. 19, 
645-650. 
Plescia, O. , Braun, W. and Palczuk, N. (1964) Proc. 
Natl. Acad. Sci. USA 52, 279-283. 
171 
Pohl, F., Thomae, R. and Dicapua, E. (1982) Nature 300, 
545-546. 
Poirier, m.C. (1981) j. Natl. Cane. Inst. 67, 515-519. 
Poncet, P. , Matthes, T. , Billecocq, A. and Dighiero, G. 
(1988) Mol. Immunol. 25, 981-989. 
Pryor, W . a . ( 1 9 8 6 ) cancer and free radicals. In: 
Antimutagenesis and anticarcinogenesis mechanisms 
(Shankel, D.M., Hartman, P.E., Kada, T. and 
Hollaender, A. Eds.) pp 45-59. Plenum press. New 
York 
Pryor, W.A. (1988) Ann. Rev. pnysiol. 48, 657-663. 
Que, B.G., Downey, K.M. and So, A.G. (1980) 
Biochemistry 19,^5987-5991. 
Rauch, J., Massicott, H. and Tannenbaum, H. (1985) J. 
Immunol. 134, 180-186. 
Rauch, J., Murphy, E. , Roths, J.B., Stollar, B.D. and 
Schwartz, R.S. (1982) J. Immunol. 129, 236-241. 
Rauch, J., Tannenbaum, H. , Stollar, B.D. and Schwartz, 
R.S. (1984) Eur. J. Immunol. 14, 529-534. 
Reininger, L. , Oilier, P., Poncet, P., Kaushik, A. and 
Jaton, J.C. (1987) J. Immunol. 138, 316-323. 
Repine, J.E., Pfenninger, O.W., Talmage, D.W., Berger, 
E.M. and Pettijohn, D.E. (1981) Proc. Natl. Acad. 
Sci. USA 78, 1001-1003. 
Rhaese, H.-J. and Freese, E. (1968) Biochim. Biophys. 
Acta 155, 476-490. 
Rhaese, H.-J., Freese, E. and Melzer, M.S. (1968) 
Biochim. Biophys. Acta 155, 491-504. 
Rich, A., Nordheim, A. and Wang, A.H.J. (1984) Ann. . 
Rev. Biochem. 53, 791-846. 
Riordan, J.F. and Vallee, B.L. (1972) Methods Enzymol. 
25, 500-506. 
Roti Roti, J.L. and Cerutti, P.A. (1974) Int. J. Rad. 
Biol. 25, 413-417. 
Roubinian, J.R., Talal, N. , Greenspan, J.S., Goodman, 
J.R. and Siiteri, P . k . ( 1 9 7 8 ) J. Exp. Med. 147, 
1 5 6 8 - 1 5 8 3 . 
172 
Roudier, J., Silverman, G.J., Chen, P.P., Carson, D.A. 
and Kipps, T.J. (1990) J. Immunol. 144, 1526-1530. 
Rubin, R.L., Balderas, R.S., Tan, E.M., Dixon, F.J. and 
Theofilopoulos, A.N. (1984) J. Exp. Med. 159, 1429-
1440. 
Rubin, R.L. and Carr, R.I. (1978) J. Immunol. 122, 
1604-1607. 
Rubin, R.L., Reimer, G., McNally, E.M., Nusinow, S.R., 
Searles, R.P. and Tan, E.M. (1986) Clin. Exp. 
Immunol. 63, 58-67. 
Rudkin, G.T. and Stellar, B.D. (1977) Nature 265, 472. 
Rumore, P.M. and Steinman, C.R. (1990) J. Clin. Invest. 
86, 69-74. 
Sage, E. (1993) Photochem. Photobiol. 57, 163-174. 
Samuni, A., Aronovitch, J., Gadinger, D. , Chevion, M. 
and Czapski, G. (1983) Eur. J. Biochem. 137, 119-
129. 
Sanderson, B.J.S. and Morley, A.A. (1986) Mut. Res. 
164, 347-351. 
Santella, R.M., Dharmaraja, N., Gasparro, F.P. and 
Edelson, R.L. (1985) Nucleic Acids Res. 13, 2533-
2545. 
Sanz, I., Casali, P., Thomas, J.W., Notkins, A.L. and 
Capra, J.D. (1989 a) J. Immunol. 142, 4054-4061. 
Sanz, I., Dang, H.Y., Takei, M. , Talal, N. and Capra, 
J.D. (1989 b) J. Immunol. 142, 883-887. 
Sasaki, T., Endo, F., Mikami, M., Sekiguchi, Y., Tada, 
K., Ohno, Y., Ishido, N. and Yoshinaga, K. (1984) J. 
Immunol. Methods 72, 157-165. 
Scholes, G. (1983) Br, J. Radiol. 56, 221-232. 
Scholes, G. and Weiss, J. (1953) Biochem. J. 53, 567-
578. 
Schraufstatter, I.U., Hyslop, P.A., Hinshaw, D.B., 
Spragg, R.G., Sklar, L.A. and Cochrane, C.G. (1986 
a) Proc. Natl. Acad. Sci. USA 83, 4908-4912. 
Schraufstatter, I.U., Hinshaw, D.B., Hyslop, P.A., 
Spragg, R.G. and Cochrane, C.G. (1986 b) J. Clin. 
Invest. 77, 1312-1320. 
173 
Schraufstatter, I.U., Hyslop, P.A., Jackson, J.H. and 
Cochrane, C.G. (1988) J. Clin. Invest. 82, 1040-
1050. 
Schroeder, H.W. Jr., Hillson, J.L. and Perlmutter, R.M. 
(1987) Science 238, 791-793. 
Schulte-Frohlinde, D. and Von Sonntag, C. (1985) In: 
Oxidative stress (Sies, H. Ed.) pp 11-4 0. Academic 
press. New York 
Schwartz, R.S. and Stollar, B.D. (1985) J. Clin. 
Invest. 75, 321-327. 
Sealey, P.G. and Southern, E.M. (1985) In: Gel 
electrophoresis of nucleic acids; a practical 
approach (Rickwood, D. and Haines, B.D. Ed.) pp 39-
79. IRL press, Oxford 
Seaman, E., Levine, L. and Van Vunakis, H. (1966) 
Biochemistry 5, 1216-1223. 
Seaman, E. , Van Vunakis, H. and Levine, L. (1972) J. 
Biol. Chem. 247, 5709-5715. 
Seeberg, E. and Steinum, A.L. (1980) J. Bacterid. 141, 
1424-1427. 
Setlow, R. (1961) Biochim. Biophys. Acta 49, 237. 
Shadley, J.D. and Wolff, S. (1987) Mutagenesis 2, 95-
96. 
Shaw, E. (1970) In: The enzymes (Boyr, P.D. Ed.) Vol. 
1, pp 91-14 6. Academic press. New York 
Shindo, H. and Zimmerman, S.B. (1980) Nature 283, 690-
691. 
Shio, D.D., Lumry, R. and Rajender, S. (1972) Eur. J. 
Biochem. 29, 377-385. 
Shishido, K. and Ando, T. (1974) Biochem. Biophys. Res. 
Commun. 59, 1380-1388. 
Shivakumar, S., Tsokos, G.C. and Datta, S.K. (1989) . 
J. Immunol. 143, 103-112. 
Shoenfeld, Y., Rauch, J., Massicotte, H. , Datta, S.K., 
Andre-Schwartz, J., Stollar, B.D.and Schwartz, R.S. 
(1983 a) N. Engl. J. Med. 308, 414-420. 
Shoenfeld, Y., Isenberg, D.A., Rauch, J., Madaio, M. , 
Stollar, B.D. and Schwartz, R.S. (1983 b) J. Exp. 
Med. 158, 718-730. 
174 
Siiteri, P.K., Jones, L.A., Roubinian, J.R. and Talal, 
N. (1980) J. Steroid. Biochem. 12, 425-432. 
Simic, M.G., Bergtold, D.S. and Karam, L.R. (1989) Mut. 
Res. 214, 3-12. 
Simic, M.G. and Jovanovic, S.V. (1986) Free radical 
mechanisms of DNA base damage. In: Mechanisms of DNA 
damage and repair (Simic, M.G., Grossman, L. and 
Upton, A.C. Eds.) pp 39-50. Plenum press. New York 
Simic, M.G., Taylor, K.A., Ward, J.F. and Von Sonntag, 
C. (Eds.) (1988) In: Oxygen radicals in biology and 
medicine. Plenum press. New York. 
Siminovitch, K.A., Misener, V., Kwong, P.C., Song, Q.-
L. and Chen, P.P. (1989) J. Clin. Invest. 84, 1675-
1678. 
Slaga, T.J., Klein-Szanto, A.J.P., Triplet, I.L., 
Yotti, L.P. and Trosko, J.E. (1981) Science 213, 
1023-1025. 
Slor, H. and Lev, T. (1973) Biochim. Biophys. Acta 312, 
637-644. 
Solanki, V., Yotti, L. , Logani, M.K. and Slaga, T.J. 
(1984) Carcinogenesis 5, 129-131. 
Solomon, G., Schiffenbauer, J., Keiser, H.D. and 
Diamond, B. (1983) Proc. Natl. Acad. Sci. USA 80, 
850-854. 
Souroujon, M. , White-Scharf, M.E., Andre-Schwartz, J., 
Gefter, M.L. and Schwartz, R.S. (1988) J. Immunol. 
140, 4173-4179. 
Spitz, D.R., Li, G.C., McCormick, M.L., Sun, Y. and 
Oberley, L.W. (1988) Radiat. Res. 114, 114-124. 
Steinberg, A.D. (1992) Clin. Immunol. Immunopathol. 63, 
19-22. 
Steinberg, A.D., Krieg, A.M., Gourley, M.F. and 
Klinman, D.M. (1990) Immunol. Rev. 118, 129. 
Steinberg, A.D., Melez, K.A., Raveche, E.S., Reeves, 
J.P., Boegel, W.A., Smathers, P.A., Taurog, J.D., 
Weinlein, L. and Duvic, M. (1979) Arth. Rheum. 22, 
1170-1176. 
Steinman, C.R. (1984) J. Clin. Invest. 73, 832-841. 
Stollar, B.D. (1970) Science 169, 609-611. 
Stollar, B.D. (1973) In: The antigens (Sela, M. Ed.) pp 
1-85. Academic press, New York 
Stollar, B.D. (1975) CRC Crit. Rev. Biochem. 3, 45-69. 
Stollar, B.D. (1979) Trends Biochem. Sci. 4, 5-7. 
Stollar, B.D. (1981) Clinics. Immunol. Allergy 1, 243-
260. 
Stollar, B.D. (1986) CRC Crit. Rev. Biochem. 20, 1-36. 
Stollar, B.D. (1989) Intern. Rev. Immunol. 5, 1-22. 
Stollar, B.D. (1991) Mol. Immunol. 28, 1399-1412. 
Stollar, B.D., Gavron, T., Mclnerney, T., Swartz, G.M. 
Jr., Wassef, N. and Alving, C.R. (1989) Mol. 
Immunol. 26, 73-79, 
Stollar, B.D., Levine, L. , Lehrer, H.I. and Vunakis, 
H.V. (1962) Proc. Natl. Acad. Sci. USA 48, 874-880. 
Stollar, B.D. and Papalian, M.J. (1980) J. Clin. 
Invest. 66, 210-219. 
Stollar, B.D. and Stollar, V. (1970) Virology 42, 276. 
Stollar, B.D. and Ward, M.J. (1970) J. Biol. Chem. 245, 
1261-1266. 
Strehler, B.L. (1986) Exp. Gerontol. 21, 283-319. 
Striebich, C.C., Micell, R.M., Schulze, D.H., Kelsoe, 
G. and Cerny, J. (1990) J. Immunol. 144, 1857-1865. 
Sundquist, W.I., Lippard, S.J. and Stollar, B.D. (1987) 
Proc. Natl. Acad. Sci. USA 84, 8225-8229. 
Swinehart, J.L., Lin, W.S. and Cerutti, P.A. (1974) 
Radiat. Res. 58, 166-175. 
Tachon, P. (1989) Free Rad. Res. Commun. 7, 1-10. 
Takei, M. , Dang, H. and Talal, N. (1987) Clin. Exp. 
Immunol. 70, 546-554. 
Takei, M., Dang, H., Wang, R.J. and Talal, N. (1988) J. 
Immunol. 140, 3108-3113. 
Talal, N. (1979) N. Eng. J. Med. 301, 838-839. 
Talal, N. (1981) La Ricerca Clin. Lab. 11, 101-108. 
Talal, N. (1989) Clin. Immunol. Immunopathol. 53, 1-3. 
176 
Talal, N. and Ahmad, A.S. (1987) Int. J. Immunotherapy 
3, 65-70. 
Tan, E.M. (1957) J. Clin. Invest. 46, 735-741. 
I 
Tan, E.M. (1982) Adv. Immunol. 33, 167-240. 
Tan, E.M. (1989) Adv. Immunol. 44, 93-151. 
Tan, E.M., Carr, R.I., Schur, P.H. and Kunkel, H.G. 
(1966) J. Clin. Invest. 45, 1732-1740. 
Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., 
McShane, D.J., Rothfield, N.F., Schaller, J.G., 
Talal, N. and Winchester, R.J. (1982) Arth. Rheum. 
25, 1271-1277. 
Tan, K.H., Meyer, D.J., coles, B. and Ketterer, B. 
(1986) FEBS Lett. 207, 231-233. 
Tan, K.H., Meyer, D.J.,Gillies, N. and Ketterer, B. 
(1988) Biochem. J. 254, 841-845. 
Teoule, R. and Cadet, J. (1978) Radiation induced 
degradation of the basic component in DNA and 
related substances-final products. In: Molecular 
biology, biochemistry and biophysics (Hutterman, J., 
Kohnlein, W,, Teoule, R. and Bertinchamps, A.J. 
Eds.) Vol. 27, pp 171-2 03. Berlin, Springer 
Ternynck, T. and Avrameas, S. (1986) Immunol. Rev. 94, 
99-112. 
Theofilopoulos, A.N. and Dixon, F.J. (1981) Immunol. 
Rev. 55, 179-216. 
Theof ilopoulos, A.N. and Dixon, F.J. (1982) Am. J. 
Pathol. 108, 319-365. 
Theofilopoulos, A.N. and Dixon, F.J. (1985) Adv. 
Immunol. 37, 269-390. 
Theof ilopoulos, A.N. and Dixon, F.J. (1986) In: 
Systemic lupus erythematosus (Lahita, R.G. Ed.) pp 
121-202. Wiley, New York 
Theofilopoulos, A.N. and Dixon, F.J. (1987) 
Experimental murine systemic lupus erythematosus. 
In: Systemic lupus erythematosus (Lahita, R.G. Ed.) 
pp 121-202. Churchill Livingstone, New York 
Theofilopoulos, A.N., Prud'homme, G.J., Foeser, T.M. 
and Dixon, F.J. (1983) Immunol. Today 4, 287-291. 
177 
Thomae, R. , Beck, S. and Pohl, F.M. (1983) Proc. Natl. 
Acad. Sci. USA 80, 5550-5553. 
Thomas, T.J., Baarsch, M.J. and Messner, R.P. (1988) 
Anal. Biochem. 168, 358-366. 
Tofigh, S. and Frenkel, K. (1989) Free Had. Biol. Med. 
7, 131-143. 
Travers, A.A. (1989) Ann. Rev. Biochem. 58, 427-452. 
Trepicchio, W. Jr., Maruya, A. and Barrett, K.J. (1987) 
J. Immunol. 139, 3139-3145. 
Tron, F., Charron, D., Bach, J.-F. and Talal, N. (1980) 
J. Immunol. 125, 2805-2809. 
Tron, F., Jacob, L. and Bach, J.F. (1983) Proc. Natl. 
Acad. Sci. USA 80, 6024-6027. 
Tron, F., Jacob, L., Lety, M.A. and Bach, J.F. (1982) 
Clin. Immunol. Immunopathol. 24, 351-360. 
Tsokos, G.C. (1992) Clin. Immunol. Immunopathol. 63, 7-
9. 
Tsokos, G.C. and Balow, J.E. (1984) Prog. Allergy 35, 
93-162. 
Viswamitra, M.A., Shakked, Z., Jones, P.O., Sheldrick, 
G.M., Salisbury, S.A. and Kennard, O. (1982) 
Biopolymers 21, 513-533. 
Von Sonntag, C. (1987) In: The chemical basis of 
radiation biology, Taylor and Frances, New York 
Vuillaume, M. (1987) Mut. Res. 186, 43-72. 
Wang, A.H.-J., Quigley, G. , Koplak, F.J., Crawford, 
J.L., Van Boom, J.H., Van der Marel, G. and Rich, A. 
(1979) Nature 282, 680-686. 
Wang, R.J., Ananthaswamy, H.N., Nixon, B.T., Hartman, 
P.S. and Eisenstark, A. (1980) Radiat. Res. 82, 269-
276. 
Ward, J.F., Blakely, W.F. and Joner, E.I. (1985) 
Radiat. Res. 103, 383-392. 
Watts, R.A., Ravirajan, C.T., Staines, N.A. and 
Isenberg, D.A. (1990) Immunology 69, 340-354. 
Weitzman, S.A., Weitberg, A.B., Clark, E.P. and 
Stossel, T.P. (1985) Science 227, 1231-1233. 
178 
Willson, R.L. (1979) In: Oxygen free radicals and 
tissue damage. Vol. 65, p 19. Ciba foundation 
symposium (new series). 
Yamasaki, H. , Pulkrabek, P., Grunberger, D. and 
Weinstein, I.B. (1977) Cancer Res. 37, 3756-3760. 
Yusa, T., Crapo, J.D. and Freeman, B.A. (1984) Biochira. 
Biophys. Acta 798, 167-174. 
Zarling, D.A., Arndt-Jovin, D.J., Robert-Nicoud, M. , 
Mcintosh, L.P., Thomae, R. and Jovin, T.M. (1984 a) 
J. Mol. Biol. 176, 369-415. 
Zarling, D.A., Arndt-Jovin, D.J., Mcintosh, L.P., 
Robert-Nicoud, M. and Jovin, T.M. (1984 b) J. 
Biomol. Struct. Dyn. 1, 1081-1107. 
Zimmerman, R. and Cerutti, P. (1984) Proc. Natl. Acad. 
Sci. USA 81, 2085-2087. 
Zouali, M. and Eyquem, A. (1984) Immunol. Lett. 7, 187-
190. 
Zouali, M. , Migliorini, P., Mackworth-Young, C.G. and 
Stollar, B.D. (1988 a) Eur. J. Immunol. 18, 923-927. 
Zouali, M., Stollar, B.D. and Schwartz, R.S. (1988 b) 
Immunol. Rev. 105, 137-159. 
179 
RESEARCH PAPERS PUBLISHED/COMMUNICATED 
1 . Ara, J., Ali, A. and Ali, R. (1992). Antibodies against 
free radical modified native DNA recognize B-
conformation. Immunol. Invest. 21, 553-563. 
2. Ara, J. and Ali, R. (1992) . Reactive oxygen species 
modified DNA fragments of varying size are preferred 
antigen for human anti-DNA autoantibodies. Immunol. 
Lett. 34, 195-200. 
3. Ara, J. and Ali, R. (1993). Assay of antinuclear 
antibodies by ELISA using nuclei as antigen. Eur. J. 
Clin. Cham. Clin. Biochem. 21, 000-000. 
4. Ara, J. and Ali, R. (1993) . Polynucleotide specificity 
of anti-ROS DNA antibodies. Clin. Exp. Immunol, 
(submitted after revision). 
5. Autoimmunity - A review. Jahan Ara and Rashid Ali 
(Communicated). 
RESEARCH PAPERS PRESENTED AT SCIENTIFIC MEETINGS 
1. Ara, J. and Ali, R. (1989). ELISA: As an alternative to 
FANA assay for antinuclear antibodies. Paper presented 
at XVI Annual Conference of Indian Immunology Society 
held at SEVAGRAM, October 12-14, 1989. 
2. Ara, J. and Ali, R. (1990). Antigenicity of free radical 
modified DNA. Paper presented at the XVII Annual 
Conference of Indian Immunology Society held in Lucknow, 
December 1-3, 1990. 
180 
